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iABSTRACT
Bioartificial Liver (BAL) is a term for medical devices designed to replace natural liver 
functions. The idea behind the use of artificial livers is to either externally support an 
injured liver to recovery or bridge a patient with a failing liver to transplantation. Central 
to all BAL systems is a bioreactor for culturing liver cells. The main function of this 
reactor is to provide a cell adhesion matrix and supply the necessary nutrient solution. A 
high cellular oxygen uptake rate combined with low solubility in aqueous media makes 
oxygen supply to the liver cells the most constraining factor in current reactor designs. 
Devices with parallel-plate channel geometry promise high efficiency for blood 
detoxification and liver metabolism. However, due to their specific flow regime oxygen 
depletion in the medium is a major problem in these devices.
This thesis explores a unique method of controlling and measuring dissolved oxygen 
in BAL cell-culture bioreactors and lab-on-a-chip devices. Testing is performed using 
simulations, prototype bioreactor devices and in-vitro measurement of dissolved oxygen. 
Several strategies developed to fabricate the bioreactors and integrate oxygen sensing are 
presented. Emphasis is placed on techniques that provide compatibility with commonly 
used microfabrication processes, while allowing for laterally-resolved measurement of 
oxygen in a re-usable, low-cost setup. 
The most significant contribution presented is the development and assessment of the 
tapered cell-culture bioreactor with integrated PS/PtOEPK oxygen sensor. The 
combination adopts a unique approach to oxygen control. Bioreactor shape is used to 
modulate the oxygen supplied to cells via the resulting shear-stress function. By linearly 
increasing the shear-stress oxygen concentration can be maintained constant over the 
length of the reactor. Using the integrated oxygen sensor, the resulting concentration 
profile can be monitored in real-time with high lateral resolution. The advantage of the 
device over existing techniques is that no additional oxygenation inside the reactor 
chamber is required to maintain a certain concentration profile and that oxygen 
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concentration can be mapped in-situ without having to introduce further chemicals into 
the perfusion medium.
This thesis presents a number of other contributions: a grayscale mask process, 
development of the PS/PtOEPK sensor patterning method and signal optimization 
regime, demonstration of the multi-stream flow application, an experimental setup for 
sensor calibration and a process to pattern cell-adhesion proteins simultaneously with the 
oxygen sensor, a multi-layer BAL prototype and the results of a brief experiment to test 
an approach using vertically aligned carbon nanotube bundles as fluidic conduits for bile 
drainage.
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Abbreviations used in this thesis are listed here for easy reference.
AHS Alginate-entrapped Hepatocyte Spheroid
ALF acute hepatic failure
AMC Academic Medical Center
BAL bio-artificial liver
BC boundary condition
BLSS Bioartificial Liver Support System
BMP bitmap
CCD charge-coupled device
CFD computational fluid dynamics
CNT carbon nanotubes
CSMHS Christchurch School of Medicine and Health Sciences
CV central vein
Da Damkohler number
DC direct current
DI deionized
DIC differential interference contrast
DMEM Dulbecco's Modified Eagle's Medium
DO dissolved oxygen
EBL electron beam lithography
ECM extra cellular matrix
FEM finite element method
FHF fulminant hepatic failure
FMB Flat Membrane Bioreactor
HA hepatic artery
HF hydrofluoric acid
HFS hollow fiber system
HMS Harvard Medical School
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HSC hepatic stellate cell
HV hepatic vein
IPA isopropyl alcohol
JPEG Joint Photographic Experts Group
LDLT living donor liver transplantation
LLS Lobule-like Structure Module
LOC lab on a chip
LSEC liver sinusoidal endothelial cells
LSS liver support system
MARS Molecular Absorbent and Recirculating System
MELS Modular Extracorporeal Liver Support
MIBK methyl isobutyl ketone
MW molecular weight
NIR near infrared
OLT orthotopic liver transplantation
OPTN Organ Procurement and Transplantation Network
OXY-HFB Oxygenating Hollow Fiber Bioreactor
PDF pressure driven flow
PDMS polydimethylsiloxane
Pe Peclet number
PE polyethylene
PEB post exposure bake
PMMA polymethyl methacrylate
PS polystyrene
PtOEPK platinum(II) octaethylporphyrinketone 
PUF Polyurethane Foam Module
PV portal vein
Re Reynolds number
RF radio frequency
RFB Radial Flow Bioreactor
RIE reactive ion etching
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ROI region of interest
RT room temperature
SEM scanning electron microscopy
SHF subfulminant hepatic failure
TPE thermoset polyester
UCLA University of California Los Angeles
US ultrasound
VACNT vertically aligned carbon nanotubes
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1The most exciting phrase to hear in 
science, the one that heralds new 
discoveries, is not 'Eureka!' (I 
found it!) but 'That's funny...’
Isaac Asimov 
1920-1992, Russian-born American 
Author and Professor in Biochemistry
CHAPTER 1  
Introduction
1.1   OVERVIEW AND OBJECTIVES
Oxygen concentration can modulate cellular functions and depletion of available 
dissolved oxygen can lead to cell death [1]. Oxygen is the substrate of multicellular life 
and cells have been found to be able to sense reduced oxygen availability (hypoxia), 
triggering homeostatic responses, which impact on virtually all areas of biology and 
medicine [2-4]. Gradients of oxygen concentration are considered to be one of the main 
parameters controlling metabolic and functional zonation in organs such as the liver [5]. 
Understanding of this phenomena and the ability to replicate it in-vitro are fundamental 
to the design of cell-culture bioreactors and microfluidic devices for cell-biology studies 
and in biomedical devices. However, to date, there has not been a great deal of focus on 
the control and measurement of oxygen concentration in microfluidics-based bioreactors. 
The work presented in this thesis is targeted towards bio-artificial liver (BAL) bioreactors 
for the treatment of liver diseases, which provide an additional challenge in form of the 
large oxygen consumption exhibited by hepatocytes. 
Existing parallel-plate bioreactors have great potential for ease of fabrication and 
system scale-up, however, these rectangular geometries suffer from oxygen depletion 
problems due to the nature of fluid flow at the micro-scale. Equally, existing oxygen 
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detection schemes are either difficult to integrate with these devices, do not provide 
spatially-resolved concentration information or require large amounts of expensive 
fluorescent dyes. Furthermore, as technology and understanding of biological processes 
improve, system scale-up becomes more feasible thereby increasing the importance of 
ease of integration.
The aim of the research presented here is to contribute to a better understanding of 
oxygen concentrations in microfluidic cell-culture bioreactors. This thesis describes the 
development, testing and evaluation of a novel toolbox to detect and control the 
distribution of dissolved oxygen in a microfluidic bioreactor, such as used in BAL 
systems. In particular, the goal is to provide the necessary means to evaluate the 
hypothesis of the effect of geometry on the oxygen concentration profile. 
1.2   THESIS CONTRIBUTIONS
The most significant contribution to the field made by this thesis is the tapered cell-culture 
bioreactor with integrated PS/PtOEPK oxygen sensor [6]. The combination adopts a 
novel approach to oxygen control and the results presented demonstrate that this method 
is feasible. The device has several advantages over existing systems, as are described. 
Other major contributions include:
1 The species transport model [7]. The modified version of Prof. Tim David’s model 
of platelet transport [8] is used to calculate the specific bioreactor shape corre-
sponding to a desired concentration profile. Computational fluid dynamics simula-
tions were performed, which validate the model predictions for dissolved 
oxygen [6].
2 The grayscale mask process [9]. A novel approach to reducing the turn-over time 
for prototype grayscale masks has been developed. Resulting devices complement 
the solutions of the 2D application of the species transport model.
1.2 Thesis Contributions
3
3 The PS/PtOEPK sensor patterning method and signal optimization [10]. This has 
been developed in order to allow for sensor integration with PDMS microfluidic 
devices and selectively localized cell-culture. It also has applications in areas other 
than bioreactors, particularly when highly homogeneous or spatially resolved sen-
sor response is required.
4 The multi-stream flow application [11]. A novel device has been fabricated for par-
allel high-throughput flow assays with in-built oxygen measurement in a single 
bioreactor. Controlling the oxygen concentration of individual streams improves 
the validity of cell-based experiments and allows to determine the coefficient of 
diffusion of oxygen in different perfusion media.
Other, more minor, contributions can be found throughout this thesis. These include 
innovations such as an experimental setup for sensor calibration and a process to pattern 
cell-adhesion proteins simultaneously with the oxygen sensor. Such developments are by 
no means unique; however, the approach taken may well be original and of benefit to 
others in the future. 
Also worthy of mention is the BAL prototype, a multi-layer PDMS device demonstrating 
the feasibility of device scale-up towards a clinically relevant bioreactor size.
Finally, the results of a brief experiment to test an approach using vertically aligned 
carbon nanotube bundles as fluidic conduits for bile drainage are reported. Results are 
promising, which makes this a strong candidate for future work. 
The following publications have resulted from this work:
•   V. Nock, R. J. Blaikie, and T. David, “Microfluidics for Bioartificial 
Livers”, New Zealand Medical Journal (2007), Vol. 120, No. 1252, pp. 
2-3.
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•   V. Nock, R. J. Blaikie, and T. David, “Micro-patterning of Polymer-based 
Optical Oxygen Sensors for Lab-on-Chip Applications”, Proceedings of 
SPIE (2007), Vol. 6799, DOI: 10.1117/12.759023.
•   V. Nock and R. J. Blaikie, “Fabrication of optical grayscale masks for 
tapered microfluidic devices”, Microelectronic Engineering (2008), Vol. 
85, No. 5-6, pp. 1077-1082.
•   V. Nock, R. J. Blaikie, and T. David, “Patterning, integration and 
characterisation of polymer optical oxygen sensors”, Lab on a Chip 
(2008), Vol. 8, No. 8, pp. 1300-1307, DOI: 10.1039/b801879k.
•   V. Nock, R. J. Blaikie, and T. David, “Generation and detection of laminar 
flow with laterally-varying oxygen concentration levels”, Proceedings of 
MicroTAS (2008), Vol. 1, pp. 299-301.
•   V. Nock, R. J. Blaikie, and T. David, “In-situ Optical Oxygen Sensing for 
Bioartificial Liver Bioreactors”, Proceedings of ICBME (2008), in press.
•   V. Nock, R. J. Blaikie, and T. David, “Oxygen Control For Bioreactors 
And In-vitro Cell Assays”, AIP Conference Proceedings, in 
preparation.
The work described in this thesis has also been presented in various forms:
•   Poster presentation, “Microfluidics for Bioartificial Livers”, MacDiarmid 
Institute Student Symposium (Wellington, NZ, October 2005).
•   Oral presentation, “Microfluidics for Bioartificial Livers”, MacDiarmid 
Institute Bionano-Network Meeting (Christchurch, NZ, January 2006).
•   Oral presentation, “Microfluidics for Bioartificial Livers”, German-New 
Zealand Workshop on Nanotechnology (Wellington, NZ, March 2006).
•   Oral presentation, “Microfluidics for Bioartificial Livers”, Health 
Research Society of Canterbury Scientific Meeting, University of 
Canterbury (Christchurch, NZ, March 2006).
•   Oral presentation, “Microfluidics for Bioartificial Livers”, Showcase 
2006, University of Canterbury Postgraduate Conference (Christchurch, 
NZ, October 2006), Audience Best Presentation Award.
•   Poster presentation, “Microfluidics for Bioartificial Livers”, Running Hot 
- Science in New Zealand Conference (Christchurch, NZ, November 
2006).
1.2 Thesis Contributions
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•   Poster presentation, “Bioartificial Livers - A Place in Therapy?”, 
MacDiarmid Institute Student Symposium (Christchurch, NZ, November 
2006).
•   Poster presentation, “Design and Fabrication of a Bioartificial Liver 
Bioreactor”, AMN-3 Satellite Meeting on Nano- and 
Bionano-Technology, Quantum Transport and Quantum Functional 
Semiconductors NBT-QT (Wellington, NZ, February 2007).
•   Oral presentation, “Microfluidics for Bioartificial Livers”, 3rd 
International Conference on Advanced Materials & Nanotechnology 
AMN-3 (Wellington, NZ, February 2007).
•   Poster presentation, “Electron Beam Lithography for the Fabrication of 
Grayscale Masks”, 3rd International Conference on Advanced Materials 
& Nanotechnology AMN-3 (Wellington, February 2007), Runner-up Best 
Student Poster Award.
•   Oral presentation, “Design and Fabrication of a Bioartificial Liver 
Bioreactor”, Durmont d’Urville Workshop on Microfluidics 
(Christchurch, NZ, April 2007).
•   Oral presentation, “Last Drinks Please! - An Update on Bioartificial Liver 
Research”, Showcase 2007, University of Canterbury Postgraduate 
Conference (Christchurch, NZ, August 2007), College of Engineering 
Best Presentation Award.
•   Oral presentation, “Plasma-Patterning of Fluorescence-based Oxygen 
Sensors”, 33rd International Conference on Micro-and 
Nano-Engineering MNE (Copenhagen, Denmark, September 2007).
•   Poster presentation, “Fabrication of Optical Grayscale Masks for Tapered 
Microfluidic Devices”, 33rd International Conference on Micro-and 
Nano-Engineering MNE (Copenhagen, Denmark, September 2007).
•   Poster presentation, “Optical Sensing of Dissolved Oxygen in Bioreactor 
Devices for Bioartificial Livers”, MacDiarmid Institute Student 
Symposium (Hamilton, NZ, November 2007).
•   Oral presentation, “Micro-patterning of Polymer-based Optical Oxygen 
Sensors for Lab-on-Chip Applications”, Microelectronics, MEMS, and 
Nanotechnology AU07 (Canberra, Australia, December 2007).
•   Oral presentation, “Integrated Optical Oxygen Sensors for PDMS-based 
Microfluidic Devices”, MacDiarmid Institute Bionano-Network Meeting 
(Christchurch, NZ, January 2008).
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•   Oral presentation, “From Electrons to Liquids - Using Semiconductor 
Technology to improve Biomedical Devices”, University of Canterbury 
NanoLab User Meeting (Christchurch, NZ, April 2008).
•   Oral presentation, “Microfluidics for Bioartificial Livers - How 
Semiconductor Technology can improve Biomedical Devices”, 
Departmental Seminar, Electrical and Computer Engineering, University 
of Canterbury (Christchurch, NZ, May 2008).
•   Oral presentation, “In-situ Oxygen Gradients for Cell-Culture 
Bioreactors”, Health Research Society of Canterbury Scientific Meeting, 
University of Otago, Christchurch School of Medicine & Health Sciences 
(Christchurch, NZ, September 2008).
•   Poster presentation, “Generation and detection of laminar flow with 
laterally varying oxygen concentration levels”, 12th International 
Conference on Miniaturized Systems for Chemistry and Life Sciences 
MicroTAS (San Diego, USA, October 2008).
•   Oral presentation, “Beyond Imaging: Applications of Fluorescence 
Microscopy”, MacDiarmid Institute Student Symposium (Wellington, NZ, 
November 2008).
•   Oral presentation, “In-situ Optical Oxygen Sensing for Bioartificial Liver 
Bioreactors”, 13th International Conference on Biomedical Engineering 
ICBME (Singapore, December 2008).
•   Accepted for oral presentation, “Graduated Oxygen Levels using Multiple 
Laminar Streams”, 4th International Conference on Advanced Materials 
& Nanotechnology AMN-4 (Dunedin, NZ, February 2009)
The work presented in this thesis has further been reported in the following non-peer 
reviewed forms:
•   “Polymer Optical Oxygen Sensor for Microfluidic Devices” in Technical 
Insights: Sensor Technology Alerts (July 2008), Frost&Sullivan.
•   Photography, “Prototype of a silicone multi-layer Bioartificial Liver 
Bioreactor”, University of Canterbury College of Engineering Research 
Photo Competition 2008 (Christchurch, NZ, November 2008), 3rd Prize.
In addition, the author has contributed to the following presentations and paper on work 
related to, but not directly relevant to this thesis:
1.3 Thesis structure
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•   V. Nock, A. Ghanbari, W. Wang, R. J. Blaikie, G. Chase, X. Chen, and C. 
Hann, “Force pattern characterization of C. elegans in motion”, 
Showcase 2008, University of Canterbury Postgraduate Conference 
(Christchurch, NZ, September 2008), oral presentation, College of 
Engineering Best Presentation Award.
•   A. Ghanbari, V. Nock, W. Wang, R. J. Blaikie, G. Chase, X. Chen, and C. 
Hann, “Force pattern characterization of C. elegans in motion”, 15th 
International Conference on Mechatronics  and Machine Vision in 
Practice (Auckland, NZ, December 2008), oral presentation.
•   A. Ghanbari, V. Nock, W. Wang, R. J. Blaikie, G. Chase, X. Chen, and C. 
Hann, “Force pattern characterization of C. elegans in motion”, 
Proceedings of M2VIP (2008), pp. 680-685.
1.3   THESIS STRUCTURE
To guide the reader through the thesis an outline of the structure is shown in Fig. 1.1. The 
illustration compares a natural liver sinusoid and the developed bioreactor device and 
indicates which parts of the device are covered in which chapter of the thesis. In general, 
the reader is assumed to have a basic knowledge of semiconductor processing 
technologies and their application to the fabrication of microfluidic devices, but not a 
background in fluidic transport phenomena and bio-artificial liver devices. Hence, a 
review of BALs is presented in this thesis, as well as some fundamental microfluidics 
phenomena. 
Chapter 2 - Introduction to Bio-Artificial Livers, introduces essential background 
concepts, including a brief introduction to liver anatomy, liver diseases and the principles 
behind treatment of these using BAL devices. An outline of the historical development of 
BALs is also presented, together with a summary of major engineering challenges relating 
to BAL bioreactors.
Following this, Chapter 3 - Theoretical Background, discusses common flow phenomena 
at the micro-scale and their application to derive the general transport equation. It further 
shows how these equations can be applied to yield the relationship between geometry, 
shear-stress and oxygen concentration. The use of this relationship for passive 
8Introduction
concentration control is demonstrated for the special case of constant oxygen 
concentration by means of analytical calculation and numerical fluid dynamics 
simulations.
Chapter 4 - Bioreactor Design and Fabrication, and Chapter 5 - Oxygen Sensor 
Integration, cover the fabrication of the two device designs and integration of the oxygen 
sensing layer into the bioreactor devices. Two novel fabrication processes for tapered 
microfluidic channels and for polymer matrix-based optical oxygen sensors are 
introduced.
In Chapter 6 - Experimental Fluidic Setup, and Chapter 7 - Characterisation of Oxygen 
Measurement, the developed measurement setup and the sensor calibration procedure for 
application of the devices to oxygen sensing are discussed in detail. The latter chapter 
covers sensor use for measurement of both gaseous and dissolved oxygen, as well as 
methods to optimize the sensor intensity response. In addition, a review of oxygen sensing 
in the context of the Lab-on-a-chip concept is given and the applicability of the developed 
processes and devices to on-chip oxygen visualization and detection are described. 
Figure 1.1: Guideline through this thesis.
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Multi-stream parallel flow generation with variable oxygen concentrations and 
measurement of coefficient of diffusion are demonstrated in this context.
This is followed by the penultimate Chapter 8 - Cell Integration, which addresses issues 
relating to in-vitro cell-culture and its potential influence on sensor performance. Oxygen 
sensing with cells is shown and the chapter finishes by introducing a novel concept of an 
auxiliary bile drainage system for BAL devices.
A summary of the work presented in this thesis is provided in Chapter 9 - Conclusions 
and Future Work, as are recommendations for future research.
Appendices A, B, C and D cover the detailed derivation of the relationship between 
oxygen concentration profile and bioreactor shape. The nomogram given in Appendix F
illustrates the determination of the dissolved oxygen concentration in an example liquid 
for a given temperature, salinity and pressure.
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The art of medicine consists in 
amusing the patient while nature 
cures the disease.
Voltaire 
1694-1778, French Philosopher
CHAPTER 2  
Introduction to Bio-Artificial Livers
In this chapter the liver as organ is introduced. General function and related diseases are 
summarized. This is followed by a closer look at the range of different medical treatments 
available, with particular focus on Bioartificial liver (BAL) systems and their current 
status. The second part of the chapter discusses engineering challenges related to BALs 
and relates the research presented in this thesis to current cell-culture and BAL devices.
2.1   THE LIVER
The liver performs more than 500 different functions, all of which are essential to life. The 
vital organ’s unique ability to regenerate, or regrow, cells that have been destroyed by 
injury or disease has always been a source of fascination to humans. 
One of the first accounts of the liver’s fascinating regenerative capabilities can be 
found in greek mythology. In the myth of the titan Prometheus, king of the gods Zeus 
hides the fire from humans as retribution to a deceit by the titan. Prometheus in return 
steals the fire from Zeus and returns it to the humans. The angered Zeus then punishes the 
titan by chaining him to a mountain and having his liver eaten by an eagle. Each day the 
liver would grow back, making it an endless punishment until the eagle was finally killed 
by the hero Heracles. Figure 2.1 shows the famous mythological scene as painted by Peter 
Paul Rubens in the early 17th century.
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However, despite this extraordinary capability the liver may undergo irreversible changes 
that permanently interfere with function and pose a significant threat to survival in form 
of complete organ failure. Throughout medical history there have been continuous efforts 
to understand and treat liver failure. A number of strategies and liver support devices have 
been proposed but success has so far been limited. 
The recent advent of and continuing progress in microfabrication has created the 
possibility to enhance liver support systems to a state far beyond current systems. With 
fabrication technology reaching biological size scales and by applying the growing 
knowledge of microfluidic systems it will be possible to closer map the real liver and 
thereby provide a better environment for liver cell function. In the following sections the 
anatomy of the liver, its functions as an organ and its diseases will be introduced. 
Strategies for treatment of liver failure will be discussed, followed by an overview of 
current existing liver support devices and their shortcomings.
2.1.1 STRUCTURE AND PHYSIOLOGY
2.1.1.1 Macro-Anatomy
Located in upper right-hand part of the abdomen the liver is the largest organ within the 
human body, weighing up to 2.5 kg [12]. As a soft organ the liver is susceptible to 
traumatic injury and being essential for life its removal results in ensured death within a 
few hours [13]. For external protection it is therefore attached to the diaphragm and 
sheltered by the rib cage. Of pyramidal shape, the basic liver structure is divided into two 
main lobes with the right lobe being about six times the size of the left lobe. As depicted 
in Fig. 2.2, the liver is connected to the gastro-intestinal tract from where it receives portal 
blood loaded with dissolved foods via the hepatic portal vein. In addition, oxygen-rich 
arterial blood is supplied from the aorta by means of the hepatic artery.Upon passage 
through the liver arterial and portal blood drain via hepatic veins into the inferior vena 
cava and finally the right atrium of the heart. In comparison, the liver shows the fourth 
highest specific blood perfusion rate of all organs in the human body with a typical rate 
of ~1000-1400 cm3/min (up to a maximum of ~5400 cm3/min [14]) and average 
pressures of 9 mmHg in the portal vein to 0 mmHg in the hepatic vein [15]. 
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Serving as an entrance for both the portal vein and the hepatic artery is the porta hepatis, 
a fissure at the undersurface of the liver. Once inside, the portal vein and hepatic artery 
branch forming portal canals where major branches are combined together with those of 
the bile duct. From branches of these portal canals arterial and portal blood passes into the 
spaces between liver cords called sinusoids. Through these sinusoids the blood drains into 
the central hepatic vein (Fig. 2.3). Bile produced by the liver cells is channelled in bile 
canaliculi and bile ductule which empty into the bile ducts. These individual ducts exit the 
liver and combine with the cystic duct from the gall bladder to the common bile duct. The 
Figure 2.1: Chained Prometheus, oil on canvas painting by Peter Paul Rubens, 
1611-1612.
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Figure 2.2: The human liver’s hepatic portal and venous 
drainage system (Adapted from [13]).
Figure 2.3: Part of a liver lobule depicting flow of blood from 
portal canal through sinusoid to the hepatic vein (Adapted 
from [13]).
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common duct unites with the pancreatic duct at the ampulla of Vater and both empty into 
the small intestines at the sphincter of Oddi (Fig. 2.4).
In summary, the intricate natural microfluidic system formed by the liver’s macro 
anatomy provides the highest state of cell culture environment for the liver cells. It 
enables them to simultaneously provide metabolic functions and remove toxins from the 
blood for delivery into the body’s waste system, all modulated via the essential oxygen 
supplied by the hepatic artery. 
2.1.1.2 Micro-Anatomy
Understanding what makes the liver structure so suited for liver cell function is the key to 
successful bioengineering of a potential artificial liver and therefore necessitates a closer 
look at the organ’s micro anatomy. Inside the liver, portal canals, hepatic veins and groups 
of liver cells together form the liver lobule as a basic functional unit. Cylindrical in 
structure, with a diameter of 0.8 to 2 mm and with a depth of several mm, about 50,000 
to 100,000 of these liver lobules make up a human liver [15]. Each lobule is composed of 
hepatic cellular plates one to two cells thick and arranged around a central vein, as can be 
seen in Fig. 2.5.
2.1.1.3 Sinusoids
The hepatic planes form the liver sinusoids, through which the blood flows from portal 
vein and hepatic artery to the central vein. Oxygen-rich arterial blood often enters as far 
down the sinusoid as 1/3 of its total length away from the interlobular septa, the dense 
Figure 2.4: Bile drainage system of the human liver (Adapted from [13]).
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fibrous tissue supporting the portal canals (see middle sinusoid in Fig. 2.5). With an 
average length of 500 μm, the sinusoid diameter varies from slightly more than 4 μm in 
zone 1 at the portal tract to around 5.5 μm in zone 3 near the hepatic venule [16]. In 
comparison, the diameter of red blood cells (erythrocytes) is an average of 7.8 μm. As a 
result, sinusoidal walls, made up by porous endothelial cells, as well as the blood cells 
have to distort to allow passage through the sinusoids. This process of “forced sieving” or 
“endothelial massage” is thought to facilitate the exchange of metabolites between blood 
and liver cells. Furthermore, tapering of the sinusoids is complemented by a gradient in 
diameter and frequency of pores or fenestrae as they are also called. In the direction of 
blood flow towards the central vein the porosity of the sinusoid wall increases as the 
diameter of fenestrae decreases but their frequency increases [16]. Regulation of dietary 
lipids is shown as one example of fenestrae function in Fig. 2.6. Here a large lipoprotein, 
the chylomicron, is blocked from entering the space of Disse while its smaller remnants 
are able to pass and thus get in direct contact with the hepatocytes.
2.1.1.4 Cellular Level
On the cellular level the human liver consists of five main cell types. Whereas the first 
four of them are of different lineage and usually classified as sinusoidal cells, the last one 
is the actual liver cell, the hepatocyte. All together they create an integrated functional 
Figure 2.5: Part of a liver lobule with hepatic plates formed by cords of 
hepatocytes (Adapted from [15]).
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system, which allows the liver to perform its role as multifunctional organ in the 
body [16]:
Liver Sinusoidal Endothelial Cells (LSEC)
Endothelial cells provide the inner lining of the sinusoids, thereby preventing direct 
contact between hepatocytes and blood cells, platelets and the largest of colloids 
circulating in the blood. However, contrary to those in capillaries, LSECs have fenestrae 
which are not occluded by a basement membrane and thereby provide what is also termed 
as the “liver sieve” [16]. The fenestrae in the liver sinusoids range from numerous 
(5-20 /μm2) small openings (mean diameter 0.175 μm, range 0.1 to 0.3 μm) to rare 
(<0.1 /μm2) large openings (0.3 to 1 μm diameter) [14] and allow plasma access to the 
space of Disse behind. 
Kupffer Cells
Supplementing the endothelial cells inside the sinusoids are Kupffer cells, tissue 
macrophages capable of recognizing and destroying bacteria, endotoxins and other 
foreign macromolecules in the blood. 
Figure 2.6: Scanning electron micrograph showing fenestrated endothelial 
lining of a sinusoid wall. A chylomicron (C) is prevented from accessing the 
space of Disse while its smaller remnants (r) fit through the pores (from [17]).
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Hepatic Stellate Cells of Ito
Located outside the sinusoid in the space of Disse, the hepatic stellate cells of Ito (HSC) 
act as storage for fat soluble Vitamin A in form of retinyl esters. Furthermore, they 
activate to myofibroblasts and synthesize collagen when retinol depleted [12].
Pit Cells
Like the Kupffer cells, Pit cells are natural killer cells or large granular lymphocytes 
located intrasinusoidally attacking neoplastic or tumor cells.
Hepatocytes - The Liver Cells
Polyhedral in shape and with a typical diameter of 18 μm, hepatocytes or main liver cells 
account for about 60 % of liver substance or 80 % of liver cell population [14]. As shown 
in Fig. 2.7 hepatocytes are separated from blood-carrying sinusoids by endothelial cells 
and the space of Disse, which itself drains into the lymphatics. The outer plasma 
membrane facing the space of Disse forms microvilli, increasing the surface area 
manyfold [13]. At their contact line adjacent hepatocytes form intercellular spaces, the 
bile canaliculi, used to transport bile away into the bile drainage system and eventually 
the small intestines.
Inside the hepatocyte cell mitochondria provide chemical energy, as well as synthesis 
of glucogen and the enzymes cause deanimation and urea synthesis. The endoplasmatic 
reticulum in turn synthesizes the specific liver proteins for blood coagulation, while the 
ribosomes on its margin synthesize the enzyme necessary for the utilization of glucose 
obtained from glucogen [13].
2.1.2 LIVER FUNCTIONS
Playing an important role in such vital tasks as molecule synthesis, detoxification, waste 
product disposal and general metabolism makes the liver a truly complex multifunctional 
organ. Over 5000 different functions have currently been assigned to the liver, with the 
main functions performed by the liver distinguished into:
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(i)  vascular functions for storage and filtration of blood;
(ii) metabolic functions concerned with the majority of metabolic systems in the 
body;
(iii) secretory and excretory functions responsible for formation of bile flow 
through bile ducts into gastrointestinal tract.
The following section will introduce the individual functions described above in greater 
detail.
2.1.2.1 Functions of the Hepatic Vascular System
One of the main vascular functions of the liver is to act as a blood reservoir. As mentioned 
before, the typical flow rate for blood through the liver is ~1450 ml/min with around 
1100 ml entering via the portal vein and an approximately further 350 ml from the hepatic 
artery. This corresponds to almost 29 % of the overall resting cardiac output. In normal 
pressure situations the blood volume in the liver including hepatic veins and hepatic 
sinusoids amounts to 450 ml, about 10 % of the total blood volume. In high pressure 
Figure 2.7: Drawing of a hepatocyte with part of 
Kupffer cell and sinusoid (Adapted from [13]).
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situations as much as 0.5 to 1 l of extra blood can be stored [15]. 
The second important vascular function is blood cleansing. Various gut bacteria, 
endotoxins and foreign macromolecules are picked up by the blood, mainly while flowing 
through intestinal capillaries. Macrophages like Kupffer cells line the sinusoids and digest 
these bacterias upon contact. It is estimated that less than 1 % of bacteria contained in the 
portal blood manage to pass through the liver and on into the rest of the circulation system.
A further auxiliary function and direct result of blood vessel porosity in the liver is 
the formation of large quantities of lymphatic fluid. Both fluid and proteins passing 
through into the space of Disse are drained by lymphatic vessels as depicted in Fig. 2.5. 
This leads to the liver supplying nearly half of all lymphatic fluid produced in the body at 
resting conditions [15].
2.1.2.2 Metabolic Functions
As also described in [15], the most important metabolic functions of the liver can be 
further subdivided into carbohydrate, fat, protein and miscellaneous metabolisms. In the 
following a summary of functions regarding each metabolism is given.
Carbohydrate Metabolism
The specific functions carried out by the liver in carbohydrate metabolism are:
(i)  storage of glycogen;
(ii) conversion of galactose and fructose to glucose;
(iii) gluconeogenesis;
(iv) formation of other important compounds from intermediate products of 
carbohydrate metabolism.
In general, the liver acts as a glucose buffer by storage and release, thereby maintaining a 
normal concentration of glucose in the blood. Should the glucose level fall too low amino 
acids are converted into glucose raising the concentration back to normal 
(gluconeogenesis).
2.1 The Liver
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Fat Metabolism
While many cells in the body can perform fat metabolism, the following functions mainly 
take place in the liver:
(i)  supply of energy by oxidation of fatty acids;
(ii) formation of most lipoproteins;
(iii) synthesis of cholesterol and phospholipids;
(iv) conversion of carbohydrates and proteins to fat.
Protein Metabolism
Compared to carbohydrate and fat metabolism, protein metabolism is certainly the most 
important metabolic function of the liver since it can not be replaced by any other part of 
the body. In fact, loss of all liver protein metabolic functions results in death within a few 
days. Briefly the main functions of the liver are:
(i)  deanimation of amino acids;
(ii) formation of urea for removal of ammonia from body fluids;
(iii) formation of ~90 % of all plasma proteins;
(iv) interconversions among amino acids and other compounds important to 
metabolic processes (such as non-essential amino acids for example).
Deanimation of amino acids in particular is essential for their conversion into energy, 
carbohydrates or fat and almost all deanimation takes place in the liver. Ammonia 
produced by the deanimation process and bacteria in the gut are removed by formation of 
urea. Absence of this function leads to a rapid rise in the ammonia concentration in the 
plasma, followed by hepatic coma and eventually death.
Miscellaneous Metabolic Functions
Besides the main metabolic functions described above the liver performs a variety of 
further functions related to the metabolism. Given below is an example of four 
miscellaneous functions:
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(i)  Storage of vitamins with capacity for up to 10 months of vitamin A, 3 to 4 
months of vitamin D and 1 to several years of vitamin B12;
(ii) formation of substances utilized in blood coagulation process (requires 
vitamin K to be present);
(iii) storage of iron in form of ferritin (provides an iron buffer system for blood); 
and
(iv) chemical detoxification and excretion of various drugs, hormones and other 
substances such as calcium.
2.1.2.3 Secretory and Excretory Functions - Bile
Hepatocytes in the liver secret around 600-1200 ml of bile per day into the intestinal tract. 
The major constituents of the bile thereby are bile acids, cholesterol, water, bilirubin and 
other organic substances. Once introduced into the intestines, acids contained in the bile 
aid in emulsifying large fat particles into several smaller ones. While these can be attacked 
more easily and broken down by lipases, the acids also assist in transporting and 
absorbing digested fat end products to and through the intestinal mucosal membrane. Bile 
further serves as a means to excrete waste products from blood, in particular cholesterol 
and bilirubin, a pigment created by degradation of hemoglobin during the destruction of 
old red blood cells.
2.1.3 DISEASES OF THE LIVER
Being such a multifunctional organ a variety of diseases are linked to the liver and affect 
it both directly and indirectly. Although, compared to other organs, the liver has the 
unique ability to regenerate and regrow after loss of more than 70 % of its substance, the 
human body can not substitute its functions in case of total liver failure. In general, a large 
number of liver diseases are associated with jaundice indicating increased levels of 
bilirubin in the blood. While being a standard product of hemoglobin breakup, excess 
levels of the pigment can be caused by abnormal levels of red blood cell destruction, 
impaired uptake or transport, defective conjugation of bilirubin and drug-impaired 
difficulties in canalicular excretion for example [13]. A condition in which the liver is 
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damaged beyond self-regeneration and ceases to function is termed liver failure. Due to 
the liver’s importance to human survival, those diseases that ultimately lead to a complete 
liver failure are the most serious. 
Depending upon the time span between the onset of symptoms, such as jaundice, and 
cessation of liver function failures are classified into:
(i)  Subfulminant Hepatic Failure (SHF, within 2-8 weeks);
(ii) Fulminant Hepatic Failure (FHF, within 2 weeks);
(iii) Acute Hepatic Failure (ALF, within 48 hours).
In contrary to the rare acute cases the process of liver failure is most often either chronic 
or occurs gradually over several years. Common causes of hepatic failure include 
hepatitis, liver inflammation, by virus or occasionally poisons, autoimmunity or 
hereditary conditions, with Hepatitis C being the most common cause worldwide [18]. 
Another particularly widespread reason for failure is Cirrhosis, the replacement of dead 
liver cells by and formation of fibrous tissue in the liver. This is usually a result of 
excessive alcohol consumption, viral hepatitis or general contact with liver-toxic 
chemicals. A third major cause is auto-immune liver disease, including autoimmune 
hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis, which accounted 
for 29 % of all liver transplantations in the United Kingdom in 2000 [19]. Further less 
common diseases include hereditary hemochromatosis, Wilson's disease and 
hepatocellular carcinoma or liver cancer. Figure 2.8 shows the major causes for liver 
failure by diagnosis for 17,922 people registered as awaiting transplantation with the 
Organ Procurement and Transplantation Network (OPTN) in the United States as of 
September 2005 [20].
2.1.4 LIVER FAILURE TREATMENT
The most effective treatment for irreversible liver failure as of today is Orthotopic Liver 
Transplantation (OLT). In this procedure a failed liver is removed from the patient's body 
and a healthy liver from a recently deceased human donor is transplanted into the same 
location. From the first successful transplantation in a human being reported in 1968 [19]
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the number of livers transplanted annually in the US has risen to 6,500 in 2007 [20]. When 
compared to the almost 20,000 patients currently waiting for transplantation it becomes 
obvious that a severe shortage of donor livers exists.
Other alternative options to OLT have therefore emerged in the form of Living Donor 
Liver Transplantation (LDLT) [21], the use of marginal [22], domino [23] and split 
livers [24]. In LDLT part of a donor’s healthy liver is surgically removed and inserted into 
a recipient, while the donor liver recovers to its previous size. Originally the procedure 
was introduced for parents to donate part of their liver as replacement for the damaged 
liver of their child, but today even adult-to-adult LDLT is possible to a certain degree. 
However, not only as with OLT is the procedure accompanied by high costs and shortage 
of available donors, it also introduces an additional risk for the donor due to the major 
surgical procedure of removal.
While in general these procedures may help reduce the shortage of donor livers, 
additional less invasive and more cost-effective options are required. Of the alternatives 
to whole organ transplantation the four main cellular approaches under investigation are 
displayed in Fig. 2.9. 
Hepatocyte transplantation (Fig. 2.9(a)) is a method where isolated liver cells are 
injected into the liver or other ectopic sites to engraft and proliferate [26]. The time as to 
when a clinical benefit occurs can be up to 48 hours, which makes it a possible procedure 
Figure 2.8: Diagnosis by disease for liver transplantation in the United 
States September 2005.
Cirrhosis: Type C
28%
Other
31%
Cirrhosis: Cryptogenic- 
Idiopathic
6%
Cirrhosis: Fatty Liver 
(Nash)
1%
Alcoholic Cirrhosis With 
Hepatitis C
6%
Primary Biliary Cirrhosis 
(Pbc)
4%
Alcoholic Cirrhosis
15%
Primary Sclerosing 
Cholangitis (Psc)
5%
Cirrhosis: Autoimmune
4%
2.1 The Liver
25
for treatment of most non-emergency conditions. Best results have been obtained for 
treating specific metabolic disorders, although long-term function of transplanted 
hepatocytes is usually not detected [27]. In a related approach implantable constructs 
(Fig. 2.9(b)) are produced by culturing hepatocytes ex-vivo on or in synthetic or 
biodegradable support scaffolds [28]. The two major types of implantables are 
hepatocytes in open matrices that allow host tissue ingrowth and hepatocytes 
encapsulated by a selective membrane, whereas the main advantage of the latter lies in the 
possible use of non-allogeneic cell sources [27]. Pig livers (Fig. 2.9(c)) are being 
investigated as the main source for transgenic xenograft and could eventually provide an 
unlimited supply of transplant livers, however graft rejection continues to be a major 
problem [29]. A fourth major approach is the development of extracorporeal bioartificial 
liver (BAL) devices (Fig. 2.9(d)) designed to support or replace a failing liver. Similar in 
concept to kidney dialysis machines the extracorporeal approach with its principles and 
systems will be presented in greater detail in the following section.
Figure 2.9: Main alternative approaches to cellular 
therapies for the treatment of liver disease (Adapted 
from [25]).
(a)
(b)
(c)
(d)
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2.2   LIVER SUPPORT SYSTEMS
The preeminent need for a liver support system (LSS) stems from the large current 
discrepancy between donor liver demand and supply. But even with an unlimited pool of 
transplantable livers the desire to find a close-to-ideal match between donor and recipient 
demands time, which might not be given especially in cases of ALF. Thus a working 
system able to effectively replace a large spectrum of liver functions could be used for 
both adjunct and temporary liver support [27]. In the first case the system would deliver 
longer term adjunct support to a liver with reduced functional capabilities such as chronic 
deficiency, allowing for endogenous liver regeneration. In the second case a greater 
spectrum of functions would be replaced over the critical phase of liver failure or the 
device used to bridge a complete and acute liver failure to OLT. Considering a mortality 
rate of ~90 % for severe FHF restoring essential liver functions should improve the 
survival rate, increase the availability of donor livers and avoid expensive transplantation 
processes [30]. 
From a historical point of view hepatic coma following liver failure was long thought 
to originate from small dialyzable toxins accumulating in the blood. Consequentially this 
led to the development of various systems aiming to remove these toxins. Recently 
however, and with the rising appreciation of the liver’s multifunctional role, the notion 
that viable hepatocytes should be an essential part of any LSS has gained increased 
support [31]. As shown in Fig. 2.10, a system can be classified either biological or 
non-biological depending on whether it uses viable liver cell preparations or artificial 
kidney dialysis principles as an active component. Systems that use a combination of both 
are classified as hybrid. Different measures such as neurological improvement and degree 
of elimination/production of substances are used to assess treatment outcome.
2.2.1 NON-BIOLOGICAL LIVER SUPPORT
Several non-biological approaches to liver support have been explored and their general 
success is considered limited mainly due to their inability to replace the synthetic and 
metabolic functions of the liver. The following historical summary of the different 
approaches is based on the review by Barshes et al. [32].
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2.2.1.1 Hemodialysis
One of the first approaches to be used was modified hemodialysis in the mid-1950’s due 
to its successful application in kidney failure. Early trials showed ammonia removal but 
no survival impact. While the advent of better membranes such as polyacrylonitrile has 
recently led to more encouraging results, no controlled trials have been reported. 
2.2.1.2 Reciprocal (Albumin) Dialysis
A concept introduced in 1976 is that of reciprocal dialysis, where the dialysate 
composition is used to correct plasma amino acid levels. In 1993 it was combined with an 
albumin-impregnated membrane containing carrier proteins to facilitate transfer of 
substances to the dialysate.
2.2.1.3 Hemofiltration
In hemofiltration low-to-middle molecular weight solutes are convectively removed from 
the blood. Similar in principle to hemodialysis, hemofiltration however is a slower 
Figure 2.10: Classification of liver support approaches and examples.
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continuous process that thereby places less strain on a patient’s circulatory system. 
Studies of combined hemofiltration and plasma exchange have shown increased 
neurological activity and survival.
2.2.1.4 Hemoperfusion
Contrary to filtration, hemoperfusion removes molecules from the blood by perfusion 
over a sorbent material such as charcoal-based sorbents, synthetic resins or anion 
exchange resins [32]. While coated charcoal has been most thoroughly tested with good 
general results, a controlled clinical trial could not show significant survival 
improvement [31]. In hemodiabsorption or hemodiafiltration charcoal perfusion is 
combined with a cation exchange resin to form a single access device. This process was 
used in the BioLogic-DT sorption-suspension dialyzer but also did not yield an 
improvement in survival [32].
2.2.1.5 Plasmapheresis
A therapy commonly used to treat autoimmune diseases, plasmapheresis or the removal 
of parts of blood plasma, was first introduced as treatment for FHF in 1968. As result of 
these early trials only transient improvements and no effect on long-term survival could 
be observed [31]. More recent studies with high-volume plasma exchange however 
demonstrated improved survival of patients with drug induced liver failure and 
plasmapheresis in general is considered to be effective in removal of serum inflammatory 
mediators not removable by hemodialysis [31].
Two examples of commercially available non-biological liver failure treatment 
devices both use a variant of albumin dialysis. In the Molecular Absorbent and 
Recirculating System (MARS®, Gambro AB, [33]) water-soluble and protein-bound 
toxins are removed from the blood via a albumin treated hollow fiber membrane and a 
recirculating albumin dialysate cleansing the membrane outside. Prometheus® (Fresenius 
Medical Care AG), shown in Fig. 2.11, uses fractionated plasma separation and 
membrane-based high-flux hemodialysis resulting in increased filtration of 
albumin-bound substances compared to MARS [32]. Analysis of several randomized 
clinical studies using MARS® did not show an overall benefit contrary to the survival 
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improvements seen in non randomized trials. For Prometheus, substantial decreases in 
bilirubin, urea, creatinine and ammonium were reported, but other disease and coma 
scores did not improve [35].
2.2.2 BIOLOGICAL LIVER SUPPORT
Compared to non-biological approaches, purely biological ones show encouraging results 
but their clinical implementation has proven to be more difficult.
2.2.2.1 Cross Circulation
For a limited number of cases treatment of FHF was attempted by cross-circulating a 
patient’s blood through another healthy human or baboon. Although this led to a decrease 
Figure 2.11: Prometheus liver support 
system (From [34]).
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in bilirubin level, neither neurologic status nor survival were increased, whereas the risk 
for disease transmission is significant for the healthy partner.
2.2.2.2 Ex-vivo Liver Perfusion
The extracorporeal perfusion of a whole or partial liver is a further biological approach 
showing short-term neurological improvement. Until recently the use of pig livers 
however did not improve long-term survival and is associated with considerable 
complications due to rejection of the xenograft and zoonoses, the interspecies 
transmission of diseases. The use of human livers unsuitable for transplantation and liver 
slices can alleviate this, but this is again limited due to general shortage in organ supply.
2.2.3 EXTRACORPOREAL SYSTEMS BASED ON LIVER CELL PREPARATIONS
Situated between purely biological and non-biological approaches are bioartificial liver 
systems incorporating preparations of isolated parenchymal liver cells in some form of 
artificial bioreactor. The main goal pursued with these systems is to provide an 
environment for cell survival and biochemical/synthetic function combined with in-vivo
like levels of transport [25] that could bridge the time until a donor organ is available for 
transplantation. A large variety of different concepts and device designs exist in various 
stages. The next sections will summarize the current status of BAL systems and discuss 
major design issues.
2.3   CURRENT STATUS OF BIOARTIFICIAL LIVER SUPPORT
2.3.1 HISTORICAL BACKGROUND
The advent of the term “artificial liver” began in the late 1950s with in-vitro experiments 
using fresh liver tissue homogenates, which demonstrated metabolic functions and 
ammonia to urea conversion. Around 1960 several early BAL devices were introduced for 
the perfusion of a patient’s blood over liver tissue preparations in a bioreactor [32]. These 
devices showed only a reduced applicability mainly due to limitations in cellophane 
membrane technology [31]. The first clinical use of an artificial liver was reported in 1959 
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by Tokyo University and consisted of cation and anion exchange reactors in combination 
with a cellophane dialysis membrane and donor animals [32]. A major new series of 
devices followed the introduction of hepatocyte isolation by enzymatic digestion in 
1969 [36]. New techniques such as cuprophane membrane material and synthetic 
capillaries with cells cultured in extrafiber space were introduced in the 1970s. 
Conjugation of bilirubin, ureagenesis, protein synthesis and drug metabolism for human 
hepatocytes were all demonstrated in devices using these technologies [37-39]. Further 
concepts innovated in the mid to late 1970s were those of plasma separation and 
high-flow plasma re-circulation with the liver cells placed in the circulatory loop. These 
developments were followed by the first clinical report on the use of an isolated 
hepatocyte suspension based system in 1987 [31]. 
2.3.2 EXISTING BAL SYSTEMS
In the time since 1990 several different systems have been evaluated both in clinical or 
preclinical trials and in-vitro tests. The following summary is based on the recent review 
by Park and Lee [30].
2.3.2.1 Systems in Clinical Trials
A total of nine BAL systems have undergone clinical trial since 1990. Seven of those are 
hollow fiber system (HFS), which are summarised in Table 2.1, while the rest are based 
on porous matrix technology, summarised in Table 2.2. Four [40-42,44] out of the seven 
HFSs have similar bioreactor configurations and are represented in Table 2.1 by the 
HepatAssist system.
HepAssist
This system was first developed by Rozga et al. [44] and marketed by Circe Biomedical 
Inc. It uses microcarrier-attached cryopreserved porcine hepatocytes placed in the 
extracapillary space of 0.2 μm-pore polysulphone hollow fiber membranes. The patient’s 
plasma flows through the capillaries after passing a column of activated charcoal. A 
circuit diagram depicting the operation method of the system is shown in Fig. 2.12.
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Hollow Fiber Systems
BAL system HepatAssist 
(Arbios) 
[43,44]
ELAD 
(Vital Therapies) 
[45-48]
LSS(MELS) 
(Charite, 
Germany)
[49-52]
BLSS 
(Excorp Medical) 
[53,54]
Bioreactor
configuration
Flow system Polysulphone 
0.2 μm-pore 
hollow fiber 
membranes
Hollow fiber and 
direct plasma 
through cellulose 
acetate membrane
Hydrophilic 
interwoven 
hollow-fiber 
membranes, multi-
compartment
Cellulose acetate 
hollow fibers
Shape of cells Microcarrier 
attached irregular 
aggregates
Large aggregates Tissue-like 
organoids
Collagen gel 
entrapped
Hepatocyte 
source
Cryopreserved 
porcine 
(5-7x109)
Human cell line 
C3A 
(100-400 g)
Discarded human/ 
porcine 
(600 g)
Porcine 
(70-120 g)
Immunological 
barrier
None Yes (70-120kD) None (300kD) Yes (100kD)
Perfusion
(plasma 
separation
rate) 
[ml/min]
Plasma (50) Blood (NA) Plasma (31) Blood (NA)
Reactor flow  
rate 
[ml/min]
400 200 100-200 100-250
Neurological 
improvement
Yes Probably Yes No
Ammonia 
removal
18% -8% (increased) NA 33%
Bilirubin 
removal
18% -20% (increased) NA 6%
Table 2.1: Configuration, characteristics and clinical results of hollow fiber BAL systems 
(Adapted from [30]).
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HepatAssist was extensively tested in Phase II/III clinical trials but did not reach primary 
endpoint (30-day survival) in the overall study population [43]. An improved 
second-generation device based on the original system and termed HepatAssist-2 is 
available from Arbios Systems, Inc. (Los Angeles, USA) for Phase III clinical trials [43]. 
ELAD
Compared to the other systems, the ELAD or extracorporeal liver assist device is unique 
as it is the only one to use the human hepatocyte cell line C3A. These cells are derived 
from the HepG2 human liver cancer cell line and cultured in the extrafiber space of hollow 
fiber cellulose acetate membranes. Full blood flows through the fibers and plasma is 
filtered across the membrane to the hepatocytes. The system underwent four clinical trials 
including a discontinued Phase II trial [48] with inconclusive results since it was 
introduced by Hepatix/VitaGen. Currently it is under further development by Vital 
Therapies, Inc. (San Diego, USA). 
LSS(MELS)
Gerlach et al. at the Charite University Hospital in Berlin, Germany, introduced the liver 
support system (LSS) with a novel bioreactor design [49]. As shown in Fig. 2.13, a 
multitude of independent interwoven hollow fiber capillaries create a three-dimensional 
matrix seeded with self-assembling hepatocyte aggregates. Both human hepatocytes from 
discarded donor livers and porcine hepatocytes are used. Plasma enters the reactor via a 
Figure 2.12: Diagram of the HepatAssist system (Adapted from [43]).
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first set of fiber membranes closed at one end. After passage through the extracapillary 
space it exits the reactor via a second set of fibers. A third set of hydrophobic membranes 
is used to supply oxygen to the cells by diffusion through the membrane. During a Phase 
I clinical trial using human hepatocytes the LSS was combined with a MARS dialysis 
device yielding the modular extracorporeal liver support (MELS). Together the systems 
successfully supported six patients to OLT with improvement in neurological and 
coagulation states [51]. MELS components are being marketed by Hybrid Organ GmbH 
(Berlin, Germany) [52]. 
BLSS
Commercialized by Excorp Medical, Inc. (Minneapolis, USA) the bioartificial liver 
support system (BLSS) differentiates itself from other HFS by using porcine hepatocytes 
mixed with a collagen solution. This mixture is then infused into the extracapillary space 
of cellulose acetate hollow fibers while blood is perfused through the lumen of the fibers. 
Preliminary results of Phase I clinical trials with BLSS show a decrease in both ammonia 
and bilirubin but no significant improvements in neurological states. Phase II trials are 
currently being conducted [55]. 
Figure 2.13: Bioreactor design used in the LSS-BAL 
(Adapted from [39]).
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Porous Matrix Devices
The bioreactor configuration of the other two BAL systems also in clinical trials 
(Table 2.2) differs from HFS bioreactors in so far as that porous matrices are used as 
scaffolds for hepatocyte attachment. 
Porous Matrix Systems
BAL system RFB-BAL
(University of Ferrara, 
Italy)[56,57]
AMC-BAL
(University of Amsterdam, 
Netherlands)[58]
Bioreactor
configuration
Flow system Radial flow, direct 
perfusion
Nonwoven hydrophilic polyester 
matrix for cell attachment, hollow 
fibers for oxygen supply and a 
spacer between the matrix, direct 
perfusion
Shape of cells Aggregates Small aggregates
Hepatocyte source Porcine (200 g) Porcine (1.2x1010)
Immunological 
barrier
None None
Perfusion
(plasma separation 
rate, ml/min)
Plasma (22) Plasma (40-50)
Reactor flow rate
(ml/min)
200-300 150
Neurological  
improvement
Yes Yes
Ammonia removal 33% 44%
Bilirubin removal 11% 31%
Table 2.2: Characteristics and clinical results of porous matrix BAL systems (Adapted 
from [30]).
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In the radial flow bioreactor (RFB) developed at the University of Ferrara, Italy, 
plasma enters the centre of the module and passes through a porous matrix containing 
hepatocyte aggregates. A 33 % reduction of ammonia and 11 % for bilirubin compared to 
the initial levels were observed during treatment with the RFB-BAL [57].
The second example in this group is the Academic Medical Center (AMC) BAL 
developed at the University of Amsterdam, Netherlands [58]. In this device small porcine 
hepatocytes aggregates are attached to a matrix of nonwoven hydrophilic polyester 
interspersed with hollow fibers for oxygen supply. Plasma is directly perfused through the 
matrix. During trials the system successfully supported six out of seven patients to OLT 
and led to, neurological improvement, as well as 44 % reduction in ammonia and 31 % in 
bilirubin. 
2.3.2.2 Systems in Preclinical and in-vitro Tests
The field of other major BAL devices in preclinical trials is divided into four HFSs 
(Table 2.3), one porous matrix and two encapsulation systems (Table 2.4), and two 
flat-plate systems (Table 2.5).
LIVERx2000
The first HFS, the LIVERx2000 system developed at the University of Minnesota and 
Algenix (St. Paul, USA) was approved for clinical trials but no results have been 
published yet [59]. It uses cellulose-diacetate hollow fibers into which a solution of 
porcine hepatocyte spheroids in collagen gel is injected. Upon contraction of the gel an 
oxygenated medium can be recirculated through the fiber lumen to nourish the 
hepatocytes while the exterior of the capillaries is perfused with whole blood.
LIVERaid
LIVERaid is a second BAL system available from Arbios Systems [43]. It utilizes a 
proprietary multi-compartment hollow fiber module with fiber-within-a-fiber geometry. 
The two compartments in the single-cartridge device are filled with porcine liver cells and 
chemical sorbents thereby providing whole liver functions and blood detoxification.
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OXY-HFB
Developed at the Eberhard-Karls University, Germany, the oxygenating hollow fiber 
bioreactor (OXY-HFB) consists of a furled hollow fiber matt [60]. Porcine hepatocytes 
are seeded into the extracapillary space onto the surface of the fibers. Medium or plasma 
enters through the centre of the rolled matt and exits radially outwards and upwards. 
Oxygen is pumped through the fibers in opposite direction to the plasma flow [61].
LLS
The liver lobule-like structure module (LLS) is one of two BAL systems designed at 
Kyushu University, Japan [62]. It employes a close-spaced regular arrangement of 
blood-conducting hollow fiber membranes. Centripetal force is used to create 
high-density porcine hepatocyte organoids in the space surrounding the fibers.
PUF-HALSS
The second system from Kyushu University is a porous matrix design based on a 
multicapillary polyether rigid-type polyurethane foam module (PUF). Isocyanate and 
polyol are used as cell-culture substratum while a cylindrical block of PUF provides a 
sponge-like macroporous structure with a porosity of 98.8 % [64]. Pores are 
interconnected and animal hepatocyte spheroids form upon inoculation into the 
packed-bed module. Plasma flows directly through capillaries created by the pores 
allowing for good mass transfer to the cells. 
UCLA-BAL
In the University of California Los Angeles (UCLA) BAL bioreactor porcine hepatocytes 
are microencapsulated within biocompatible semipermeable calcium alginate/polylysine 
sodium alginate composite membranes as shown in Fig. 2.14 [65]. The microcapsules are 
arranged in a packed-bed configuration and directly perfused with whole blood. Free 
cell-to-cell interactions are possible within capsules while the membrane provides 
immuno-isolation from blood components.
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AHS-BAL
An optimized version of this system was developed in the form of the alginate-entrapped 
hepatocyte spheroid (AHS) BAL at Dongguk University, South Korea [66]. Here 
hepatocytes are cultured in suspension to form spheroids prior to encapsulation, as 
hepatocyte spheroids were found to show higher liver-specific functions in-vitro than 
dispersed single hepatocytes.
Hollow Fiber Systems
BAL system LIVERx2000
(Algenix) [59]
LIVERaid 
(Arbios) [43]
Oxy-HFB 
(Eberhard Karls 
University, 
Germany) [60,61]
LLS-HALSS 
(Kyushu 
University, 
Japan) [62]
Bioreactor
configuration
Flow system Collagen gel 
encapsulated 
hepatocytes in 
cellulose 
diacetate-based 
fiber perfused with 
oxygenated 
medium, extrafiber 
space with blood
Multi-compartment 
hollow fiber within 
a fiber geometry 
combining 
hepatocytes with 
sorbent based toxin 
removal
Sheets of 
oxygenating and 
integral heat 
exchange fibers, 
hepatocytes seeded 
on fiber surface in 
extrafiber space 
perfused with 
plasma
Hollow fibers 
acting as blood 
capillaries with 
hepatocytes in 
extra fiber space
Shape of cells Hepatocyte 
spheroid suspension 
in collagen gel
NA Tissue-like Organoid
Hepatocyte 
source
Porcine (60-70 g) Porcine (1.5x1010) Porcine (2.5x109) NA
Immunological 
barrier
Yes (100 kD) NA None NA
Perfusion Blood Blood Plasma Blood
Table 2.3: Hollow fiber BAL systems in in-vitro tests.
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Flat Membrane Bioreactor Devices
The fourth family of devices, summarised in Table 2.5, is comprised of flat membrane 
bioreactor (FMB) systems. 
FMB1-BAL
In the FMB-BAL system presented by Bartolo et al. [67] hepatocytes are cultured 
between two layers of collagen. The bottom and top of these layers are enclosed by 
membranes and structural support. A gas permeable membrane at the bottom allows for 
Porous Matrix and Encapsulation Systems
BAL system PUF-HALSS 
(Kyushu University, 
Japan) 
[63,64]
UCLA-BAL
(UCLA, USA)
[65]
AHS-BAL 
(Dongguk 
University, 
South Korea) [66]
Bioreactor
configuration
Flow system Triangular arranged 
multicapillaries in 
polyurethane foam 
packed bed module 
with interconnecting 
pores
Microencapsulated 
hepatocytes within 
biocompatible semi 
permeable calcium 
alginate-polylysine-s
odium alginate 
composite 
membrane in packed 
bed configuration
Ca-alginate-entrappe
d hepatocyte 
spheroids in packed 
bed configuration
Shape of cells Spheroid Microencapsulated Microencapsulated 
spheroids
Hepatocyte 
source
Porcine (200 g) Porcine Porcine
Immunological 
barrier
None Yes (NA) NA
Perfusion Plasma Blood Plasma
Table 2.4: Porous matrix and encapsulation-based BAL systems in in-vitro tests.
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oxygen supply from an integrated gas channel to the cells while a microporous membrane 
at the top separates the cells from medium flow. An additional permeable membrane is 
used as the top cover for the medium channel. Sustained albumin production and urea 
synthesis at a constant rate were shown over a perfusion period of 18 days [67].
FMB2-BAL
Shito et al. [68] at the Massachusetts General Hospital developed a further FMB-BAL. In 
their design a hepatocyte monolayer is seeded onto a glass slide pre-coated with collagen. 
The slide is placed in a support structure with a gas permeable polyurethane membrane 
covering the plasma channel. Hepatocytes are directly exposed to plasma flow which is 
oxygenated via the membrane separating plasma and a gas flow chamber above it. 
Efficacy of the BAL system for treatment of FHF was demonstrated in rats and resulted 
in increased animal survival rates [69]. Scale-up of both FMB systems to a clinically 
relevant surface area is achieved by stacking several individual modules connected in 
parallel.
2.3.3 COMPARISON OF CURRENT BAL SYSTEMS
A direct performance comparison of the systems presented above is very difficult. 
Different stages of system development and trial status, as well as variation and 
complexity of trial-specific parameters such as patient group only allow for a generalized 
Figure 2.14: Schematic of the UCLA-BAL 
process used for hepatocyte encapsulation 
(Adapted from [65]).
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evaluation. Within the group of BAL devices in clinical trial the first generation 
HepatAssist system has the disadvantages of smaller relative cell numbers (5% of liver 
mass compared to 10% for other systems), short treatment time (6-8 h compared to 
12-24 h) and mass transfer limited by diffusion through the fiber membrane (compared to 
direct hepatocyte perfusion with plasma in the RFB, LSS(MELS) and AMC BAL 
systems). 
A further very important factor with major influence on BAL performance is oxygen 
supply. It is this issue that is addressed in this thesis. Systems with integral oxygenators 
like LSS(MELS) and AMC-BAL try to eliminate hypoxic space and oxygen gradients 
inside the bioreactor by use of separate fibers for oxygen transport. This trend towards 
Flat-Plate Systems
BAL system FMB1-BAL
(Leibniz Institute for 
Biotechnology and 
Artificial Organs, 
Germany)[67]
FMB2-BAL 
(Massachusetts General 
Hospital, USA) 
[68,69]
Bioreactor
configuration
Flow system Hepatocyte 
monolayer 
sandwiched between 
collagen layers 
separated from plasma 
and oxygen channels 
by membranes
Hepatocyte monolayer on 
collagen in direct contact 
to plasma flow oxygenated 
through membrane from 
separate channel
Shape of cells Monolayer Monolayer
Hepatocyte 
source
Porcine 
(2x108-4x109cells)
Porcine (1.39x106)
Immunological 
barrier
Yes (NA) None
Perfusion Plasma Plasma
Table 2.5: Flat-plate BAL systems in in-vitro tests.
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integration of separate oxygen or nutrient supply channels to overcome mass transfer 
limitations is one of the most significant to be observed in the newer preclinical BAL 
systems. The second trend summarised in Table 2.6 is the use of improved cell culture 
techniques for prolonged and enhanced liver functions.
2.4   ENGINEERING CHALLENGES IN BAL DESIGN 
Despite the obvious progress towards a functional BAL seen in the liver support systems 
presented above, a variety of critical engineering challenges still remain to be addressed. 
This section discusses three of the main challenges and introduces the proposed research 
into this context. Table 2.7 shows a summary of engineering constraints as identified by 
Chan et al. [27] for designing an artificial liver. 
One of the first questions for extracorporeal devices is whether to use Plasma or 
Whole Blood for Perfusion of the liver cells. In today’s systems this question is largely 
answered in favour of perfusion with plasma. The use of whole blood is in general simpler 
Hepatic function
and treatment 
time
Culture method Current status of application
Preclinical Clinical
Long-term and 
enhanced functions
Liver-like structure
3D co-culture LSS(MELS)
2D co-culture
Collagen sandwich FMB1, 
FMB2
Spheroids or 
organoids
LLS, AHS, 
PUF
AMC
Microencapsulation AHS
Porous matrix PUF RFB, AMC
Extracellular matrix BLSS, 
LIVERx2000
Short-term and 
poor functions
Microcarrier HepatAssist
Table 2.6: Application of cell culture techniques to BAL systems.
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because it does not require additional plasma separation and has an increased oxygen 
carrying capability compared to plasma. However, it is associated with 
thrombocytopenia, as well as hemolysis, and heparin anticoagulation medication has to 
be given, making it unsuitable for patients with invasive intracranial pressure 
monitoring [32].
The second question is Procurement of Liver Cells. While primary human 
hepatocytes would be the natural choice for BAL devices, their availability is limited due 
to the general organ shortage and in-vitro replication of cells and their liver-specific 
functions have yet to be demonstrated [27]. So far a derivation of HepG2 cancer cells 
termed C3A are the only human cells reported to be used in an artificial liver device. 
However, by comparison, adult porcine hepatocytes are suggested to perform at higher 
levels of liver-specific functions than C3A cells and a risk of transmission of 
tumourigenic products to the patient exists [27]. Porcine hepatocytes on the other hand are 
readily available, but their use is being associated with potential hyperacute rejection, 
inter-species transmission of diseases and liver function mismatch. Investigations are 
underway as to whether the dedicated breeding of transgenic pigs could solve these 
problems [27], while stem cells could provide the major source for human liver cells in 
the future [70]. In the meantime, a recently proposed suicide gen terminated variety of 
HepG2 (HepG2/tk) shows the potential of higher levels of liver-specific functions and 
increased safety compared to previous tumorous cell lines [71].
The third and probably most interesting question from an engineering point of view 
is that of Cell Culture Technique and Bioreactor Design. Up until today, the most 
Parameter Desired Value/Property
Minimum functional capacity 1%-10% of liver
Maximum priming volume 1 l
Maximum distance between 
cells and nutrient supply
1 mm
Maximum size of cell aggregates 100 μm
Scaffold material Biocompatible and supports hepatocyte
differentiated function
Table 2.7: Design constraints for BALs (Adapted from [27]).
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widely used bioreactor design for BAL systems is that of hollow fiber configuration 
introduced in Section 2.3.1. In HFS however, substrate transport limitations prevail due 
to relatively large fiber diameters and the fiber wall membrane barrier [27]. While the 
introduction of separate fibers for oxygen and nutrient supply helps to ease this problem, 
it also significantly increases the complexity of running such a bioreactor [72]. For 
systems with alternative topology like the flat-plate bioreactor, additional membranes and 
channels for oxygen supply also increase fabrication complexity. In general, when 
designing an artificial bioreactor for liver cells the best standard to compare to is the 
natural environment, the liver. Here hepatocytes exhibit distinctive epithelia polarity, 
meaning that their plasma membrane is divided into domains with differing functions 
according to the surrounding cells. Furthermore, they form cell-to-cell communication 
structures like bile canaliculi, a tight junction and a gap junction, and show highly 
efficient regeneration and differentiated functions [30]. 
The main factor influencing the latter is the location of the hepatocytes within the 
liver structure. Maintenance of this functional heterogeneity depends on various factors, 
including gradients of hormones, substrates, oxygen and extracellular matrix 
composition; the relative importance of these individual factors is currently 
unknown [27]. 
The high oxygen uptake rate of hepatocytes, combined with its relatively low 
solubility in aqueous media deprived of oxygen carriers (such as plasma), is considered 
to be the most constraining parameter in the design of BAL devices [27]. Studies by Allen 
and co-workers [73,74] on the influence of oxygen tension on hepatocyte function 
indicate a functional zonation depending on the oxygen gradient through a bioreactor. 
Figure 2.15 shows a sketch of the hepatic zonation as found along the liver sinusoid. The 
metabolic activity of hepatocytes creates oxygen and hormone gradients, which lead to 
regionally dominating metabolic or detoxification functions [73]. The results of Allen et 
al. suggest that by modifying environmental conditions such as oxygen gradient, 
hepatocyte metabolism can be modulated towards in-vivo behavior. As can be seen in 
Fig. 2.16, one way to achieve this form of spatial control could be to compartmentalise 
the bioreactor into separate modules [27]. Another possibility could be to use 
micropatterning and microfabrication for selective placement of cells in the 
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Figure 2.15: Characteristics of hepatic zonation. Liver functions 
are categorized depending on cell location into a periportal and a 
perivenous zone. HA: hepatic artery, PV: portal vein, CV: central 
vein (Adapted from [73]).
Figure 2.16: Potential bioreactor designs: (A) single unit, all 
functions; (B) two subunits for ammonia conversion to urea 
and glutamine; (C) three subunits with two under high oxygen 
tension to clear ammonia and a third under low oxygen 
tension for P450 detoxification (Adapted from [27]).
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device [75,76]. 
Recent experiments on the stress response of hepatocytes in relation to oxygen 
concentration have further indicated that cells cultured at perivenous concentrations are 
more susceptible to anoxia-induced damage than their periportal counterparts [77]. These 
results, and the everlasting desire to deepen the general understanding of intercellular 
signaling, have lead to a continuing interest in the development of oxygen transport 
improvements [78] and high-throughput, physiologically relevant cell-culture and 
analysis devices [79-81].
2.4.1 CONCEPT OF GEOMETRY-BASED OXYGEN CONTROL
As discussed in the introduction presented in this chapter, BAL devices with cell-culture 
bioreactors constitute one of the most promising means of treatment for liver diseases. 
With increasing knowledge of liver functions and their related micro-anatomical 
phenomena, the importance of being able to recreate these in-vitro becomes ever more 
significant. Although flat-plate bioreactors can be constrained by species transport 
limitations and require active measures to counteract species depletion, the same physics 
underlaying these limitations can be used in conjunction with microfabrication and 
microfluidics technology, to render them into an ideal platform for simplified control of 
species concentration, such as dissolved oxygen. In addition, and as shown in the 
following Chapter 3, this particular device category allows reactors to be scaled-up in a 
biomimetic fashion similar to the liver lobule, where sinusoids are radially arranged 
around a central blood vessel. 
The goal of this thesis is thus to demonstrate passive oxygen control based on 
bioreactor geometry and integrated oxygen sensing. To achieve this, a “hybrid” 
bioreactor, based on a tapering design for oxygen control but retaining the previously 
mentioned fabrication, integration and cell-culture advantages of the flat-plate design, is 
designed and developed. To visualize the principle used for oxygen control, a schematic 
of the interconnection between bioreactor geometry and oxygen concentration profile is 
shown in Fig. 2.17. A comprehensive mathematical derivation of the analytical model is 
presented in the following Chapter 3 - Theoretical Background. In brief, a specific 
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geometry produces a particular velocity profile based on the laminar flow conditions. This 
profile is linked to the shear stress through the resulting velocity gradient at the bioreactor 
wall, which, in turn, influences the oxygen concentration profile via the conservation 
equation. 
For example, a properly designed gradual tapering of the bioreactor height along its 
length leads to a increasing velocity gradient and shear stress profile, which then helps to 
maintain a close-to-constant longitudinal oxygen concentration to cells cultured within 
the device. The existence of this connection allows for both, the calculation of a 
concentration profile based on the available geometry, as well as the derivation of a 
geometry based on a desired oxygen concentration profile. The latter case is of great 
interest for cell-culture bioreactors and BAL devices in particular as it enables one to 
design constant or custom oxygen concentration gradient bioreactors simply by adjusting 
the geometry. 
Besides the introduction and numerical evaluation of this theory, this thesis also 
strives to lay the groundwork for a future experimental verification of devices based on 
this model and their integration for use in a prototype BAL. To facilitate this several 
significant points have to be addressed, such as device fabrication and interfacing, 
integration of an oxygen sensor, sensor calibration for use with biological media, cell 
procurement, seeding and culture, oxygen measurement in culture and comparison to 
Figure 2.17: Schematic of the oxygen control principle: Bioreactor geometry is linked to the 
oxygen concentration profile via the velocity profile and shear stress.
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analytical model, integration of a bile drainage system and device scale-up to a volume 
relevant to clinical trial. All of these points are introduced in the following chapters of this 
thesis, with four of them covered comprehensively, paving the way for a future 
application of devices based on the model.
2.5   SUMMARY
As discussed in this chapter, failure of basic liver function in humans is a serious 
condition, with a high mortality if left untreated. Major metabolic processes occur in the 
liver alone and can not be compensated by other organs. Despite the almost mystical 
self-healing abilities exhibited by the liver, orthopic transplantation remains the most 
successful treatment method to date. With increasing knowledge of liver macro- and 
micro-anatomy however, novel medical approaches and devices become feasible. One 
such promising approach is the use of BALs to bridge a patient to transplantation or 
support a damaged liver during self-repair. First devices have been shown to increase 
patient survival in clinical tests, but remain expensive and complicated to run. On the 
other hand, constant progress in micro fabrication has enabled general biomedical devices 
to closer and closer resemble size scales observed naturally in micro-anatomy. Several 
microfluidic liver cell-culture and BAL devices based on this new technology have been 
proposed. Most, if not all of them, have to rely on special setups to overcome oxygen 
transport limitations, which lead to increased device complexity and potential failure 
points. 
To avoid the need for separate oxygen supply channels the use of custom-shaped 
microchannels for the generation of arbitrary oxygen gradients in a bioreactor is proposed 
in this thesis. In the next chapter analysis of a theoretical model for laminar flow and 
computational fluid dynamic simulations are used to show that, by modifying wall shear 
stress in a microchannel, custom concentration gradients of a solute transported by a fluid 
in the channel can be induced. When applied to the oxygen supply for cells growing on 
the channel boundary, this could simplify bioreactor construction by overcoming the 
problem of too low oxygen tension, as found in conventional parallel-plate reactors. 
Furthermore, if this bioreactor would be employed in an bioartificial liver device it could 
2.5 Summary
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provide the zonation described above simply by tailoring the shape of the channel to the 
desired concentration gradient. 
While the applicability of this effect to general cell culture devices and BALs is 
obvious, it is not limited solely to this task. Selected examples of other applications that 
could profit from controlled concentrations in microfluidic systems are fluid-based 
biomedical sensors [82] and passive micromixers [83]. The former are usually located on 
one of the channel walls and of finite dimension. A geometrically-induced constant 
concentration of a dissolved analyte over the length of the sensor could potentially 
increase measurement precision. For the latter induced gradients could help to overcome 
the laminar flow separation seen in microfluidic channels and thereby facilitate the 
mixing of different flows.
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By medicine life may be prolonged, 
yet death will seize the doctor too.
William Shakespeare 
1564-1616, English Poet and Playwright
CHAPTER 3  
Theoretical Background
This chapter covers the theoretical background of the gradient-generating effect 
investigated in the proposed research. First, key properties and the fundamental equations 
used to describe fluid flow at the micro-scale are introduced. Then these equations are 
used, in combination with Prof. Tim David’s theory on platelet transport [8], to derive an 
analytical model for shear stress dependent species transport. When solved for a desired 
oxygen concentration this model returns the channel geometry required to produce the 
corresponding shear stress function. To demonstrate applicability to BAL and cell-culture 
oxygen supply the model is solved to yield a channel geometry that generates a constant 
concentration of oxygen at the bottom surface along the overall reactor length. Results 
obtained with the analytical model are further compared to computational fluid dynamic 
simulations for a 2D and 3D model geometry.
3.1   KEY PROPERTIES OF MICROFLUIDICS
To simplify the theoretical analysis, only Newtonian fluids are considered. Water is an 
example of a fluid considered Newtonian under most circumstances; its stress / rate of 
strain curve is linear and passes through the origin. The constant of proportionality is 
known as the viscosity. In common terms, this means the fluid continues to flow, 
regardless of the forces acting on it. For example, water is Newtonian, because it 
continues to exemplify fluid properties no matter how fast it is stirred or mixed. In 
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contrast, in a non-Newtonian fluid stirring can leave behind a “hole” that gradually fills 
up over time or causes the fluid to become thinner, the drop in viscosity causing it to flow 
more. Blood is an example of non-Newtonian fluid. It is a highly specialized circulating 
tissue consisting of several types of cells suspended in a fluid medium known as plasma. 
If the cells are removed, the remaining plasma is mainly composed of water, proteins and 
inorganic electrolytes and behaves more like a Newtonian fluid. Whilst the BAL devices 
proposed here could potentially be used with either whole blood or separated plasma, the 
analysis and design are carried out assuming a Newtonian fluid.
3.1.1 SHEAR STRESS
A viscous fluid moving along a solid boundary, like a channel wall, will incur a shear 
stress on that boundary. The no-slip condition dictates that the speed of the fluid at the 
boundary (relative to the boundary) is zero. At some height from the boundary the flow 
speed must equal that of the bulk fluid. The region between these two points is named the 
boundary layer. Shear stress is imparted onto the boundary as a result of this loss of 
velocity. Figure 3.1 shows a schematic of the tangential shear force applied to a certain 
boundary area. In general, the relationship for the wall shear stress is given by 
. (3.1)
For a Newtonian fluid in a two-dimensional microchannel, as displayed in Fig. 3.2, 
Newton’s law of viscosity can be used to mathematically represent the shear stress by
Figure 3.1: Tangential force on an area.
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, (3.2)
where  is the shear stress,  the fluid viscosity,  the fluid velocity in x-direction and 
 the position across the channel.
3.1.2 VISCOSITY
Serving as a mechanism to transfer kinetic into thermal energy analogous to friction of 
solid bodies, the viscosity of a fluid  can be defined as a measure of its resistance to 
flow, as already described in Equation (3.2) for a simple channel geometry. In general 
terms the viscosity is defined as
[shear stress] = [strain rate] (3.3)
For non-compressible fluids in general, the shear stress is proportional to the rate of 
change of the shear strain , with components of tensor  given by
(3.4)
Figure 3.2: Schematic indicating the wall shear stress 
(tangential) caused by a liquid moving past a wall. 
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and  components of the velocity vector. The dynamic or shear viscosity parameter  
is related to kinematic viscosity  by
, (3.5)
where  is the density. By definition, the viscosity of a Newtonian fluid depends only on 
temperature and pressure1, but not on the forces acting upon it.
3.1.3 THE BASIC EQUATIONS OF FLUID DYNAMICS
To describe fluid flow in a non-deformable control volume , bounded by surface  
with  the unit normal outward, the following equations for Conservation of Mass, 
Momentum and Energy can be formulated using principles of mechanics and 
thermodynamics [85],
(3.6a)
(3.6b)
, (3.6c)
where  is the density,  is the velocity field and E the total specific energy. In addition, 
all external forces on the volume are represented by ,  is the heat flux vector and  the 
stress tensor. For Newtonian fluids the latter is composed of normal components and the 
viscous stress tensor ,
(3.7)
, (3.8)
with being the pressure,  the unit tensor and ,  the first and second viscosity 
coefficients, respectively. For incompressible fluids the second viscosity coefficient  
disappears as no changes in volume can occur, leading to Equation (3.4).
1.and on the chemical composition of the fluid if the fluid is not a pure substance.
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Since we are interested in the transport (diffusion, convection) of another species 
(e.g. oxygen) dissolved in a fluid, a mathematical description of this process is required. 
This description is found in form of the conservation of chemical species equation, which 
can be written in general vector form as
, (3.9)
where  is the diffusion velocity and  a source term for the species. By applying Fick’s 
Law of Diffusion,
, (3.10)
it follows that
, (3.11)
with  a constant diffusion coefficient. Furthermore, noting that  for an 
incompressible constant density fluid (Equation (3.6a)), 
. (3.12)
Hence Equation (3.9) can be re-written as
. (3.13)
Applying the law of conservation of species to a small Cartesian volume element 
gives [86]
, (3.14)
where  is the concentration,  the velocities in x,y,z-direction,  the diffusion 
coefficient and  a term for production or consumption of the species in the volume.
By use of the continuum Equation (3.6a) in combination with Equations (3.7, 3.8), 
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the momentum Equation (3.6b) can be rearranged to give
. (3.15)
To complement the laws of conservation, the equation of state for ideal gases,
, (3.16)
where  as the difference of specific heats, can be used to rewrite the energy 
Equation (3.6c) to
, (3.17)
with . Combined the system of Equations (3.6a), (3.15), (3.16) and 
(3.17) is known as the Navier-Stokes equations.
3.1.3.1 Simplification for Incompressible Flow
In case of an incompressible fluid  and the equations for Conservation of 
Mass (3.6a) and Momentum (3.6b) become
. (3.18)
(3.19)
or for Cartesian coordinates 
(3.20)
and
,
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,
,
where gravity has been accounted for as a body force, and the values of will 
depend on the orientation of gravity with respect to the chosen set of coordinates.
3.2   DERIVATION OF CONSTANT OXYGEN CONCENTRATION
The goal of this derivation is to provide a constant oxygen concentration along the 
channel boundary. By keeping the concentration constant, areas of low oxygen tension 
along the channel length can be avoided, which would increase hepatocyte survival and 
function. Furthermore, this would eliminate the need for separate oxygen supply channels 
simplifying device fabrication. 
To derive the concentration gradient a channel with parallel-plate configuration (as 
shown in Fig. 3.3) is considered. Assuming flow in the x-direction, no bulk flow reaction 
( ) and unlimited width in z-direction, the species transport in the channel can be 
described by the two-dimensional steady-state convection and diffusion 
Equation (3.13) [87]
, (3.21)
Figure 3.3: Model of parallel-plate channel.
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where  is the concentration of species ,  the velocities in -directions 
respectively and  the diffusion rate coefficient for species .
Only diffusion in y-direction is considered, while dispersion in the flow direction 
(x-direction) is assumed to be negligible in comparison to the convective 
contribution [87,88]. To non-dimensionalize the conservation equation the following 
characteristic scales for mass fraction  (initial concentration), length  (e.g. depth of 
channel) and velocity  (average velocity) are chosen
. (3.22)
Equation (3.21) can then be rewritten (see Appendix A) as the non-dimensional ‘reduced’ 
mass conservation equation 
, (3.23)
with the Peclet number, , defined as the ratio of convection to diffusion according to
. (3.24)
Using the similarity variable  as introduced by David et al. [8,87]
, (3.25)
then, under the assumption of linear velocity profile, Equation (3.23) can be rewritten as 
a one-dimensional equation (see Appendix B)
. (3.26)
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To solve this ordinary differential equation the boundary conditions have to be 
determined. A large distance from the surface, in the centre of the sinusoid, the species 
concentration is
, (3.27)
where  corresponds to the concentration  in the bulk of the fluid.
Furthermore, at the surface (for ) it can be said, that the reaction rate at the 
fluid-wall interface balances the rate of diffusion to the surface. For liver cells situated on 
the surface, the reaction rate or oxygen uptake can be modelled by Michaelis-Menten 
kinetics [73,74,88]: 
, (3.28)
where  is the diffusion constant,  is the cell seeding density,  the cell-dependent 
maximum oxygen uptake rate,  the Michaelis-Menten constant and  the 
concentration. 
It is shown in Appendix C that the solution to Equation (3.26) along with the 
boundary conditions given by Equations (3.27) and (3.28) is
, (3.29)
where  is the non-dimensional Damkohler Number defined as
. (3.30)
To obtain an expression for the concentration on the surface, Equation (3.29) is now 
solved for  (see Appendix D) and 
(3.31)
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is obtained as surface concentration, where 
. (3.32)
Since the goal of this calculation is to obtain a constant concentration of oxygen along the 
wall, the result for  
(3.33)
needs to be constant for all . This in turn requires that  remains constant. 
Appendix E shows that this requirement is met if the wall shear stress increases 
linearly with  according to , where  is a constant of proportionality and 
 the wall shear stress at . An example of a flow chamber with linear shear stress 
generated via the chamber shape was shown by Usami et al. [90]. In their work the stress 
gradient was used to test platelet adhesion, while the theory presented here allows for the 
derivation of any desired solute concentration. Equation (3.33) also allows the 
concentration gradient profile at the boundary to be determined for other shear stress 
gradients or, by numerical inversion, the required stress gradients to produce an arbitrary 
concentration profile.
3.3   DERIVATION OF REQUIRED CHANNEL GEOMETRY
As found by the calculations above, diffusion of oxygen to cells on the channel wall can 
be kept constant by increasing shear stress in linear proportion to the channel length. In 
this section the required geometry to achieve this is derived using the previously found 
results.
3.3.1 MODEL FOR THE PARALLEL-SIDED CHANNEL
The derivation starts with an infinitely long 2D channel and the Navier-Stokes equation 
of momentum conservation for stationary incompressible flow,
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, (3.34)
where  is the pressure,  the kinematic viscosity and  the fluid velocities in x,y- 
directions.
Due to the assumption of an infinitely long channel and steady flow regime the velocity 
in x-direction  is considered to be slowly varying, and therefore
 and . (3.35)
Using this Equation (3.34) becomes
. (3.36)
In addition, from the conservation of mass Equation (3.20)  it follows 
that the fluid velocity perpendicular to the channel is constant across the channel width. 
Since channel walls are parallel and perpendicular velocity at the boundary must be zero, 
 across the channel equals zero, leading to the equation for Poiseuille flow
, (3.37)
which represents the balance between the pressure gradient and the viscous nature of the 
flow.
After integrating Equation (3.37) twice,
, (3.38)
and the boundary conditions can be used, as follows, to determine the integration 
constants. Since the velocity at the boundaries is equal to zero the constants  can 
be determined to 
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(3.39)
for  and 
(3.40)
for , where  is the channel height.
After inserting these results into equation (3.38) the function for velocity is found to be
, (3.41)
which is the parabolic velocity distribution typical to plane Poiseuille flow (see Fig. 3.4).
3.3.2 MODEL FOR TAPERING CHANNEL
To be used in the equation for velocity (3.41), as determined before for a parallel-sided 
channel, it is assumed that , i.e. the overall change in shape is small. Prior to 
substitution into the equation the variables need to be non-dimensionalized according to:
, (3.42)
Figure 3.4: Parabolic velocity distribution for 
Poiseuille flow in a channel of height H, arrows 
depicting velocity.
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with the dimensionless constants defined as follows
; ; ; ; . (3.43)
The above constants are inserted into Equation (3.42), which, after rearranging, results in 
, (3.44)
where  is the Reynolds number defined as the ratio of inertial and viscous effects in the 
system,
. (3.45)
To determine the flow rate the velocity profile is integrated across the channel height 
leading to
, (3.46)
which results in
. (3.47)
Equation (3.47) can be rearranged to find
, (3.48)
which then is inserted into equation (3.44) to give
. (3.49)
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The non-dimensionalised shear stress for laminar flow of an incompressible fluid at the 
wall of a parallel-plate channel is known to be
. (3.50)
From calculations in Section 3.2 it was derived that, to provide a constant oxygen 
concentration along the wall, the shear stress on the same must increase proportionally 
with distance  along the sinusoid:
, (3.51)
which corresponds to
(3.52)
and 
(3.53)
respectively. This result points out, that to keep the concentration constant, the profile of 
the channel height has to vary proportional to  along its length, ensuring a 
linearly increasing shear stress at the wall. Figure 3.5 shows a sketch of such a tapered 
channel geometry.
3.3.3 SUMMARY OF THE THEORETICAL ANALYSIS
The goal of the previous sections was to derive an analytical model of a channel geometry 
providing a constant oxygen concentration at the channel boundary. It was found that this 
could be achieved by varying the wall shear stress and an equation relating the required 
channel width-to-length was obtained as
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, (3.54)
where  is the distance from centre of channel to the wall,  the flow rate through 
channel,  the Reynolds number,  constant of proportionality for the increasing shear 
stress on the wall,  the wall shear stress at  and  the distance along channel 
length. Depending on cell type (oxygen uptake rate, cell seeding density) and channel 
dimensions (Reynolds number, flow rate) the individual parameters in equation (3.54)
can be determined. 
3.4   ANALYTICAL AND SIMULATION RESULTS
In this section the results obtained from the analytical model are verified using a 
commercially available finite-element (FEM) simulation software package. Drawing 
from the geometrical layout derived in Section 3.3.3, FEM simulations using the 
commercial software package COMSOL Multiphysics [91] were performed. 
Multiphysics allows the combination of various application modes in one model to create 
a computational fluid dynamics (CFD) simulation with coupled multiphysics. To 
visualize the geometrical effect on concentration gradients a 2D flat-plate channel was 
compared to a simple form of a tapered channel. The results shown here were obtained by 
coupling the incompressible Navier-Stokes fluid flow application mode with that of 
convective and diffusive mass transport. Figure 3.6 shows the equations and boundary 
conditions used in the modelling. 
Figure 3.5: Model of the 2D tapered channel.
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In the momentum balance part, shown in Fig. 3.6(a), the governing equation is the 
incompressible Navier-Stokes equation. The upper and lower channel wall BCs are 
no-slip, meaning the velocity  at the boundaries. On the left side channel entrance a 
fully-developed parabolic flow profile is assumed, while the right side pressure is set to 
zero for outflow condition. For the tapered channel a constant velocity profile was set as 
the boundary conditions on the left side inlet.
Mass balance in Fig. 3.6(b) is governed by the convection and diffusion equation 
with the reaction part  in the channel domain. The concentration at the left side 
channel entrance is assumed to be constant , while convective flux is the boundary 
conditions at the channel exit and insulation/symmetry at the upper channel boundary. 
This means that there is no oxygen transport over the upper boundary. Oxygen 
consumption of hepatocytes present on the lower channel boundary is modelled via 
negative mass flux according to Michaelis-Menten kinetics [88]. The flux term  is 
defined as:
Figure 3.6: Governing equations and boundary conditions in the finite-element model: 
(a) momentum balance with incompressible Navier-Stokes equation; (b) mass balance 
with convection and diffusion equation.
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, (3.55)
where  is the cell seeding density,  the cell-dependent oxygen uptake rate,  the 
Michaelis-Menten constant and  the oxygen concentration at the lower boundary. 
During simulation negative concentrations can occur as a result of numerical noise, 
discontinuous concentrations, an incorrect reaction term or mesh resolution. Two avoid 
negative concentration the flux term on the boundary was modified to be
. (3.56)
Physical parameters used in the simulation are from experimental data for rat 
hepatocytes [88], with the hepatocyte seeding density , the 
oxygen uptake rate of the hepatocytes , the 
diffusivity of oxygen in water/plasma , and the Michaelis-Menten 
constant . Also, in the mass transport application mode the inlet 
concentration on the left boundary is set to , as 
given in [88], a value which corresponds to oxygen in physiological salines such as 
plasma and is lower than the solubility in pure water at atmospheric pressure and room 
temperature (9.1 mg/l at 20ºC, see Appendix F). Density and viscosity of the fluid were 
modelled to be, as for water,  and  respectively. To 
reduce calculation time, the channel length of 5.4 cm in the x-direction was scaled-down 
by a factor of 100 in the two-dimensional model.
3.4.1 PARALLEL VS. TAPERED CHANNEL IN 2D
Steady-state simulation results [7] for a parallel-plate (A) and a tapered channel based on 
a Bezier-curve upper boundary (B) are shown in Fig. 3.7. The arrows in both plots 
illustrate the flow profile with the typical parabolic shape for laminar flow at a Reynolds 
Number of Re = 3 corresponding to a channel length of 75 mm and depth of 200 μm for 
the parallel-plate design and 200-150 μm for the tapered design. Analyte concentration is 
illustrated by color, with red denoting areas of high concentration and dark blue those with 
zero concentration. When comparing the results for the two geometries the effect of the 
N0
κ Vmax c x 0,( )⋅ ⋅
Km c x 0,( )+
-----------------------------------–=
κ Vmax Km
c x 0,( )
N0 c 0>( )⋅
κ 109hepatocytes m2⁄=
Vmax 3.8 10
16– mol s⁄ hepatocyte⁄⋅=
DO2 2 10
9– m2 s⁄⋅=
Km 6.62 10
3– mol m3⁄⋅=
c0 1.892 10
1– mol m3⁄⋅ 3.0272mg l⁄= =
ρ 1 103kg m3⁄⋅= μ 1 10 3– kg m s⋅( )⁄⋅=
68
Theoretical Background
tapered channel derived earlier can be observed. This becomes even more apparent when 
the concentrations on the lower boundaries of both channels are plotted together. In 
Fig. 3.8 the relative concentration and wall shear stress on the lower channel surface are 
Figure 3.7: Steady-state concentration gradients and flow profile for: (A) a parallel-plate; 
and (B) a tapered channel. Arrows denote the flow profile, colors the local concentration 
from red/high to blue/low (geometry not to scale).
Figure 3.8: Comparison of relative oxygen concentration (red) and wall shear 
stress (blue) for parallel-plate and tapered channel designs.
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plotted versus channel length. For the parallel-plate channel (broken line) the wall shear 
stress (bottom graph) is constant over the length due to the constant height of the channel. 
However, the oxygen concentration (top graph) decreases around 25 % from entrance to 
channel exit. For the tapered channel with a non-optimized shape (full line) the wall shear 
stress increases almost linearly over the reactor length. While, as predicted by theory, the 
surface concentration remains almost constant, decreasing only around 2 % over the total 
length relative to the bulk concentration at the channel entrance. This modelling shows 
that, as predicted by the analysis, channel geometry-induced wall shear stress control 
allows the surface oxygen concentration to be controlled.
3.4.2 ANALYTICAL MODEL VS. FINITE ELEMENT SIMULATION IN 2D
To investigate the applicability of the model derived in Section 3.2, both analytical 
solution and finite element simulation were applied to the case of a parallel-plate channel 
geometry as given in Fig. 3.3. For the analytical model Mathematica [92] was used to 
encode the equations, while FEM was performed using Multiphysics as described above. 
Results were combined and plotted using Matlab [93]. The dimensions for the 2D model 
were given as channel height H = 140 μm, channel length (in x-axis) X = 75 mm with 
physical parameters again taken from [88]. In Fig. 3.9 the oxygen concentration on the 
lower boundary of the parallel-plate channel as obtained by both analytical (full line) and 
FEM model (broken line) is compared. Results are plotted for three different cases of 
Reynolds number: Re = 0.07 corresponds to an average fluid velocity of 
, Re = 0.7 to  and Re = 7 to 
.
It can be seen from Fig. 3.9 that the analytical model compares well with the FEM 
simulations for high Re conditions. However, for Reynolds numbers equal to and lower 
than 0.7 the discrepancies between the analytical solution and the FEM result increase and 
the analytical model can no longer be used to predict the oxygen concentration. This is 
mainly due to the boundary condition (Equation (3.27), ) used in the 
derivation of the model. Hereby it is assumed that the concentration of the dissolved 
species e.g. oxygen, approaches the bulk or entrance concentration at a large distance 
U0.07 4.76 10
6– m s⁄⋅= U0.7 4.76 10
4– m s⁄⋅=
U7 4.76 10
2– m s⁄⋅=
η ∞ c η( ) c
∞
→;→
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from the lower boundary, for example the middle of the channel. When looking at the 
FEM result for the oxygen distribution in the parallel-plate channel at Re = 0.07 
(Fig. 3.10) it becomes obvious that the boundary condition is no longer valid.
To determine a lower limit of the model in terms of flow conditions the behavior for 
further Reynolds numbers was investigated in more detail. Figure 3.11 compares oxygen 
concentration along the device length for different values of Re ranging from 70 to 1.4.
As can be seen, within the dimensions of the particular geometry and for flow conditions 
of  the analytical model compares well with the results obtained via FEM 
simulation. In summary, numerical verification of the analytical model demonstrates its 
usefulness as a starting point for device design. However, for extreme values of Re, FEM 
simulations give better guidance and should be used in general to fine-tune the final 
device geometry.
Figure 3.9: Comparison of oxygen concentrations on the lower boundary of the 
parallel-plate channel obtained by analytical (full line) and finite element (dashed line) 
modelling for Reynolds numbers Re = 0.07, 0.7 and 7.
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Figure 3.10: FEM result for the oxygen distribution in the parallel-plate channel at Re = 0.07 
(geometry not to scale). 
Figure 3.11: Relative oxygen concentration on the lower boundary along channel 
length for Reynolds numbers from 1.4 to 70 in the parallel-plate reactor. Both 
analytical (full line) and simulation results (dashed line) are shown.
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3.4.3 SIMULATION RESULTS FOR THE THREE-DIMENSIONAL BIOREACTOR
Similar to the tapered depth model investigated above, the analytical derivation can be 
used to design a three-dimensional geometry with constant oxygen concentration [6]. 
Problems with the fabrication of the vertically tapered design, described in detail in the 
following Chapter 4, ultimately lead to the derivation of this laterally-tapered geometry1. 
Again, the wall shear stress was designed to increase linearly along the channel length. 
However, this time the linear increase was obtained by tapering the width of the channel 
rather than the depth. The function of channel width derived for this design corresponds 
to the height function for the two-dimensional case and is given by
, (3.57)
where y is the distance from the centre axis x,  the initial width at the entrance 
for ,  the total length of the reactor and x the position along the axis.
The initial geometry function was evaluated in MATLAB and exported as a geometry 
element into Multiphysics as an geometry element. This element was then used to create 
a two-dimensional footprint and the final three-dimensional geometry by extrusion of the 
footprint along the z axis. Using internal symmetries only half of the model has to be 
solved, which is shown in Fig. 3.12(a) for the oxygen concentration in the reactor and an 
inlet flow rate of 8 μl/min. Boundary conditions and governing equations used in the 
model were the tree-dimensional versions of those introduced in Fig. 3.6. Cells were 
simulated to cover the entire lower boundary up to the widest point depicted by a dotted 
line in the inset in Fig. 3.12(b).
Simulation results for the wall shear stress and oxygen concentration along the centre 
line of the lower boundary are plotted in (b) and (c) of Fig. 3.12, respectively. Inlet flow 
rate was used as parameter for the simulation and results are given for flow rates of 0.8, 
4, 8 and 40 μl/min. As can be seen from the wall shear stress graph (Fig. 3.12(b)), the 
geometry leads to an almost linear increase in stress in the region were the cells are 
1.Using planar microfabrication it is much simpler to create laterally-tapered structures than 
vertically-tapered ones.
y 2 W⋅ entrance
Ltotal
Ltotal x–
------------------⋅=
2 W⋅ entrance
x 0= Ltotal
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modelled. For 40 μl/min, the highest flow rate shown, the wall shear stress value peaks at 
0.7 dyn/cm2, which is significantly lower than physiological values observed to influence 
hepatocyte function [94]. At the same time, relative oxygen concentration remains almost 
constant over the length of the reactor, dropping to about 90% at the outlet for a flow rate 
of 40 μl/min. This indicates that the lateral design is a valid substitute for the initial 
vertically tapered geometry, while allowing for significantly easier fabrication of devices 
based on this design.
3.5   SUMMARY
By combining the Navier-Stokes description of laminar flow with the law of the 
conservation of species a two-dimensional model for solute transport inside a 
microchannel has been derived. A non-dimensionalized version of this model was solved 
by applying it to a theoretical parallel-plate channel geometry seeded with liver cells and 
a general solution for the species concentration inside the channel was obtained. This 
general form indicates that the special solution for constant oxygen concentration along 
the channel boundary can be found by employing an initial geometry providing linearly 
increasing wall shear stress. The two-dimensional shape function of this required 
geometry was consecutively derived from the solution and found to be proportional to the 
inverse square root of the shear stress. For comparison a channel with the derived 
vertically tapering shape was successively implemented and simulated using FEM 
software to confirm the model predictions. The analytical model was found to follow the 
CFD simulation results for a large range of Reynolds numbers and fluid shear stresses. 
Further, fully three-dimensional simulations of a horizontally tapered reactor shape 
showed the same effect as observed for the initial geometry due to laminar flow being 
predominant inside the device. Following derivation and flow characterisation of the 
designed reactors, the next chapter will discuss the fabrication of fluidic devices based on 
the particular geometries described above.
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Figure 3.12: Simulated flow and transport characteristics for a 3D model 
of the linearly increasing wall shear stress bioreactor. Dimensions of the 
bioreactor, cell-culture area and flow direction are shown in (a). The wall 
shear stress and relative oxygen concentration along the centre line on the 
lower boundary are plotted in (b) and (c), respectively.
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Any sufficiently advanced 
technology is indistinguishable 
from magic.
Arthur C. Clarke 
1917-2008, British Author, 
Inventor and Futurist
CHAPTER 4  
Bioreactor Design and Fabrication
In this chapter two different bioreactor designs and their respective fabrication 
technologies are described. The first section introduces the general methods used and the 
main differences between the two designs. The following two sections each focus on one 
of the bioreactor designs. For each design the fabrication process and related issues are 
discussed in detail. The last section utilizes the chosen design to explore strategies for 
potential system scale-up.
4.1   DESIGN CONSIDERATIONS
To reproduce the size scales found in the liver, the natural environment for the hepatocyte 
cell, microfabrication technology has to be employed to fabricate artificial bioreactor 
devices used as a matrix for support of cellular function. Whilst originally developed for 
the production of microelectronic chips, microfabrication technologies have been 
adopted, with some application specific additions and modifications, to produce 
increasingly complex networks of micro-sized fluidic channels. 
The combination of fabrication, functionalization and use of these channel networks, 
reservoirs and interfacing structures together with active parts, such as pumps and valves, 
and sensors is summarized in the field of microfluidics. While years of process 
development in the microelectronics industry have produced a pool of mature fabrication 
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technologies, their adaption to the fabrication of fluidic devices is not without problems. 
One of the most fundamental limitations in the standard microelectronics process chain 
of material deposition, lithographic pattern transfer and structural change by selective 
etching is its layer-based nature. To achieve the high precision necessary for electronics, 
materials are deposited in ultra smooth layers and structured laterally by use of 
photoresists. Structuring beyond the horizontal axes, with the exception of vertical vias, 
is practically non-existent in microelectronics fabrication. In microfluidics, and to a 
certain extend in micro-optics, vertically tapered structures on the other hand, can yield 
some very interesting properties and applications such as the shear-based transport 
phenomena discussed in the previous chapter. 
A device incorporating a vertically tapered version of the bioreactor shape would 
have the advantage to allow for direct comparison of experimental results with the 
analytical model derived in the previous chapter. Due to this, vertical structuring was 
initially investigated for bioreactor fabrication. Grayscale lithography, a variation of 
standard binary lithography modified to allow for vertical structuring by a single 
exposure, was used to develop a device fabrication process. This initial design (Design A) 
is based on a change in reactor depth over reactor length to obtain a wall-shear stress 
change. Due to the complexity of this process and rough surface features of device molds 
produced with grayscale lithography a second design (Design B) was later developed. 
This Design B is based on a constant depth with tapering width and can be fabricated 
using standard single-layer binary lithography. However, direct comparison of 
experimental results obtained from Design B with the proposed two-dimensional 
analytical model is not possible due to the approximations used in the derivation of the 
model. In this case the results of the full three-dimensional fluid dynamics simulation 
have to be used for comparison and to account for boundary effects. The following 
discusses development of a fabrication process for both bioreactor designs and the 
potential of system scale-up towards a full bioartificial liver device using Design B. 
4.2 Constant Width, Tapering Depth Bioreactor
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4.2   CONSTANT WIDTH, TAPERING DEPTH BIOREACTOR
The reactor shape of Design A is derived from the results provided by the analytical 
model. Cell seeding will be facilitated on the bottom surface of the channel and the taper 
of the channel depth is chosen to provide constant oxygen concentration on the bottom 
surface over the channel length. Figure 4.1 shows a 3D rendering of Design A as used in 
FEMLAB to simulate fluid flow and species transport. The target channel geometry for 
the prototype is 500 μm wide, tapering from 200 μm at the input end to 150 μm at the 
output end.
4.2.1 FABRICATION OF THE MOLD
Soft lithography and replica moulding of polydimethylsiloxane (PDMS) [95] is used to 
create the microfluidic systems. Therefore, a master mould incorporating the tapered 
channel profile should be fabricated in photoresist using graytone (or grayscale) 
lithography on a standard mask aligner [96]. To achieve this flood exposure through 
graytone masks will be undertaken with a conventional contact/proximity aligner (Süss 
MA6). The masks themselves are written on a glass substrate pre-coated with tungsten, 
and polymethyl methacrylate (PMMA) as electron beam resist, using the Raith 150 
electron beam lithography (EBL) system.
Figure 4.1: COMSOL model of the vertically tapered Design A (geometry not to 
scale).
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m
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4.2.1.1 Grayscale Lithography
The idea behind graytone lithography is to use an optical mask to modulate light intensity 
passing through to photoresist beneath. In projection lithography this is achieved by the 
use of mask patterns close to or below the resolution limit of the projection system. As 
illustrated in Fig. 4.2, if the pixels on the mask and their spacing are larger than the 
resolution of the lithography system (a) the diffraction orders are collected according the 
numerical aperture and the pixels are reconstructed on the photoresist. However, if pixels 
and spacing are below the resolution limit (b) only the zeroth spatial diffraction order is 
captured on the resist. For a constant pitch  a square unit cell can be defined with 
side length . Here  is the critical pitch for collecting the first diffracted order from 
the structure,
, (4.1)
where  is the wavelength and  the numerical aperture of the exposure system [97]. 
The modulation of intensity passing through the mask is then dependent on the area fill of 
Figure 4.2: Behavior of diffracted light assuming the critical pitch PC is the smallest pitch 
where the numerical aperture accepts the first diffraction order. Orders in the shaded region 
are not accepted by the system (from [97]).
P PC<
P PC
PC
λ
NA
-------=
λ NA
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this unit cell, which in turn is dependent on the number of primary pixels covering the unit 
cell. 
Figure 4.3 illustrates the bottom-up pattern design for a mask fabricated and designed 
based on this approach. A primary sub-pixel of side length  is used to fill a unit cell of 
side length  according to the desired fill factor and corresponding intensity modulation. 
The unit cell is then instanced and multiplied to create the overall pattern. Assuming a 
resolution limit  of >1 μm (Süss MA6 Mask Aligner in vacuum mode) and a primary 
pixel side length  of 100 nm, 10x10 or 100 different levels of intensity can theoretically 
be realized on the mask. The background in Fig. 4.3 is a micrograph of an actual grayscale 
mask after development of PMMA resist. Implementation of the mask design is either in 
the commercial software package L-Edit Pro (Tanner Inc.) or alternatively in the Raith 
software package. A primary pixel is used to create unit cells with filling factors from 100 
to 0 % transmission. These unit cells are then instanced and multiplied to create larger 
patterns with a desired fill factor. Finally an arbitrarily sloped profile is then achieved by 
Figure 4.3: Illustration of the grayscale mask pattern layout: A primary pixel of side length a is 
used to fill the unit cell (P) and create a large-scale pattern of defined intensity modulation.
a
P
PC
a
Unit Cell Pitch 1 m
Primary Pixel Side Length 100nm
10um
a
P
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arranging a succession of areas with increasing or decreasing fill factors. When calibrated 
with the resist contrast function, the correlation between these areas of different fill factors 
and developed resist depth leads to the final structure.
4.2.1.2 Optical Grayscale Mask Fabrication Process
Based on the inhouse capabilities at the UC Nanofabrication Laboratory a novel optical 
grayscale mask fabrication process was developed [9]. Large scale binary channel 
patterns were combined on the final mask with smaller, high-resolution grayscale features 
in a two step process. Figure 4.4 outlines the major process steps required to obtain a 
complete grayscale mask. In all cases standard 25x75 mm glass microscope slides and 
22x22 mm glass coverslips of thickness No. 2 (ESCO) were used. 
Figure 4.4: Schematic of the complete grayscale mask fabrication process.
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The substrates were first cleaned using acetone, methanol and IPA consecutively 
before blow drying with nitrogen gas. A 100 nm thick absorber layer of tungsten was 
sputter-deposited in 300 W DC argon plasma using an Edwards Auto500 DC/RF 
magnetron sputtering system (Fig. 4.4(a)). For grayscale features PMMA (4% HMW in 
xylene) was spun onto the tungsten at 4000 rpm for 1 min (Fig. 4.4(b)). This was followed 
by a 90 s softbake at 180°C on a hotplate. For electron beam exposure samples were 
loaded into a Raith150 Electron Lithography system. 
Grayscale mask patterns were prepared using the internal Raith software package and 
exposed at a typical dose of 60 μAs/cm2, as indicated in Fig. 4.4(c). After exposure, 
samples were developed in 3:1 IPA:MIBK for 30 s, rinsed with IPA and blow dried with 
nitrogen gas. Prior to pattern transfer, PMMA was hardbaked for 5 min at 100°C on a 
hotplate. Samples were then placed in an Oxford PlasmaLab 80Plus and the resist pattern 
was transferred into the tungsten layer via RIE (Fig. 4.4(d)). Typical process parameters 
for the RIE etch were 80 sccm SF6 gas flow rate, 0.15 torr etching pressure and 200 W 
power for 15 s at a temperature of 313 K. Remaining resist was stripped by immersing the 
samples in acetone and applying ultrasound. Finally samples were rinsed with methanol, 
followed by IPA and blow drying in nitrogen gas. In a second step larger patterns of 
channels were integrated on mask with the grayscale features by repeating steps (b) to (d) 
in AZ1518 positive photoresist and aligning the optical photolithography to the 
underlaying features. Samples processed accordingly were used as masks in optical 
grayscale lithography. 
Figure 4.5 shows an example of a grayscale test pattern written on the Raith EBL 
system. A glass cover slip was used as substrate with a covering layer of 100 nm thick 
sputter-deposited tungsten. The pattern was written into PMMA resist and successively 
etched into the tungsten via Reactive Ion Etching. The inset in the right top corner shows 
a micrograph of the mask after development and hardbaking of PMMA resist. The main 
image shows a micrograph of the same mask in transmission after RIE and stripping of 
PMMA.
In Fig. 4.6 a close-up of the mask pattern is shown. Scanning Electron 
Microscopy (SEM) was used to image the unit cells and tungsten primary pixels of the 
same pattern as in Fig. 4.5. The filling factor and thereby grayscale level on the left is 
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smaller than on the right, while the unit cell pitch on the left is 0.9 μm compared to 0.8 μm 
on the right (insets). Depending on the actual resolution limit of the mask aligner used the 
unit cell outline should not be visible in the grayscale photoresist structures for 
P < resolution limit, resulting in smoother resist surfaces.
During development of the grayscale process it was found that the main step limiting 
mask fabrication was the dry-etching of the tungsten absorber layer. Tungsten layers 
thicker than 150 nm could not be etched with high enough resolution and selectivity 
towards the PMMA resist used. Replacing tungsten with a chrome-based absorber did not 
prove feasible, as chrome could not be dry etched in the RIE tool. Initial wet etch trials 
with sputter-deposited chrome showed similar lack of selectivity and were unable to 
replicate the primary pixels with sufficient resolution (minimum dimension ~100 nm) on 
the mask. An increase in hardbake time to enhance the durability of the PMMA resist 
layer towards the wet processing conditions did not show any significant improvement. 
For masks containing combinations of grayscale patterns and channel designs 
writing the whole pattern on the Raith150 is not feasible due to excessive write times for 
Figure 4.5: Optical transmission micrograph of a grayscale pattern in tungsten 
after RIE. The pattern is used to test the effect of different values for unit cell pitch 
P. Inset shows the same pattern after development of PMMA, prior to RIE.
50 m
After EBL (PMMA on tungsten)
After RIE (tungsten on glass, in transmission))
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the binary channel parts of the pattern. To circumvent this limitation the two-step mask 
fabrication process based on printed foil masks was developed. First the grayscale pattern 
of the mask is fabricated as described above. Then the larger binary patterns of the 
channels are fabricated on the same mask as follows.
AZ1518 positive photoresist was applied after grayscale patterning onto the tungsten 
layer. The resist was spun on at 3000 rpm for 1 min followed by softbake of 1 min at 
100°C on a hotplate. Channel masks were drawn using Corel Draw® graphics software 
and printed on transparent foil by a commercial high-resolution printer (Precision 
Lithographics, Christchurch NZ). A Süss MA6 mask aligner was used to align the printed 
masks with the grayscale pattern on the substrate and to expose the resist. Samples were 
then developed for 1 min in AZ MIF300 developer, rinsed with DI water and blow dried 
with nitrogen gas. 
This was followed by a hardbake of 5min at 100°C on a hotplate. Pattern transfer was 
via RIE using the same etch recipe as for the grayscale process with a typical etch duration 
of 30 s. After RIE, remaining photoresist was stripped by immersion in acetone and 
applying ultrasound. Finally, masks were rinsed with methanol, followed by IPA and blow 
Figure 4.6: SEM of the different filling factors and unit cell pitches (insets) on 
the grayscale test pattern mask.
0.8 m0.9 m
84
Bioreactor Design and Fabrication
drying with nitrogen gas. The transmission micrograph in Fig. 4.7 shows an example of a 
mask fabricated using this process. The larger channel structure in the lower part was 
aligned to the pattern after creation of the grayscale pattern and exposed using standard 
lithography, thereby significantly reducing the electron beam write time required.
4.2.1.3 Optical Projection Grayscale Lithography in Photoresist
Fabricated grayscale masks were used for optical projection lithography in thick 
photoresist. Two choices of thick resists were investigated, namely SU-8 as the most 
popular negative resist currently in use for mold making in microfluidics and AZ4562 
(both from Microchem) as one of the thickest positive resists available. Achievable 
thickness of the resist mold is an important parameter as this decides the depth of the final 
bioreactor and needs to be large enough to accommodate Hepatocyte cells (est. 
Ø~25 μm). SU-8 was available in preparations 2025, 2075 and 2100, where the latter can 
Figure 4.7: Transmission micrograph of a grayscale mask 
fabricated by the two-step process with alignment to a larger 
channel pattern. Grayscale calibration regions are drawn in two 
rows above two different test channel structures.
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be spun up to 300 μm thick in a single layer. Being an epoxy-based resist it has the 
potential to be used directly as a structural material for MEMS applications. AZ4562 can 
be applied up to 60 μm in a single spin coating, but requires a very stable processing 
environment in this thickness range. 
As substrates, 22x22 mm coverslips and 10x10 mm diced Si wafer pieces were 
cleaned using acetone, followed by methanol and IPA. After blow drying with nitrogen 
gas, samples were dehydrated at 95°C in a convection oven for 1 h. Prior to application 
of resist samples were cooled to room temperature. 
SU-8 Negative Resist
Fabricated grayscale masks were used to create sloped structures in SU-8 2075 
photoresist with high aspect ratio as needed for microfluidic channels. Since SU-8 is a 
negative photoresist conventional frontside exposure through a grayscale mask would 
lead to peeling off of middle tone structures (see Fig. 4.4(f)). The process used in 
conventional front-side projection lithography has to be modified towards back-side 
exposure through a transparent substrate [98]. Figure 4.4(e) and (f) illustrate the 
difference between substrate penetration lithography (right) and standard frontside 
lithography (left) with a negative resist. If exposed from the front through a grayscale 
mask SU-8 or any other negative resist crosslinks only to a certain depth. This depth 
directly corresponds to the intensity modulation effect of the mask. If the crosslinking 
threshold of SU-8 is not reached polymerization will not reach the substrate surface and 
the resist structures will be free floating. During development middle and low tone 
structures lift-off as they are not in contact with the substrate underneath. In substrate 
penetration lithography, as shown on the right side of Fig. 4.4(e), SU-8 is spun onto a thin 
transparent substrate. Resist and substrate are inverted and placed on a spacer. The 
grayscale mask is then brought into contact with the backside of the substrate and 
exposed. Since, in this case, crosslinking starts from the substrate-resist interface features 
adhere after development. A further advantage of this process is that initial resist 
thickness, planarity and edgebead removal are no longer critical.
Thin clean coverslips (VWR, No. 0, thickness 100-120 μm) were treated with 
OMNICOAT adhesion promoter (Microchem). The promoter was applied by spinning 5 s 
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at 500 rpm (acceleration 84 rpm/s) followed by 30 s at 3000 rpm (acceleration 340 rpm/s) 
and hardbaking for 1 min at 200°C on a hotplate. After cooling to room temperature 
negative resist SU-8 2075 was applied to the coverslips with a final thickness of 
100-200 μm by a two step spin-coating process. First resist was poured onto the coverslip 
and evenly distributed by rolling a clean glass rod over it. Then a spread cycle of 10 s at 
500 rpm (acceleration 84 rpm/s) followed by a final cycle of 30 s at 1500 rpm 
(acceleration 10030 rpm/s1) were applied. This was followed by a softbake of 2 h at 95°C 
on a hotplate. Samples were inverted and placed on a rubber spacer in a custom holder. 
The tungsten side of the grayscale mask was aligned and brought into contact with the 
backside of the coverslip. Vacuum was applied to the holder in a Süss MA6 mask aligner. 
A HOYA-34 filter was place on top of the stack and exposed in multi-exposure mode, 25x 
with a 10 s exposure and 60 s wait step, in order to reduce resist heating during exposure. 
The exposure light intensity through the stack was measured to be 3.3 mW/cm2 at a 
wavelength of 365 nm. After exposure a post exposure bake (PEB) was performed for 
15 min at 95°C on a hotplate. Development was for 20 min in 
(1-Methoxy-2-Propyl)acetate on an orbital shaker. This was followed by rinsing with IPA 
and samples were blow dried with nitrogen gas. Grayscale resist structures were imaged 
using the Raith150 SEM function and a 10 nm sputter deposited layer of tungsten.
Figure 4.8 shows a SEM image of grayscale calibration pillars in SU-8 2075. The 
initially resist thickness after spin-coating was 200 μm. Patterns on the grayscale mask 
consisted of 100-by-100 μm squares of different transmission factors. The bottom row 
pillars correspond (from right to left) to 100%, 30%, 40%, 50% and then in 5% steps to 
100% transmission on the mask. As can be seen from this image there is an obvious 
grayscale effect, however, compared to positive resist the surface is very rough. Also, it 
was observed that the remaining resist thickness vs. grayscale transmission (absorbed 
intensity) is rather nonlinear for SU-8 (see Fig. 4.9). This was also observed by Mori et 
al. [98] and is attributed to SU-8 being a negative resist chemically optimized for binary 
behavior. The resist will solidify above a certain energy threshold required for 
crosslinking. Figure 4.10 shows an example of this effect. Here, possibly due to 
1.High acceleration is used to help break surface tension of the highly viscous SU-8 2075 or 
SU-8 2100 and assist spreading.
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Figure 4.8: SEM image of grayscale calibration pillars in SU-8 2075.
Figure 4.9: Calibration curve recorded for grayscale in 200 μm thick 
SU-8 2075. Plotted is the remaining resist thickness as a function of 
relative mask transmission. 
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diffraction on the mask pattern boundary, shell-like empty SU-8 tips remain above what 
should be flat pillars. Development is unable to remove these semi-crosslinked tips 
chemically. Only the two lowest pillars remain tip free, which might be due to mechanical 
collapse by agitation of the developer. In general, SU-8 seems to be only of limited 
applicability as mold material for this project. The limited window of resist height relative 
to exposure dose would make it very difficult to achieve the structural control necessary 
to produce smoothly tapering mold. Furthermore, surface roughness as observed in 
Fig. 4.10 can not be circumvented by a final bake as SU-8 and other negative resist in 
general show almost no reflow behavior due to polymer chain crosslinking.
AZ4562 Positive Resist
For this process, positive resist AZ4562 was applied to the coverslips with a final 
thickness of 60 μm by spinning 3 s at 2000 rpm. This was followed by a softbake of 1 h 
at 100°C on a hotplate. Grayscale masks and samples were aligned in a Süss MA6 mask 
aligner and exposed by alternating a 10 s exposure and 60 s wait step for a total of 250 s. 
Figure 4.10: SEM close-up of grayscale in SU-8 2075 showing collapsed empty tips 
not removed during resist development.
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For development samples were immersed in 0.6% NaOH in DI1 water for 6 mins, 
followed by rinsing with DI water and blow drying with nitrogen gas. 
Grayscale resist structures were imaged using the Raith150 SEM function and a 
10 nm sputter deposited layer of tungsten. Figure 4.11 shows a scanning electron 
micrograph of a high-aspect ratio structure in AZ4562 photoresist. Total resist thickness 
was 60 μm on a 10x10 mm Prime N-type Si piece. The resist was exposed in Hard 
Contact mode on a Süss MA6 mask aligner in Multi-exposure mode. Exposure was 40x 
for 10 s each followed by a 60 s cooling step and recorded light intensity was 3.6 mW/cm2
at 356 nm wavelength. The inset show a transmission micrograph of the grayscale mask 
used for exposure. After development the structure was characterized using surface 
profilometry on a DEKTAK profilometer. Figure 4.12 shows the results of this 
measurement as a grayscale calibration plot of remaining AZ4562 resist thickness vs. 
relative pattern transmission on the mask. Patterns on the mask for the top row of pillars 
1.By recommendation from Microchem as the required developer AZ 351B was not available.
Figure 4.11: SEM image of high aspect ratio grayscale structures in AZ4562. Inset 
shows a transmission micrograph of the grayscale mask used for exposure.
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ranged from 100% to 50% in 10% steps (left to right) and 100% for the first pillar in the 
second row, followed by 10% to 50% (left to right). Height data shown in the insets in 
Fig. 4.12 was used to prepare the calibration plot. It is found that exposure dose and resist 
thickness are relatively close to a linear relationship for AZ4562, which is ideal for 
grayscale application. 
However, as can further be seen in Fig. 4.11, with this combination of grayscale 
mask, resist thickness and development the process window is very small. The resist 
surface is extremely rough even on the areas covered by the mask. This is attributed to the 
upper limit of tungsten absorber layer thickness achievable in the mask fabrication 
process not being sufficient to absorb all incident light. The smoother area around the 
inner square was obtained by increasing the absorber layer thickness using a black 
waterproof marker pen. However, this is not feasible for the actual grayscale structures, 
which will therefore show increased surfaces roughness limiting their application for 
smoothly tapering molds. A possible solution to this problem is to investigate the reflow 
properties of AZ4562 [99]. By exposure to elevated temperatures after development the 
Figure 4.12: Calibration curve recorded for grayscale in AZ4562. Plotted is the 
remaining resist thickness as a function of relative mask transmission. Insets show 
the profilometry scans used as raw data.
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resist can reflow and thereby be made to even-out existing surface roughness. Patterns 
defined through lithography prior to the reflow step have to be adjusted carefully to 
account for the change in dimensions during the resist flow. This leads to an unavoidable 
reduction in structural control and a very narrow process window. 
Figure 4.13 illustrates the application of the mask process together with resist re-flow 
(~30 min at 150°C) to fabricate a vertically-tapered microchannel in AZ4562 resist. To 
fabricate this structure the binary pattern of the channel was combined with the grayscale 
part on the optical mask. The mask was then used to fabricate the structure by single 
exposure of the resist in the MA6 optical mask aligner. The vertical arrow (across 
channel) in Fig. 4.13(a) corresponds to the scan of the initial channel depth depicted on 
the left in Fig. 4.13(b). Plotted on the right in Fig. 4.13(b) is the scan along the channel 
length (horizontal arrow in Fig. 4.13(a)). The channel tapers vertically in six steps from 
the initial depth of 22 µm to a minimum of 7 µm over a length of 1 mm. After hardbake 
the structure can be directly used as microchannel by sealing it with an appropriate lid. 
Alternatively, the structure can be used as inverse mold for replication in PDMS or a 
similar elastomer. While this example demonstrated the general applicability of the 
process developed, the essential precise control required to reproduce the final tapering 
shape, as given by the solution of the analytical model, could not be achieved in thick 
resist.
To retain the advantages of lithography-based microfabrication and to circumvent the 
problems encountered with grayscale lithography an alternative planar bioreactor design 
was developed. The design uses laminar flow characteristics to obtain the same shear 
inducing effect with a symmetric planar arrangement of the initial tapering shape 
function. By turning the tapering geometry into the horizontal plane standard lithography 
can be used for pattern transfer, as is described in the second part of this chapter.
4.3   CONSTANT DEPTH, TAPERING WIDTH BIOREACTOR
The reactor shape of Design B is indirectly derived from the results provided by the 
analytical model. Cell seeding can be on one or both the top and bottom surface of the 
channel. Since evaluation of the tapering effect on oxygen concentration requires the 
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Figure 4.13: Application example of the combined binary and grayscale mask 
process to fabricate a microchannel with an integrated feature tapering 
stepwise along the channel length. (a) Micrograph of the tapered channel 
indicating the profilometer scan directions. (b) Surface scan graph showing 
the rectangular depth profile across the channel and the stepwise tapering 
along its length.
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integration of a sensor, cells will only be cultured on one surface for the experimental 
measurement. The tapering shape of half the channel width can again be calculated using 
the analytical model and is mirrored for symmetry to provide constant oxygen 
concentration on the bottom surface over the channel length. Figure 4.14 shows a 3D 
rendering of Design B as used in FEMLAB to simulate fluid flow and species transport 
properties.
4.3.1 FABRICATION OF THE MOLD
Fabricating a planar mold with lateral tapering is significantly easier, as standard 
lithography can be used compared to grayscale lithography. No modulation of exposure 
light dose is necessary on the mask. Common printed foil masks, as well as glass masks, 
can therefore be used in simple projection mode. Furthermore, using this technique 
negative SU-8 resist can be exposed in direct contact mode from the resist side, making 
the creation of multi layer molds feasible [8].
4.3.1.1 Custom-shaped Bioreactors
In all cases standard (mechanical or test grade) 4 inch Si wafers were used as mold 
support. The substrates were cleaned for 20 min in Piranha solution (5:1 H2SO4:H2O2), 
rinsed with DI water and blow dried with nitrogen gas. Silicon wafers were dehydrated in 
Figure 4.14: FEMLAB model of Design B, reactor depth is constant (200 μm).
18.
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94
Bioreactor Design and Fabrication
a convection oven at 185°C for a minimum of 24 h prior to use. For the creation of the 
photoresist mold wafers were taken out of the oven and cooled to RT. This was followed 
by application of a thin adhesion layer of SU-8 2025. Without this layer successive 
processing of thick SU-8 2075 exhibits very low yields. Structures were observed to peel 
of after development possibly due to surface moisture and thermal stress during 
processing. SU-8 2025 was applied using a two-step spin-coating program with a spread 
cycle of 10 s at 500 rpm (acceleration 85 rpm/s) followed by 30 s at 4000 rpm 
(acceleration 340 rpm/s). Excess resist was cleaned from the wafer underside using a 
cleanroom wipe covered in acetone. Next, the resist was softbaked for 1 h at 95°C on a 
contact hotplate and allowed to slowly cool back to RT on the plate. Exposure was 
performed on a Süss MA6 mask aligner. To crosslink the whole adhesion layer the wafer 
was exposed in flood mode through a 10x10 mm Kopp 9345 (Newport Glass) filter1 for 
three times 10 s plus a 60 s wait period in between each exposure step to reduce thermal 
stress. This was followed by a PEB for 1 h at 95°C on a hotplate and cooling down to RT. 
As structural layer SU-8 2075 was applied on top of the SU-8 2025 adhesion layer in 
one or more spin coatings depending on the desired final thickness and mold design. 
Typically a two step spin-coating program was used. First SU-8 2075 was poured on to 
the wafer, spread using a cycle of 10 s at 500 rpm (acceleration 85 rpm/s) and spun to final 
thickness for 30 s at 1000 rpm (acceleration 10030 rpm/s). After cleaning the substrate 
underside, remaining solvent in the resist was removed during a 4 h softbake at 95°C on 
a hotplate and consecutive slow cooling to RT. Desired structures were then formed in the 
resist by exposure in the Süss MA6. A printed mask of the design was taped to a blank 
glass mask and placed in the mask aligner. Exposure was through the filter in “Hard 
Contact” and “Multi-Exposure” mode for 30x 10 s exposure interspersed with 60 s wait 
cycles. PEB was performed for 1 h at 95°C on a hotplate. Should a thicker layer or an 
integrated interconnect layer be required the whole process starting from spinning 
SU-8 2075 can be repeated. Exposure was then either in a long final cycle through the 
same mask or by aligning a second layer mask to the structures underneath followed by a 
final PEB. 
Finally, samples were developed in (1-Methoxy-2-Propyl)acetate (Merck) on an 
1.Used to filter out excessive energy below 350 nm for straighter sidewalls.
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orbital shaker for 20 min and an additional 10 min in fresh developer depending on 
structural thickness. After rinsing with IPA and blow drying with nitrogen gas, samples 
were given a final 4 h exposure to UV light in a custom UV-box and a hardbake for 1 h at 
100°C on a hotplate to allow for full crosslinking. Figure 4.15 shows a photograph of a 
two layer mold in SU-8 on a Si wafer. The bottom layer consists of the actual bioreactor 
shape, while a top layer defines vertical fluidic interconnects with a second device. The 
round ring surrounding the design has the thickness of both layers and is used to created 
a PDMS mold with openings on top and bottom [100].
4.3.1.2 Application of Release Layer
Mold creation was followed by the application of a fluoro-polymer based release layer on 
the Si/SU-8 mold. While PDMS is rather easily de-molded from SU-8 the lifetime of the 
master can be significantly increased by applying a release layer. Typically this is 
achieved by using the C4F8 deposition process in a DRIE etcher (Bosch Process [101]). 
Here a process based on the available Oxford PlasmaLab 80Plus RIE system and CHF3
as gas was developed. After performing a standard clean of the RIE system master wafers 
were loaded and the chamber pumped down to ~10-6 mbar. For deposition Forward Power 
Figure 4.15: Photograph of dual layer SU-8 mold. The bottom layer defines the 
reactor shape and the second layer provides vertical fluidic interconnects.
3mm
1mm
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was set to 100 W, etching pressure to 0.22 torr at 295K and CHF3 flow rate to 50 sccm 
for 20 min. Wafers were hardbaked for 20 min at 95°C on a hotplate following deposition. 
Figure 4.16 shows a photograph of a SU-8 mold with release layer. Structures on the 
master are for definition of the sensor and collagen placement on the bioreactor substrate.
4.3.1.3 Casting of PDMS Devices
After fabrication of the master mold, PDMS (Sylgard 184, Dow Corning) is used to create 
the actual channel and reactor structures. Figure 4.17 depicts the main steps of the 
multi-layer fabrication process. PDMS is a biocompatible silicone elastomer supplied as 
separate base and curing agent. To prepare the silicone for molding, 10:1 base:curing 
agent was weighed on a laboratory scale and mixed thoroughly by stirring with a glass 
rod. The mixture was then placed in a desiccator for 1 h to remove trapped air bubbles. 
Meanwhile the master mold was placed on polyethylene (PE) overhead foils on a 
hotplate. After degassing the mixture was carefully poured onto the master avoiding the 
formation of bubbles. A further foil was rolled onto the silicone and covered with a rubber 
sheet. To form top/bottom open layers using the double layer mold masters a heavy 
weight (~5 kg) was placed on top of the stack. The PDMS was then thermally cured at 
70°C for a minimum of 1 h on the hotplate. After cooling down to RT the silicone was left 
Figure 4.16: Photograph of SU-8 mold for sensor fabrication after 
plasma deposition of release layer.
3mm
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overnight to increase curing. Finally the device was peeled off the mold and placed on a 
PE sheet for storage. For fluidic sealing both the silicone and a glass microscope slide 
were exposed to 1 sccm oxygen plasma at 500 W for 10 s in a PlasmaFab wafer asher and 
brought into contact creating an irreversible seal. Visualization of channels and 
bioreactors was performed by infusion of DI water with a food color dye. Figure 4.18
shows an assembled linearly increasing wall shear stress bioreactor with a top layer 
providing interconnection to external tubing. Moving the external interfacing to the sides 
of the device allows for easier access during microscopy.
4.4   BIOREACTOR SCALE-UP STUDY
To show the feasibility of system scale-up a multi-reactor demonstrator emulating a 
bioartificial liver device was fabricated. Roy et al. [88] stated a seeding density of 
250,000 hepatocytes per 5.65 cm2 for rat hepatocytes. Processing this data it can be 
deduced that up to 13,000 hepatocytes could grow in the 29.257x10-2 cm2 available in the 
single reactor prototype. The fraction of liver mass that is necessary for patient survival 
has been estimated to between 2-12% of total liver mass. It has been reported that a BAL 
containing as little as 600 million hepatocytes (3-5%) [27] significantly increases the 
survival of pigs with induced liver failure. Using the seeding density given for rat 
hepatocytes, a bioartificial liver would therefore require a minimum of 46,200 single 
reactors to provide survival enhancing vital functions. This number can potentially be 
reduced to 23,100 by culturing cell on both bottom and top surface of the developed 
bioreactor. Furthermore, bioreactors can be combined to form larger patterns as observed 
in the liver itself. In the following, two prototype devices are introduced demonstrating 
the feasibility of device scale-up using the elastomer-based bioreactors described in this 
chapter.
4.4.1 FIRST PROTOTYPE
Figure 4.19 shows a SU-8 mold master of 18 radially aligned bioreactors joined at a 
central core. Using this layout single PDMS layers were fabricated and bonded to a glass 
substrate. In Fig. 4.20 such a device is shown with all 18 reactors filled with dye-colored 
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Figure 4.17: Main fabrication steps of the multi-layer 
PDMS bioreactor process
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DI water. This design would require 1,300 devices to provide enough seeding area to 
replace a fully grown liver. Vertical interconnect in this early example were fabricated by 
manually coring holes with a hollow needle tip. Future designs will employ the single 
layer PDMS integrated interface technology described above, where vertical 
interconnects are an integral part of the mold. The speciality of the master mold technique 
is, that once the master is fabricated, a large number of silicone devices can be cheaply 
reproduced. Therefore, to increase the seeding area for cells several of the device layers 
can be vertically stacked and sealed via PDMS-PDMS bonding. 
Figure 4.21 shows an example of two such devices bonded on top of each other. First 
the bottom layer was bonded to a glass substrate and the vertical holes cut using sharpened 
stainless steel dispensing needles (Farnell). Then the first and second layer were exposed 
to 1 sccm oxygen plasma at 500 W for 10 s in a PlasmaFab Asher and aligned using 
methanol. The methanol protects the activated surface from re-oxidation during manual 
alignment and allows for bonding once evaporated [100].
Figure 4.18: Photograph of a single linearly-increasing wall shear stress 
bioreactor bonded onto a glass substrate. A second layer provides 
interconnection to external tubing (orange) via small blocks of PDMS.
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Figure 4.19: Photograph of 18 radially arranged bioreactors in SU-8 
mold for system scale-up study.
Figure 4.20: Single layer replica of PDMS bonded on to a glass substrate. 
All 18 bioreactors are filled with dye-colored DI water from a central 
opening.
3mm
3mm
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4.4.2 SECOND PROTOTYPE
Encouraged by results from the first two-layer prototype, the SU-8 molds were redesigned 
for a second prototype. This time the molds were to incorporate all fluidic features so that 
no manual handling would be required during fabrication and assembly. All features 
crossing between the individual layers, like vertical interconnects, were included in the 
corresponding mold masters by use of multi-layer SU-8 features as mold material. A total 
of three different mold masters were required, two for the top and bottom liquid 
interconnect and distribution layers and one for the functional layer containing the 18 
radially arranged bioreactors. 
One of each top and bottom layers, as well as seven of the functional layers, were cast 
in a 10:1 PDMS mixture and thermally cured as described before. Upon release from the 
mold, layers were bonded using oxygen plasma surface activation. First, the bottom 
interconnect layer was bonded to a glass substrate and then the first of the seven 
Figure 4.21: Two-layer PDMS device with a total of 36 bioreactors in two layers. 
Vertical fluidic interconnects between the two layers are visible on the right.
3mm
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successive functional layers was bonded onto this stack. After a rest period of 24 h to 
strengthen the previous bond, the resulting stack was again exposed to oxygen plasma, 
this time together with the next functional layer. This process was repeated for all layers 
including the attachment of a square PDMS connector block to the final top layer. 
Alignment of individual layers in between bonding was performed manually by applying 
a thin layer of methanol to the activated surface of the stack. The new layer was then 
inverted onto the stack and manually aligned using the vertical through holes and special 
alignment marks integrated in the initial design. Manual alignment of the layers to be 
bonded could easily be replaced by an automatic tool similar to a wafer bonder in a future 
commercial fabrication process. External interfacing concluded the prototype fabrication 
and was performed by coring into the square connector block with a syringe needle.
After assembly of the nine layers into a single device, liquid handling was tested by 
pumping dye-colored DI water through the stack. Figure 4.22 shows a photograph of the 
device with close-ups depicting the general layout. A total of 126 bioreactors are 
integrated over seven layers, with each layer containing 18 individual reactors. Liquid is 
injected through the central inlet (Fig. 4.22(a)) on the top and travels down a centre 
column to the top distribution layer. Here the flow is separated into 18 horizontal channels 
leading to the vertical columns on the outside perimeter (Fig. 4.22(b)). These columns 
each feed one bioreactor per layer, running all the way from the top of the device to the 
bottom. After travelling through a reactor the fluid drains into a vertical central column. 
This column drains via a horizontal outlet channel on the bottom layer and a further 
vertical column connected to a hole on the topside (Fig. 4.22(c)). 
With PDMS-based microfluidic devices the hydrophobic nature of surfaces has to be 
taken into account when filling a device for the first time. Priming (pre-filling) with 
another liquid is sometimes used to overcome the initial flow resistance. In case of the 
prototype priming was not necessary to achieve filling of all the individual fluidic parts. 
However, it was observed that the slight offset in vertical alignment of the different layers 
and their interconnecting structures due to manual handling reduced the inherent 
symmetry of the device. This unbalances the flow resistance along the different parallel 
flow branches and leads to preferential filling of certain areas prior to others relative to 
the central inlet. A solution to this problem would be to use automatic handling and 
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alignment of layers during fabrication or to produce a single homogenous device by 
injection molding. The latter would also eliminate potential sealing problems between 
layers. Although observed to be very reliable and repeatable, especially despite the large 
number of individual layers, oxygen plasma bonding of PDMS requires careful handling 
and environmental control to produce good sealing. For a total of 9 bonded layers the 
Figure 4.22: Second prototype demonstrating the feasibility of device scale-up: The 
multi-layer design in PDMS integrates 126 bioreactors on seven layers around a central inlet 
(a) and common outlet (c). The number of layers in this prototype is only limited by the 
reproducibility of the manual alignment. Device was filled with dye-colored water for 
visualization.
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device showed only one small delamination between two functional layers close to the 
outlet. This however, could be enough to render the device unusable if it leads to major 
leakage and thereby pressure loss. One possible way to strengthen the PDMS-to-PDMS 
bond is to initially produce only partially cured layers by reducing the recommended 
baking time during molding and then to add a final curing bake after the assembly of the 
complete device to enhance the interstitial bond between adjacent layers.
4.5   SUMMARY
In house grayscale lithography was investigated as a means of fabricating microfluidic 
bioreactors. A process for mask fabrication was developed and used to create master 
molds in positive and negative tone photoresist. However, features produced using 
grayscale lithography were observed to exhibit excessive surface roughness, which in turn 
would affect fluid flow in channels replicated from these molds. At the current stage 
further work into process optimization would be needed to achieve a significantly lower 
surface roughness. To alleviate this problem it would need to be investigated whether a 
final reflow bake could be used to reduce surface roughness. This technique is often used 
to produce rounded master structures in resist. It is however, not applicable to high-aspect 
ratio, epoxy-based photoresists such as SU-8, and is associated with a certain loss of 
control over structural feature size. In terms of time constraints and overall project goals 
it was therefore chosen to concentrate further development on Design B. This potentially 
provides the same effect as the tapering depth Design A, with the added advantage of 
using standard fabrication technology available at the Nanofabrication Laboratory. In 
summary, the full fabrication process from mold making to final device sealing for Design 
B has been demonstrated in this chapter. The fabrication process allows for a fast and 
flexible device prototyping and potential scale-up to the automated fabrication of a full 
bioartificial liver device. The following chapters will focus on the integration of oxygen 
sensing and cell-culture into the bioreactor chip.
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When I'm working on a problem, I 
never think about beauty. I think 
only how to solve the problem. But 
when I have finished, if the solution 
is not beautiful, I know it is wrong.
R. Buckminster Fuller 
1895-1983, American Architect, 
Author, Futurist, Inventor and Visionary
CHAPTER 5  
Oxygen Sensor Integration
One of the central ideas behind the use of channel geometry is to control and improve 
species transport to cells cultured within. To determine whether the analytical model 
developed specifically for oxygen transport to liver cells is valid requires a means of 
measuring the concentration gradient of dissolved oxygen (DO) inside the bioreactor 
device. Since the gradient produced by the geometry is not ideally constant and specific 
non-constant gradients can be of biological interest, simply measuring the inlet/outlet 
concentrations will not be sufficient.
A potential sensor has to be easily integrated into the confined space of the chamber 
without influencing the flow characteristics of the reactor. It further needs to have 
sufficient sensitivity to allow for detection of the minute changes in oxygen concentration 
exhibited by live cells. This chapter therefore discusses the advantages and limitations of 
the two most common sensor technologies, amperometric and optical oxygen sensing, for 
the detection of DO in biological applications. Optical oxygen sensing is identified as 
most suited for use in the bioreactor device and a novel sensor fabrication process is 
developed to improve presently available methods. The deposition of sensor films, their 
patterning and signal optimization, as well as their integration into the PDMS-based 
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bioreactor device are discussed in detail [10]. This represents one of the major 
contributions of this thesis.
5.1   OXYGEN SENSING IN BIOLOGICAL APPLICATIONS
Oxygen concentration is increasingly recognized as a central parameter in cellular studies. 
In a natural environment, such as in mammalian organs, cellular oxygen concentration is 
maintained to normoxic (12% to <0.5% O2) conditions [102]. Regulation to within this 
relatively narrow range of normoxia is necessary in-vivo to prevent oxidative damage to 
the cell from excess oxygen (hyperoxia) and metabolic demise from insufficient oxygen 
(hypoxia) [1]. Absolute normoxic values for a specific cell are furthermore dependent on 
the cell localization within a particular organ like the liver. Here localization is exhibited 
in form of oxygen modulated zonation and gradients along the length of the sinusoid 
result in regionally dominant metabolic and detoxification functions [103]. This natural 
sensitivity to local oxygen concentration can be replicated in-vitro to selectively increase 
specific liver cell function like urea synthesis [73]. 
However, recent research has indicated that in-vitro cell-culture experiments 
performed in air (~21% O2) may introduce excessive stress on cells due to exposure to 
unnaturally high oxygen concentrations [102]. Fibroblasts exposed to different oxygen 
concentrations were found to adjust to high oxygen levels by reversible growth inhibition 
and differentiation. For neural and other stem cells in comparison, hypoxic conditions 
were observed to promote growth and influence differentiation [104]. Measurement of 
oxygen concentration is therefore of special importance when comparing in-vitro results 
to cell behavior observed in-vivo. 
In general it can be said that oxygen uptake of cells is a powerful marker for their 
metabolic status, health and response to exogenous and endogenous stimuli [105]. 
Beyond cell culture, oxygen consumption characteristics can also be used to determine the 
development status of higher organisms. For example, a direct link exists between oxygen 
consumption of pre-implantation mammalian embryo and their development status. This 
indicates that integrated oxygen detection, such as developed here, has the potential to 
provide biomedical applications and the agricultural industry with a reliable, 
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non-intrusive tool to investigate embryogenesis, gene manipulation, cloning, assisted 
reproduction and transgenic animals [106].
5.1.1 PRINCIPLES OF OXYGEN SENSING
Traditional laboratory procedures for the measurement of oxygen in solution require the 
extraction of a sample volume for external analysis. This sampling approach is limited by 
the difficulty and time needed for extraction and analysis. With fluid volumes in the range 
of micro-liters and below, as found frequently in current microfluidic LOC devices, 
analyte sampling constitutes a major disturbance of the system to be measured. This is a 
particular problem for sensing of less stable solutes such as oxygen, where retrieval is 
likely to significantly alter the sample characteristics [107]. Alternative in-situ sensing 
approaches are therefore needed and two such potential candidates are introduced in the 
this section.
5.1.1.1 Amperometric vs. Optical Oxygen Sensing
Two main technologies, amperometric electrochemical and optical sensing currently 
constitute the bulk of integrated sensors for the measurement of DO in biological 
applications. Both are tolerant to liquid exposure and exhibit the high sensitivity needed 
to detect the small changes of oxygen encountered in the cellular environment. The first 
principle, amperometric electrochemical sensing, has been applied in a variety of 
biomedical LOC devices [106,108,109]. Despite continuous interest, several significant 
limitations have been identified concerning the use of amperometric sensors. When 
exposed to organic matter sensor lifetime has been found to decrease through membrane 
fouling. Oxidation of the electrode surface area after prolonged usage and electrolyte 
depletion can be responsible for inconsistency between measurement data. A second, 
more important concern relates to the fundamental method of operation of the 
amperometric electrode [111]. The Clarke sensor operates by reducing oxygen and, in a 
low flow rate environment like the bioreactor device, is prone to show signal dependence 
on flow rate. Additional problems are posed by miniaturization itself, mainly due to the 
need to integrate a reference electrode [107].
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5.1.1.2 Optical Oxygen Sensing
By contrast, fluorescent dye-based optical sensing does not exhibit analyte depletion, and 
has therefore emerged as a promising alternative in biomedical applications. The principle 
of measurement with this type of sensors relies on the quenching of either the intensity or 
lifetime of light emitted by a fluorescent dye in the presence of molecular oxygen. 
Fluorescence occurs upon excitation of the dye molecule (fluorophore) to an exited state 
and subsequent relaxation back to the ground state via the emission of light [110]:
(5.1)
(5.2)
(5.3)
where  is Planck's constant and  are the frequencies of the excitation and 
emission light, respectively, and the molecular rate constant for oxygen quenching. One 
pathway for relaxation from the exited state of the fluorophore is via interaction with a 
secondary molecule. In case of oxygen, fluorescence quenching has a pronounced effect 
on the quantum yield as a result of the triplet ground state of the O2 molecule. The 
fluorescence intensity, , and lifetime, , and can be obtained for dissolved or gaseous 
oxygen from the Stern-Volmer equation for intensity [112]:
(5.4)
where  and  are the Stern-Volmer constants for solution and gas, respectively, 
 and  the reference values in absence of oxygen,  is the oxygen concentration in 
solution and  is the gaseous partial pressure of oxygen. Figure 5.1 illustrates the 
principle of oxygen sensing based on fluorescence for intensity quenching using sensors 
developed in this work.  The intensity signal of a sensor pattern with no oxygen present 
(0% O2) decreases upon exposure to gaseous or dissolved oxygen molecules (100% O2). 
This decrease in intensity is recorded and translated into oxygen concentration by 
comparison to a reference value. Since the fluorescence quenching is reversible, the 
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intensity reverses to its initial value once the oxygen is removed again (0% O2). Should 
other effects (e.g. sensor film inhomogeneities) cause intensity fluctuations, fluorescence 
lifetime could be used to measure the oxygen concentration, however this requires a 
significantly more complicated experimental setup to modulate the excitation and extract 
spatial information.
5.1.1.3 Sensor Materials
While this characteristic quenching is exhibited by the majority of fluorescent dyes, a 
small subgroup has been found to be especially suited due to high sensitivity and long 
fluorescence lifetimes. These dyes are commonly categorized [112] into organic 
Figure 5.1: Schematic depicting the principle of optical oxygen 
sensing. The fluorescence signal intensity of a sensor pattern 
(0% O2) is reversibly quenched in presence of oxygen molecules 
(100% O2). This signal decrease is translated into an oxygen 
concentration value relative to a reference intensity via a calibration 
curve.
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luminescent or organometallic compound probes and used in solution [105,113,114] or 
immobilized on a support matrix [88,107,115-117] for the detection of dissolved oxygen. 
For use with low-cost LOCs, dye immobilization has the advantages of increasing the 
ease of handling and reducing the amount of fluorescent dye required. Table 5.1 gives a 
list of organometallic complexes used as oxygen sensors together with 
absorption/emission wavelengths, suitable solvents for immobilizing polymer films and 
relative intensity change. 
Platinum(II) octaethylporphyrinketone (PtOEPK) suspended in a microporous 
polystyrene (PS) matrix has been identified as well suited for use in LOC devices due to 
its desirable optical properties, compatibility with standard optical components and it 
being readily available commercially. The PtOEPK dye molecule (Fig. 5.2) shows strong 
phosphorescence with a high quantum yield and long lifetime at room-temperature.
Sensors immobilized in PS have been shown to diminish only 12% under continuous 
illumination for 18 h, detected by absorbance measurement [112]. It exhibits both a 
long-wave shift and an extended long-term photostability compared to other fluorescent 
dyes [118]. This allows for the use of standard optical filters and makes sample handling 
less critical. PS was chosen as polymer matrix because it provides good 
oxygen-permeability, bio-compatibility and low auto-fluorescence.
Figure 5.2: Chemical structure of the 
PtOEPK molecule.
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5.2   SENSOR FABRICATION
The following sections discuss existing sensor fabrication processes and introduce the 
novel sensor-layer patterning process developed as part of this thesis. Whilst simple in 
concept (see Fig. 5.3), the details of the process required a significant amount of effort to 
allow for integration with the PDMS-based channels.
5.2.1 LIMITATIONS OF CURRENT FABRICATION PROCESSES
Beyond the advantages mentioned before, the PtOEPK/PS system shares one major 
limitation with most other fluorescence-based sensor materials, namely the challenge to 
fabricated micro-scale patterns and integrate them with commonly used PDMS devices. 
Organic solvents such as acetone readily dissolve PS, making it impossible to 
Probe λmax (abs)
[nm]
λmax (em)
[nm]
Suitable solvents 
for immobilizing 
polymer films
I0/I100 in various 
polymer films
Ru(dpp)3 2+ 337, 457 610 dichloromethane 4.4 in silicone film
1.1 in PS film
3.5 in PVC film
Os(dpp)3 2+ 454, 500, 580, 650 729 dichloromethane 4.5 in poly(DMS) film
Os(phen)3 2+ 432, 478, 660 720 dichloromethane -
Ir(ppy)3 376 512 THF, 
dichloromethane
1.2 in PS film
PtOEP 381, 535 646 toluene, THF, 
dichloromethane
4.5 in PS film
PtTFPP 395, 541 648 toluene, THF, 
dichloromethane
3.0 in PS film
PtOEPK 398, 592 758 toluene, chloroform 2.0 in PVC film
20 in PS film
PdOEP 393, 512, 546 663 toluene, THF, 
dichloromethane
11.5 in PS film
PdOEPK 410, 603 790 chloroform,
toluene
8.0 in PVC film
28 in PS film
Table 5.1: List of possible organometallic luminescence probes for optical oxygen sensing. 
Both Palladium OEPK and Platinum OEPK exhibit very high intensity ratios I0/I100
immobilized in PS films (Adapted from [112]).
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Figure 5.3: Schematic of the sensor fabrication process. Starting 
with a substrate, a sensor film is deposited (a) and patterned (b) to a 
desired shape. This stack is then integrated (c) into PDMS-based 
microfluidic channels, providing the fluidic enclosure, and the 
structure is seeded with cells (d).
substrate
substrate
oxygen sensordeposit sensora)
pattern sensorb) oxygen sensor
substrate
integrate with PDMS channelsc)
oxygen sensor
substrate
PDMS
seed cellsd) oxygen sensor
substrate
PDMS
cells
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subsequently apply photoresist on PtOEPK/PS films for standard lithographic patterning. 
In experiments performed with conventional positive tone resist (AZ1518, 
Microchemicals, Ulm, Germany) poor wetting of the resist on the PS film was observed. 
Figure 5.4 shows a photograph of a glass slide covered with PtOEPK/PS onto which 
photoresist was applied by spin-coating. 
As can be seen, during application the resist forms streak-shaped patterns due to 
solvent incompatibility and development in aqueous developer (AZ MIF300) leads to 
partial resist lift-off. Furthermore, removal of the photoresist with acetone after exposure 
and development, lead to the destruction of the underlaying PtOEPK/PS film surface. 
Vollmer et al. [115] proposed photoresist lift-off in combination with pipetting of 
individual PtOEPK/PS patches through openings in the resist. They demonstrated an 
integrated oxygenator device with two large, manually deposited sensor patches and 
successively calibrated these for DO measurement. However, employing the same 
technique we were unable to obtain good sensor adhesion both on untreated and 
pre-etched glass substrates. Sensor membranes repeatedly lifted-off together with the 
photoresist mask, either due to the cohesive strength of the dried PtOEPK/PS film or due 
to delamination by the lift-off solvent used. The following discusses the method proposed 
in literature and compares it to an alternative method developed as part of this thesis.
Figure 5.4: Photograph showing de-wetting and adhesion failure of AZ1518 
positive tone photoresist spin-coated onto a thin layer of PtOEPK/PS sensor 
material.
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5.2.2 DEPOSITION OF THE SENSOR LAYER
5.2.2.1 Substrate Etch and Pipetting of Sensor Films
The application of a thin film of oxygen sensitive dye PtOEPK was tested on various 
substrates including PS Petri dishes, PDMS covered microscope slides and standard glass 
microscope slides. Glass microscope slides are the preferred substrate for two reasons: 
first, compatibility of glass with PDMS plasma bonding to form an irreversible seal 
between substrate and the PDMS-based bioreactor device, and second, because the glass 
substrate reduces oxygen diffusion to the sensor through the substrate to a minimum. This 
allows for faster equilibration of the sensor layer to the measurement environment. 
For the sensor deposition experiments 5% and 7% w/w solution of PS without 
PtOEPK dye were prepared as a dummy sensor layer by dissolving PS (Sigma Aldrich, 
200k MW) in toluene. This was done to conserve the fluorescent dye since prior testing 
had not shown any significant difference in the surface properties of PS films with or 
without PtOEPK. 
The first PS application method investigated is based on the method described by 
Vollmer et al. [115]. Hereby a commercial glass etch is used in combination with 
photoresist to provide a locally defined recess (7-10 μm deep) in the glass substrate. Due 
to export restrictions the particular etch (Armour etch) employed by Vollmer et al. was not 
available for use outside the United States of America. Buffered hydrofluoric acid (HF) 
was therefore used as a substitute etch for the following experiments. HF is known to 
produce rough surfaces when used to etch glass, similar as described by Vollmer et 
al. [115] for the Armour etch. This is important as it will increase adhesion of the PS layer 
to the glass substrate from which it might otherwise be lifted off when exposed to fluid 
flow inside the reactor1. 
First experiments were performed by spin coating AZ1518 photoresist for 30 s at 
2040 rpm on a standard 25 x 75 mm glass microscope slide (ESCO Products, Oak Ridge, 
NJ, USA), followed by a softbake of 60 s at 100°C on a hotplate. The resist was then 
exposed 20 s in a Süss MA6 mask aligner using a printed foil mask. After 45 s 
development in AZ MIF300 and rinsing with DI water a 5 min hardbake at 100°C was 
1.This is also the function of the recess in the substrate.
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performed on a hotplate. Samples were then etched in buffered HF and rinsed thoroughly. 
Figure 5.5 shows the etch rate calibration data, from which an etch rate of 0.23 μm/min 
was determined. Samples were etched for 30 min to give an etch depth of 6.9 μm, 
approximately matching the value used by Vollmer et al. [115].
Remaining AZ1518 was stripped and re-applied as described above. The same mask 
was aligned to the etched pattern, the photoresist was re-exposed and developed. 
Depending on pattern size, 1 to 3 μl of PS solution were applied by pipetting to the 
exposed areas. Sensor patches were left to evaporate the toluene solvent overnight and the 
resist was stripped using acetone on the following day. It was observed that the majority 
of PS patches produced in this manner lifted-off completely with the photoresist. This was 
the case even in the dedicated sensor areas where resist was removed prior to PS 
application and the underlaying glass surface was pre-etched. Due to unavailability of the 
glass etch used by Vollmer et al. [115], it could not be determined whether this was due 
to a reduced roughness of the HF etch compared to Armour etch. Visual observation of 
the bottom of the etched patterns showed significant roughness (Fig. 5.6). 
The same experiments were further repeated with bottom/top open PDMS stencils as 
etch masks to allow for extended etch times compared to AZ1518 photoresist. Stencils 
were created as described in Chapter 3 by molding against a resist master. For etching, the 
Figure 5.5: Etch depth in glass slide for buffered HF with PDMS mask.
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stencils were brought into reversible contact with the glass substrate and the samples 
immersed in buffered HF for various times. After etching samples were rinsed thoroughly 
with DI water, immersed in DI water twice and rinsed again. Finally samples were dried 
using nitrogen gas and measured on a DEKTAK profilometer. As before the PS solution 
was applied by pipetting, however, in this case either with or without PDMS stamp 
attached. In the first case the resulting PS film was observed to peel of with the PDMS 
stamp after evaporation of toluene even if the film was confined to the glass recess only 
and not covering the PDMS. In the second case slightly better adhesion was observed, but 
the sensor confinement required greater care during application and showed large lateral 
thickness variation. Overall results from the above experiments indicated the need for a 
different, more reliable sensor fabrication method. While the advantages of the 
PtOEPK/PS material system for use as oxygen sensor are obvious, their integration into 
biological applications requires better control over sensor placement and film 
homogeneity than given by pipetting. To obtain high quality sensor films repeatable, a 
novel deposition method based on spin-coating was developed. The following section 
discusses this procedure and the properties of fabricated sensor films. 
Figure 5.6: Micrograph of a microscope slide surface etched in 
buffered HF for 30 min using a PDMS stamp as etch mask.
etched
not etched 200um
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5.2.2.2 Spin-Coating of Sensor Films
The second PtOEPK/PS application method investigated is spin-coating, a standard 
industry process used for the application of thin films and photoresist to flat substrates. 
To deposit a film onto the substrate, the material of choice is dissolved in an appropriate 
solvent and the solution then spread over the rotating substrate by centrifugal force. Films 
applied by spin-coating exhibit high thickness uniformity and repeatability. The final film 
thickness is mainly controlled through the spin speed and duration, but it also depends on 
the concentration of the solution and the solvent used. Oxygen sensitive PtOEPK is 
readily dissolvable in a PS/toluene solution, making it well suited for application by 
spin-coating. Left at RT, spin-coated PtOEPK/PS forms solid films through evaporation 
of toluene. 
The sensor material was prepared by dissolving PS pellets in toluene to yield 5% and 
7% w/w solutions. Both solutions are based on PS purchased from Sigma Aldrich, with 
the 5% w/w solution corresponding to standard grade PS with a molecular weight (MW) 
of 200.000 (Product No. 327786-1G), whereas the 7% w/w solution uses lower grade PS 
with an average MW of 280.000 (Product No. 182427-25G). PtOEPK dye was added to 
the PS solution at 1 mg per 1 ml. Oxygen-permeable films of the PtOEPK/PS sensor 
material were prepared by pipetting approximately 200 μl of the solution onto clean 
50 mm x 75 mm glass microscope slides and spinning for 30 s at different speeds on a 
standard spin-coater (WS-400B-6NPP-LITE, Laurell Technologies Corp., North Wales, 
PA, USA). After spin-coating, samples were left overnight at room temperature to 
evaporate the toluene. Thickness of the PtOEPK/PS layer was measured using a surface 
profilometer (Dektak, Veeco, Woodbury, NY, USA) at least 24 hrs after spin-coating. 
Figure 5.7 shows a plot of film thickness as a function of spin speed for the two solutions 
of PtOEPK in different MW PS. The thickness was found to decrease linearly with 
increasing spin speeds. Optical inspection of the samples showed the formation of 
smooth, continuous films on the glass substrate. A quantitative test by blowing 
pressurized nitrogen onto the films further demonstrated good adherence of the sensor 
without the need to pre-etch the substrate. As discussed later, the optical properties of 
these spin-coated films were also very good.
With a reliable sensor deposition process in place it was then possible to develop a 
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compatible patterning process, described in the next section. This process allows for the 
straightforward fabrication of laterally defined sensor structures and their integration at 
positions of interest within a PDMS-based microfluidic device.
5.3   SENSOR PATTERNING
As discussed in the previous section, spin-coating can be used to fabricate high quality 
thin films of PtOEPK embedded in a PS matrix. Coated films exhibit excellent thickness 
homogeneity and repeatability due to the nature of the application process. When used as 
oxygen sensor these film properties lead to increased homogeneity and stability of the 
sensor signal intensity. Thus improved films, in turn, allow to implement fluorescent 
intensity-based, laterally resolved measurement of oxygen concentration. While 
spin-coated films can be applied to various substrates and directly used as sensors, their 
integration into microfluidic and PDMS-based devices in particular, requires a means to 
produce design specific sensor patterns. Due to differences in surface chemistry a 
Figure 5.7: Plot of sensor film thickness on glass microscope slides as a function of 
spin speed. Thickness was measured using a profilometer after spin-coating at the 
given speed for 30 s and evaporation of toluene (> 24 h at RT). For the 5% solution 
MW 200.000 PS was used and for the 7% solution MW 280.000 PS, respectively.
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substrate fully covered in a PS thin film makes it significantly more difficult to achieve a 
permanent bond to a PDMS fluidic network with the established processes of surface 
activated PDMS-to-PDMS or PDMS-to-glass bonding. This problem can be avoided by 
limiting the PS sensor to areas within a particular fluidic feature such as a channel or 
reactor chamber. The PDMS device can thus be bonded to the exposed glass substrate 
surrounding the patterned sensor patches. 
However, incompatibility of PS with common resist solvents, like acetone, makes it 
impractical to pattern the spin-coated films by photolithography. In experiments 
performed with conventional photoresist poor wetting of the resist on the PS film was 
observed (Fig. 5.4). Furthermore, removal of the photoresist with acetone after exposure 
and development lead to the destruction of the PS film surface. Hence, a different 
approach to sensor patterning was required. The process developed as part of this thesis 
and described in the following, relies on elastomer stamps for the definition of the pattern 
and oxygen plasma etching to transfer the pattern into the sensor layer, thus creating a 
completely “dry” patterning process. 
PDMS was chosen as stamp material due to its material properties and ease of use. 
Pre-polymer mixtures of PDMS base and curing agent are routinely used in various 
applications to conformally replicate high resolution master patterns by a simple process 
of pouring, degassing and heat curing. The stiffness of the final stamp can, to a certain 
degree, be adjusted by increasing or decreasing the base/curing agent beyond the 
prescribed 10:1 w/w mixing ratio given in the Sylgard application notes  [119]. For use as 
masks the stamps are brought (pattern side down) into conformal contact with the sensor 
film to be etched. After the etching step the stamps are peeled of the film and can be 
re-used. Figure 5.8 shows a schematic summarizing the main steps of the sensor 
fabrication process. Both positive and negative elastomer stamps can be fabricated.  
The negative stamps (stencil masks) contain vertical vias for the RIE patterning, 
which can be problematic for isolated features. Hence the process was further extended to 
produce positive stamps supported on a PDMS substrate. The positive stamps contain a 
100-200 μm thick pattern detail part and a thicker PDMS backing that laterally overhangs 
the pattern by several millimeters and simplifies the stamp handling during placement. 
The extent of this overhang is determined by cutting away excess PDMS around the 
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pattern areas. The patterning process, as well as experimental results for both stamps, will 
be discussed in the following. It will be shown that both positive and negative stamps can 
be successfully used for RIE-based pattern transfer despite the large backing structure.
Figure 5.8: Schematic depicting the main steps of the sensor patterning process: (a) A resist 
master of the negative or positive stamp pattern is fabricated in SU-8 photoresist, (b) the 
stamp is replicated in PDMS and released for use as mask. (c) PtOEPK/PS solution is 
spin-coated onto a clean glass slide and the solvent toluene is evaporated. (d) The stamp is 
brought into conformal contact with PtOEPK/PS film and the pattern is transferred into 
sensor layer by oxygen plasma etching. After etching the stamp is removed for possible 
re-use. (e) Finally, the sensor pattern on a glass substrate is integrated with a PDMS 
microfluidic device by plasma bonding.
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5.3.1 SOFT LITHOGRAPHY AND PLASMA ETCHING PROCESS
PDMS stamps were produced by fabricating a master with the inverse of the desired 
sensor pattern in SU-8 negative tone photoresist on a 100 mm silicon wafer (Fig. 5.8(a)). 
As described in Chapter 4 the wafer is first covered with a thin, fully crosslinked 
SU-8 2025 adhesion layer. This is followed by applying a second, thicker layer of 
SU-8 2100. After a 2 h solvent removal bake at 95ºC on a contact hotplate, the layer was 
exposed through a mask containing the sensor pattern in a Süss MA6 mask aligner. This 
was follow by a post exposure bake of 40 min at 95ºC on a hotplate to activate resist 
cross-linking. Finally, development was performed by immersion in 
(1-methoxy-2-propyl)acetate and patterns were rinsed with isopropanol and blow-dried 
with nitrogen. To facilitate removal of the cured PDMS a fluoropolymer layer was 
deposited onto the resist mould. Meanwhile, liquid PDMS pre-polymer was prepared by 
thoroughly mixing 10:1 w/w base/curing agent. Prior to use the mixture was degassed in 
vacuum to remove any trapped air bubbles. The pre-polymer was then poured onto the 
resist master. It is then cured on a hotplate at 80ºC for 90 min. By using a weight to expel 
excess PDMS and the corresponding master, a negative stamp can be produced. To obtain 
a positive stamp the pattern detail replicated from the master is reinforced by a thick 
PDMS backing. The fabrication of a negative stamp is depicted on the left and that of a 
positive stamp on the right of Fig. 5.8(b). Once cured, the PDMS replica of the stamp 
pattern was carefully peeled off and the backing cut to size using a scalpel. 
For patterning, the stamps were brought into conformal contact with the PtOEPK/PS 
layer formed on clean glass microscope slides by spin-coating and solvent evaporation 
(Fig. 5.8(c)). The stack was then placed in an Oxford Plasmalab 80Plus reactive ion etcher 
and the layer was etched using oxygen as the reactive species (Fig. 5.8(d)). The etching 
conditions used were 50 sccm O2 flow rate, 0.55 Torr etch pressure and 200 W RF power 
applied for a typical etching time of 5 min or more depending on the film thickness of the 
spin-coated sensor layer. For a discussion of the plasma conditions and chosen etch 
pressure in relation to the successful use of “positive” stamps see the next section.
After plasma etching, PDMS stamps were peeled off and could be re-used. Prior to 
characterisation, sensors were stored in the dark to prevent possible long-term 
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photobleaching. PDMS stamps and PtOEPK/PS sensor patterns were imaged using SEM, 
optical microscopy and fluorescence microscopy. SEM micrographs were recorded using 
the imaging function of a Raith 150 electron beam lithography system, as described in 
detail in Chapter 4. Differential interference contrast (DIC) in reflected light on a Nikon 
Eclipse 80i fluorescence microscope with a 5x Nikon objective was used to record 
patterned sensor films. Due to the pattern size and amplification partial images were 
recorded and successively stitched on a PC running a freely available demo version of the 
Autostitch software package [120]. Fluorescent imaging was performed on the same 
microscope as used for DIC, but in combination with a Sony Digital Handycam in 
Nightshot mode for near infrared (NIR) image acquisition. A special filter combination 
with excitation/emission filters at 595/760 nm and a 620 nm dichroic mirror was 
purchased from Chroma (Rockingham, VT, USA).
5.3.2 PATTERNING RESULTS
Following spin-coating, sensor films were patterned to micrometer resolution using 
elastomeric stamps and plasma-assisted RIE. When placed onto PtOEPK/PS films the 
PDMS stamp formed a conformal and reversible bond, protecting the area in contact from 
reactive species produced in the etch chamber. RIE with O2 as reactive species was 
chosen as method of pattern transfer due to superior etch uniformity and the possibility of 
batch development. Wet etching with acetone or selective dissolution in the PS solvent 
toluene were discarded as possible alternatives due to excessive isotropy observed in 
initial trials. 
Etching conditions for the RIE process were adapted from data published by Taylor 
et al. [121] for films of pure PS. The process parameters reported in this work indicated a 
vertical etch rate of 27 nm/min and 108 nm/min for PS using a etcher with barrel reactor 
(100 W, 0.55 Torr, 100 ml/min) and pancake reactor (75 W, 0.025 Torr, 30 ml/min), 
respectively. Using these parameters with both available dry-etching systems (Oxford 
Plasmalab 80i, pancake reactor, and plasma asher, barrel reactor) sufficient or comparable 
etch rates for PS or PtOEPK/PS films could not be reproduced. Due to this, and 
considering the large backing of the supported positive stamps, new etch parameters were 
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determined. Process development was focussed in particular on the RIE system as the 
pancake design allows for better control of the etch direction. 
A higher etch pressure of 0.55 Torr was chosen mainly to allow for increased 
underetching of the thick stamp support through the resulting decrease in etching 
anisotropy. Furthermore, the increase in pressure also facilitates the transport of the 
significant amount of reactive species required for etching to occur under the stamp 
overhang. Simultaneously the etching power was increased to 200 W due to the 
insufficient etch rates observed in the initial test. Using these values, the general, 
unmasked vertical etch rate of PtOEPK/PS in the Oxford Plasmalab 80i reactive ion 
etcher was determined to be 150 nm/min at 200 W power and 50 sccm O2 flow rate, 
compared to 108 nm/min reported for pure PS at 75 W and 30 sccm [121]. For positive 
masks, the removal of PtOEPK/PS underneath the stamp support was found to depend on 
the feature height of the stamp pattern. For 100 µm high features a stamp backing 
overhang in excess of 5 cm could be routinely cleared in a 10 min etch compared to 7 min 
for 200 µm features. Figure 5.9 shows DIC micrographs of typical patterns replicated 
with both positive (a) and negative (b) stamps. The insets in Fig. 5.9 show photographs of 
the corresponding PDMS stamps with the thick support backing (a) and vertical 
through-holes (b) visible for positive and negative stamps, respectively. In the former, 
stamps are turned pattern-side down for use, whereas for the latter stamps are used more 
resembling a layer of photoresist and film removal is through the opening in the stencil, 
as seen in the inset in Fig. 5.9(b).
Figure 5.10 shows micrographs of a test pattern as PDMS stamp with a feature height 
of 150 µm (a), replicated by dry-etching into a PtOEPK/PS film (b) and fluorescent 
sensor signal of the film when exposed to an excitation wavelength of 590 nm (c). The 
sensor signal was measured before and after patterning and no change in intensity due to 
the oxygen plasma could be observed. As can be seen from Fig. 5.10(b) and (c), complex 
patterns such as text with 100 µm line width can be replicated. The only exceptions are 
enclosed ring structures, as found in the letter O, where the stamp prevents reactive 
species from entering the inside of the shape. This limitation however can be prevented 
during design of the pattern or by leaving an opening, as can be seen in the fern shape on 
the left side of Fig. 5.10. A variety of regular and irregular patterns were replicated and 
124
Oxygen Sensor Integration
some are shown in Fig. 5.11. Minimum feature sizes in the range of 25 µm could be 
replicated with various different stamps and this could be repeated several times by 
re-using the same stamp. Pattern fidelity was found to be good and at the current stage 
resolution is mainly limited by stamp detail. This is due to the printed masks and their 
subsequent use in the SU-8 lithography. An example of a replication error is shown in 
form of missing sensor patches in the bottom pattern of Fig. 5.11. In this case, successive 
visual observation of the stamp and SU-8 mold showed that the errors were due to 
underdeveloped features on the resist master, which were then replicated in the stamp. In 
general, if greater stamp detail is needed, for example for single cell studies, master 
fabrication could easily be improved by use of glass masks. However, this would increase 
the process cost and decrease flexibility, while most PDMS-based LOC devices do not 
require higher resolution than provided with the current process.
Figure 5.9: DIC Micrographs of PtOEPK/PS patterns replicated 
by RIE with positive (a) and negative (b) PDMS stamps. The 
insets show photographs of the corresponding elastomer stamps 
used as etch masks.
PtOEPK/PS oxygen sensor pattern
glass substrate
300um
PDMS stamp (negative)
PtOEPK/PS oxygen sensor patterns
1mm
PDMS stamps (positive)
PtOEPK/PS
a)
b)
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All the spin-coated PtOEPK/PS sensor films and individual patterns produced by 
RIE etching thereof exhibited excellent adherence under gas and liquid shear. From this 
observation it follows that no special pre-treatment of the substrate in terms of increasing 
the surface roughness or a recess is necessary. However, the fabrication process is 
applicable even in case of a substrate with pre-etched recesses. Figure 5.12 shows a 
micrograph of a 400 nm thin 5% w/w PtOEPK/PS film spin-coated onto a glass substrate 
at 3000 rpm. Prior to coating a 5 μm deep recess was etched using buffered HF. The etch 
was purposely chosen to produce a rough surface inside the recess for demonstration 
purpose. Spin-coating of PtOEPK/PS onto this substrate produced a continuos film 
covering the complete surface including the bottom of the recess. Using a PDMS stamp 
designed to the shape of the pre-etched cavity in combination with RIE the sensor pattern 
was confined to the part of the recess indicated in gray in Fig. 5.12. The thickness of the 
sensor layer was measured by performing a surface profilometry scan along the arrow 
Figure 5.10: Test pattern replicated in PtOEPK/PS by the fabrication process: 
(a) SEM micrograph of the PDMS stamp used as mask in the RIE step, (b) DIC image 
of the pattern in the PtOEPK/PS film after etching, and (c) fluorescent emission in the 
NIR from the same pattern under illumination with light of 590 nm wavelength.
300um
500uma) PDMS Stamp
b) PtOEPK/PS Sensor Pattern
c) Sensor Signal in NIR 300um
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labelled DEKTAK scan. As can be observed from the plot of the scan Fig. 5.12(a), a 
locally confined sensor pattern of constant thickness (~700 μm) was produced by the 
fabrication process inside the recess. This demonstrates the versatility of the process and 
its applicability to devices which require protection of the sensor layer and/or cells 
cultured on top of it from fluid shear. 
With the demonstration of sensor film formation by spin-coating and high-resolution 
patterning, as shown above, the remaining step to a functioning device is integration of 
the sensor with a pre-fabricated PDMS microfluidic network. Since the patterning step not 
only produced locally confined sensor patches, but also removed excess PS of the 
substrate in regions unprotected by the stamp masks, it is now possible to apply oxygen 
plasma activation to the exposed glass surface and the PDMS channels for bonding. The 
Figure 5.11: Micrographs of oxygen sensor patterns fabricated by RIE. Pattern 
dimensions are defined using a positive PDMS stamp as mask. The insets show the 
sensor signal of the same pattern in NIR after RIE. Errors in the pattern transfer as 
visible in the bottom image are mainly due to defects in the PDMS stamp.
NIR
NIR
500um
150um
200um
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next section discusses the integration process and introduces a microfluidic chip for shear 
effect comparison. The chip features integrated oxygen sensors fabricated using a 
combination of the three process steps: PtOEPK/PS sensor spin-coating, patterning by 
RIE and integration via oxygen plasma bonding.
5.4   SENSOR PATTERN INTEGRATION
To demonstrate the complete fabrication process and its applicability to PDMS-based 
microfluidic devices, the two processes described in Section 5.2.2.2 and Section 5.3.1
were combined to produce a custom sensor pattern on a glass microscope slide. This slide 
was then irreversibly sealed to a corresponding fluidic channel structure in PDMS by 
oxygen plasma bonding (Fig. 5.8(e)). This process is the main method of producing 
irreversibly sealed microfluidic devices in PDMS. Both, the surface of the PDMS channel 
network and the glass substrate with the sensor pattern, were activated in the RIE using 
oxygen plasma, manually aligned and brought into conformal contact. Surface activation 
Figure 5.12: Micrograph of a sensor pattern (gray) deposited onto a pre-etched 
recess in a glass substrate by spin-coating and RIE. The inset (a) on the top left 
shows a profilometer scan (arrow) indicating the 400 nm thick sensor layer.
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was performed using the Oxford Plasmalab 80i RIE system with a 50 sccm O2 flow rate, 
75 mTorr etch pressure and 70 W RF power for a duration of 10 s [100]. Whilst not 
significant due to the very short application time, this surface activation step will lead to 
some etching of the sensor layer by the oxygen plasma.
A blunt needle was used to cut access ports and external fluidic interfacing was 
provided by insertion of Microtight tubing sleeves (Upchurch, Oak Harbour, WA, USA). 
For visualization the device was filled with red and blue dye-colored DI water. 
Measurement of the fluorescent sensor signal before and after oxygen plasma activation 
showed that the bonding process had no influence on signal intensity.
A plasma-bonded, fully assembled bioreactor device with external fluidic 
connections is shown in Fig. 5.13. Three cell culture chambers of different shapes and 
hence, different wall shear-stress profiles, are integrated on the chip. The lateral tapering 
of the middle chamber is specifically designed to generate a linearly increasing wall shear 
stress along its length. Sensor patterns in the individual chambers are restricted to the 
outlines by the patterning process described before. Flow direction through the device is 
from left to right, as indicated by the arrow in Fig. 5.13(a). A close-up of the middle 
PDMS chamber is shown in Fig. 5.13(b). The corresponding sensor pattern realized 
within the chamber was imaged in multiple, separate DIC images, which were then 
automatically overlaid to provide the complete micrograph shown in Fig. 5.13(c). 
Intensity images on the left and right of Fig. 5.13(c) show parts of the sensor response in 
NIR for exposure to air. The large sensor shape inside the chamber and the finer patterns 
in the in-/outflow channels were fabricated simultaneously with the same PDMS stamp, 
thus demonstrating the flexibility of the stamp patterning process. 
Under certain circumstances, such as for characterisation of different substrates or 
sensor systems, it can be advantageous to be able to remove the channel structure from 
the substrate after use. In case of PDMS it is possible to obtain either a permanent seal by 
oxygen plasma bonding or a reversible seal by pressure clamping to the underlying 
substrate. For example, clamping was used to characterise several spin-coated oxygen 
sensor films for both gaseous and DO measurement with a single channel structure. After 
sensor signal measurement the reversible seal allows for removal and re-use of the 
channels. 
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To facilitate reversible clamping fluidic interconnects were machined into a 
transparent rectangular block of plexiglas. Tubing was inserted into the external holes and 
fixed with epoxy glue. Internal holes were machined to overlay the corresponding channel 
inlets on the PDMS device. A reversible seal was formed by sandwiching the glass 
substrate with oxygen sensor and the PDMS channel device between the Plexiglas block 
and the metal plate of a microscope stage warmer. The stack was secured using six screws, 
which could be individually adjusted to provide the best possible seal.
Figure 5.13: (a) PDMS-based shear device with integrated oxygen sensors and external 
interfacing. Red and blue dye in DI water was flowed through the channels to aid 
visualization and to test fluidic sealing. (b) Close-up showing the central bioreactor 
device providing linearly increasing shear stress. (c) DIC light microscopy and NIR 
fluorescence images of the sensor patterns integrated into the bioreactor and inlet/outlet 
channels.
Flow Direction
PDMS
NIR NIR
b) Bioreactor
DIC light microscopy
c) Sensor Pattern 1mm
5mm
Glass Substrate
a) Microfluidic Shear Device 1cm
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5.5   SUMMARY
This chapter has covered the development of a fabrication process to integrate polymer 
encapsulated fluorescent dye based oxygen sensors into PDMS microfluidic devices for 
in-situ DO detection. Integration of oxygen sensing into the devices introduced in 
Chapter 4 is essential to evaluate the species transport predictions made by the solution to 
the analytical model and CFD simulations in Chapter 3. Existing sensor fabrication 
methods proposed in literature were found to be unreliable and lacking in compatibility 
with layer-by-layer processing, as commonly used for fabrication of PDMS based 
microfluidic devices. Spin-coating of PtOEPK/PS sensor material was investigated as a 
robust alternative method for film formation. Sensor films deposited with this method 
were found to be well adhered without the need for a substrate pre-treatment. They further 
exhibited excellent thickness homogeneity and repeatability. Following film deposition, 
custom sensor patterns were fabricated using a newly-developed patterning process based 
on elastomer stamps and oxygen plasma etching. This process allowed to confine the 
sensors, initially spin-coated onto the whole substrate, to complex lateral shapes featuring 
high-resolution details. In the final step, patterned sensors were integrated with PDMS 
channel networks by oxygen plasma bonding to yield fully sealed devices with integrated 
optical oxygen sensors. Both oxygen plasma etching and bonding were found to have no 
influence on the sensor signal intensity.
With sensor integration completed, the following chapters cover the experimental 
procedures required for successful characterisation and calibration of oxygen 
measurement using the integrated PtOEPK/PS sensor system and their application to 
Lab-on-chip type devices. Since the spin-coating process produces very homogenous 
sensor films fluorescence intensity quenching was chosen as oxygen detection method for 
the following sensor characterisation experiments. As opposed to luminescent lifetime, 
intensity quenching has the ability to resolve laterally distributed oxygen concentrations 
within the device without the need for a complex scanning laser setup, resulting in a 
variety of potential novel applications for the sensors. 
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something everybody believes, 
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CHAPTER 6  
Experimental Fluidic Setup
In the previous chapter a novel process for the integration of optical oxygen sensors into 
microfluidic devices was described. Prior to use the sensors have to be characterized and 
calibrated for measurement of gaseous or dissolved oxygen concentration inside the 
bioreactor. This is achieved by comparing the change in fluorescent sensor signal 
intensity for different solutions of oxygen concentration to a reference value provided by 
an external sensor. After recording the calibration graph, oxygen concentration is 
determined by comparing the change of sensor intensity for an unknown concentration to 
the corresponding value determined during calibration. 
To facilitate sensor calibration, readout and successive use of the bioreactor devices 
for cell-based experiments an external fluidic setup has been designed. This chapter 
discusses the general requirements of the experimental setup and the individual 
components. The first section gives an overview of the experimental setup used for sensor 
calibration and characterisation. This is followed by a section on the main components of 
the fluidic circuit. The third section covers the generation and control of an oxygen 
reference source. Two alternative methods investigated for initial oxygenation of the 
carrier fluid are discussed in detail. The fourth and final section covers the optical sensor 
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readout and the data post-processing procedures used to generate the calibration for DO 
detection and in-situ measurement.
6.1   OVERVIEW OF THE EXPERIMENTAL SETUP
Due to the non-contact nature of the optical sensing process readout of the bioreactor 
devices can be performed on any standard fluorescence microscope. The only adjustment 
required to the microscope for use with the PtOEPK dye is the addition of an appropriate 
filter cube and imaging device. The bioreactor device can be interfaced with common 
syringe or peristaltic pumps for external fluid actuation. Alternatively, on-chip fluid 
actuation could be realized by integration of microfluidic pumps and valves. For sensor 
calibration and for use in a cell-culture setup a gas-exchanger is integrated into the flow 
circuit to provide custom dissolved oxygen concentrations. Pressure driven flow (PDF) of 
controlled flow rate is generated using an external syringe pump. The pump is connected 
via tubing to a custom external or integrated gas-exchanger producing fluid flow with 
defined oxygen concentration. A bubble trap placed before the gas-exchanger and 
bioreactor chip removes potential bubbles in the fluidic circuit. The inlet oxygen 
concentration is determined using a flow through Clarke-type oxygen sensor and provides 
a reference value for calibration of the integrated oxygen sensor. The bioreactor chip itself 
is mounted on a temperature-controlled microscope stage of a conventional fluorescence 
microscope for oxygen sensor readout. An optional second Clarke-type sensor can be 
installed at the device outlet to provide a further reference value for the oxygen 
concentration after the liquid has passed over the cell culture inside. Finally, the liquid is 
collected in a waste container for biochemical analysis to determine cell function and 
metabolisms. The following sections provide a detailed introduction of the individual 
parts of the experimental setup.
6.2   FLUIDIC CIRCUIT
Fluid actuation and generation of PDF in the flow circuit is provided by a dual push-pull 
syringe pump (PHD 2000, Harvard Apparatus, Holliston, MA, USA) in combination with 
standard 60 ml plastic syringes. The syringe pump, shown in Fig. 6.1, allows precise 
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control of the fluid flow rate from 0.0001 µl/hr to 220.82 ml/min with an accuracy of 
±1%. This covers the entire projected range of inlet velocities required to investigate the 
effect of wall shear stress on species transport inside the bioreactor. In addition, due to the 
capability of using two syringes in parallel, the pump allows one to simultaneously 
generate multiple flows of different oxygen concentrations when used with multiple gas 
exchangers. Initial sensor calibration experiments were performed using DI water as 
oxygen transport medium. For final application in conjunction with live cells pure DI 
water was replaced with Dulbecco's Modified Eagle's Medium (DMEM) as carrier fluid. 
DMEM is a variation of Eagle's Minimal Essential Medium and is based on pure water 
supplemented with various amino acids, inorganic salts (potassium chloride, magnesium 
sulfate, sodium chloride, and sodium dihydrogen phosphate), glucose and vitamins (folic 
acid, nicotinamide, riboflavin, B-12), among others [122].
From the pump the fluid is transported through transparent Masterflex tubing (Tygon 
Lab, Cole-Parmer, Vernon Hills, IL, USA) with an internal diameter of 1.6 mm to a 
custom bubble trap. The Tygon-type tubing was chosen because of its relatively low gas 
permeability of 80 and 40*1010 cc*mm/(cm2*s*mmHg) in relation to oxygen and 
nitrogen, respectively [123]. Figure 6.2 shows a photograph of the trap used to remove air 
bubbles from the fluidic circuit.These bubbles can be introduced by initial filling of the 
Figure 6.1: Photograph of the syringe pump used to provide 
PDF with constant flow rate.
Syringe Pump
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syringe. In the trap, bubbles entering through a short inlet tube rise up and are thereby 
prevented from leaving the device through the longer, lower outlet tube. Removal of the 
bubbles from the fluid is essential, as trapped air could influence measurement results by 
introducing local oxygen variations. Furthermore, the excessive shear stress created by 
the air-liquid interface transition of enclosed air bubbles over cells cultured inside the 
bioreactor device has the potential to rupture cell membranes [124] and ultimately cause 
cell lysis. 
6.3   OXYGEN REFERENCE
Since the integrated oxygen sensor patterns are to be used for detection of an unknown 
DO concentration, sensor response has to be measured for exposure to liquid flow of 
different, known oxygen concentrations. The resulting calibration curve can then be used 
to correlate sensor intensity to oxygen concentration. This initial calibration therefore 
requires a device capable of transferring gas molecules from their gaseous state into 
solution form in a controlled manner. One method commonly used for this is to bubble 
the gas of interest directly into the fluid while it passes through an enclosed container. The 
Figure 6.2: Photograph of the custom bubble 
trap used to remove bubbles from the fluidic 
circuit.
Fluid in
Bubble Trap
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main disadvantages of this method are the relatively large quantity of liquid needed to 
prime the container and the potential introduction of bubbles into the microfluidic circuit. 
Both issues can be critical in conjunction with biomedical applications. If used in a 
dialysis-like system, the former can lead to a drop in blood pressure in a patient attached 
to the device due to the limited total blood volume available in the human body, whereas 
the latter has the potential to induce stress on cells in culture. To avoid these problems two 
versions of diffusion-based gas exchangers, external macro-scale and integrated 
micro-scale types, were constructed and investigated. Controlled oxygenation of the 
carrier fluid via a gas exchanger relies on several parameters in these devices. The 
following section introduces these parameters and a brief derivation of the theoretical 
model for oxygen solubility. 
6.3.1 OXYGEN SOLUBILITY
In microfluidic applications and BAL and cell-culture devices in particular, oxygen 
supply is limited by the solubility of oxygen in the carrier fluid. Oxygenation of a liquid, 
such as water, is related to the general solubility of the gas in the respective liquid. This 
solubility, and thereby maximum concentration of DO obtainable, is dependent primarily 
on the three variables pressure, temperature and concentration of dissolved salts. For a 
constant temperature the solubility in water can be described by Henry’s law1:
, (6.1)
where foxygen is the fugacity, xoxygen the mole fraction of the solute and k is a 
proportionality constant. When taking in account temperature and pressure, this simple 
equation can be extended to a more generalized expression for oxygen solubility in 
air-saturated water:
, (6.2)
1.Formulated by William Henry, 1775-1836.
foxygen k xoxygen⋅=
S′ 3.936 10 4–× α PT p1–( )mg l⁄⋅ ⋅=
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where S’ is the oxygen solubility, α is the Bunsen absorption coefficient, PT the total 
pressure and p1 the water vapor pressure [125]. 
Table 6.1 lists a selection of solubility values of oxygen in water for certain salt 
concentrations and temperatures, including 37.4ºC for cell-culture conditions, at a total 
pressure of 760 torr. As can be seen from Table 6.1, oxygen solubility decreases with both 
increasing water temperature and salinity. Additional values dependent on salt 
concentration, temperature and pressure are tabulated in [125] or can be obtained 
graphically from the nomogram reproduced in Appendix F. From this decrease in oxygen 
solubility with salt concentration follows that the maximum amount of DO dissolved in 
physiological salines, such as blood plasma and nutrient solutions used in cell-culture, 
will be lower. If not otherwise indicated, calibration and oxygen measurement results in 
the following sections relate to data for pure DI water.
6.3.2 REFERENCE OXYGEN SENSOR
The DO concentration in the fluid after the gas exchanger is monitored via a reference 
oxygen sensor (DO-166FT, Lazar Research, Los Angeles, CA, USA). This amperometric 
sensor is based on a Clarke-microelectrode inserted into a flow-through housing made 
from acrylic. Figure 6.3 shows the individual components of the reference sensor: control 
electronics housing the signal amplifier with zero-point and calibration adjustment 
Cl-
[g/1000 g]
0 8 20
Temperature 
[ºC]
Oxygen Solubility
[mg/l]
0 14.5 13.3 11.3
10 11.3 10.4 9.0
20 9.1 8.5 7.4
30 7.5 7.0 6.1
37.4 6.7 6.4 5.9
Table 6.1: Solubility of oxygen in water as a function of temperature and salt 
concentration for a pressure of pT = 760 torr (Adapted from [125]).
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screws (a), the voltage meter showing the oxygen concentration in millivolt (b), and the 
flow-through cell with inserted microelectrode (c). 
Prior to use as reference the DO-166FT sensor is calibrated using a two-point 
calibration procedure. The first point corresponding to zero DO concentration is obtained 
by using the microfluidic circuit to flow nitrogenated water through the sensor and by 
adjusting the amplifier to zero millivolt output signal. For the second point, air-saturated 
water is flowed through the sensor chamber. The calibration value of the amplifier is then 
adjusted to coincide with the corresponding DO concentration previously calculated for 
the local temperature and partial pressure using Equation (6.2). Following oxygenation in 
the gas exchanger and measurement of the DO concentration in the reference 
microelectrode sensor, the fluid enters the bioreactor device placed on the stage of a 
fluorescence microscope through further Tygon tubing.
6.3.3 MACRO-SCALE GAS EXCHANGER
The first, macro-scale gas exchanger was constructed as a hollow fiber flow-through 
device based on a design proposed by Hamilton et al. [126]. The device utilizes the 
gas-permeability of silicone-based tubing to diffuse gas molecules from a pressurized 
gaseous environment to a fluid flowing through the tubing coiled inside the container. 
This design reduces the amount of liquid needed to prime the device to the volume 
contained inside the tubing. Depending on length and diameter of the tubing this volume 
can be adjusted to meet the constraints of the perfusion experiment.
Figure 6.4 shows a photograph of the external gas exchanger and the lid providing 
fluid and gaseous interfacing. The main compartment of the device is formed by a 1 l 
Pyrex bottle (Dow Corning, Midland, MI, USA) with a linerless polypropylene plug seal 
cap. Inside the container silicone tubing (Silastic, EW-96115-06, Cole-Parmer, Vernon 
Hills, IL, USA) is loosely coiled to provide maximum exposure to the introduced gases. 
Gas and fluid interfaces were integrated into the cap by drilling and insertion of stainless 
steel push-in fittings (Norgren, Auckland, New Zealand) and coned ports (Upchurch, Oak 
Harbor, WA, USA), respectively. After insertion, the ports and a closeable pressure relief 
opening were sealed to the lid with two-part epoxy glue. Tygon tubing was used to 
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connect ports on the gas exchanger to the bubble trap and the adjacent flow-through 
reference oxygen sensor. The gas fittings were connected via pressure regulators to 
nitrogen (oxygen-free) and oxygen (industrial grade) cylinders (BOC, Auckland, New 
Zealand). During experiments the Pyrex container was enclosed in a styrofoam box with 
a temperature sensor to provide stable environmental conditions. Prior to use of the gas 
exchanger, its oxygenation capability was measured using the Clarke-electrode reference 
sensor described before. At a flow rate of 0.5 ml/min the macro-scale gas exchanger was 
able to provide a maximum DO concentration of 18.4 mg/l or parts-per-million (ppm) in 
DI water while using pure oxygen gas for perfusion. 
Figure 6.3: Photograph of the flow-through 
Clarke-electrode. This sensor was used to provide DO 
reference values for calibration and monitor the bioreactor 
inlet concentration. The signal amplifier (a), voltage 
meter (b) and microelectrode sensor housing with fluid 
interfacing (c) are shown.
Fluid
in Fluid out
Clark electrode
Amplifier mV Metera) b)
c) Reference Sensor
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It should be noted at this point that mg/l is technically not a dimensionless number as 
required by the definition of the parts-per notation. However, ppm will be used instead of 
mg/l in the following to denote concentrations of a species in water to allow for easier 
comparison with data published in literature. While this use of ppm for water with a 
density of ρ = 1000 kg/m3 is not uncommon, concentrations in other liquids will be given 
in SI-compliant units to avoid confusion.
6.3.4 INTEGRATED GAS EXCHANGER
Dead fluid volume is a major constraint in biomedical applications. The total blood 
volume in a human patient is limited and any amount of blood removed from the body to 
fill an external system has the potential to further destabilize an already critical patient. In 
a bid to minimize the dead volume of the overall fluidic system, integration of the external 
gas exchanger on-chip was investigated using PDMS technology. Besides reducing the 
amount of tubing volume, this approach has the additional advantage that it reduces the 
Figure 6.4: Photograph of the macro-scale flow-through gas 
exchanger used to produce fluid flow of defined DO 
concentration. Top close-up shows the fluidic and gas 
interfacing.
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distance between the bioreactor and the gas exchanger. Oxygen concentration changes of 
the fluid bulk in the bioreactor can thus be realized faster due to the shorter distance. This 
could potentially enable the experimental observation of dynamic cell function in relation 
to changes of DO concentration.
The integrated gas-exchanger is based on a design proposed by Vollmer et al. [115]. 
In this design two layers of parallel channels are separated by a thin membrane of 
gas-permeable PDMS. The membrane allows gas molecules, and oxygen in particular, to 
diffuse from the top channels pressurized with the respective gas to the fluid flowing 
through the channels underneath. As mentioned above, this continuous diffusion-based 
gas transfer into the fluid prevents the introduction of gas bubbles, a problem commonly 
observed when actively bubbling gas through a fluid. PDMS exhibits high diffusivity for 
oxygen and other gases and is therefore well suited as membrane material. Table 6.2 lists 
the diffusivity of hydrogen, oxygen, nitrogen and carbon dioxide as observed for cured 
PDMS. 
Figure 6.5(a) shows a photograph of a single gas exchanger with 64 parallel channels.
Incoming fluid is distributed to the individual channels from a single inlet, while gas 
moves through a meandering channel exactly overlaying the fluidic layer. The device was 
fabricated by replica molding of two 100 μm thick SU-8 molds on Si wafer. The first mold 
incorporates the structure of the fluid layer and was spin-coated with PDMS pre-polymer 
(Sylgard 184, 10:1 w/w base:curing agent, 1500 rpm for 30 s) to form the fluidic channel 
and the thin membrane separating gas from fluid. Simultaneously a second mold with the 
Penetrant
DO2 x106
[cm2/s]
H2 140 ± 5
O2 34 ± 1
N2 34 ± 1
CO2 22 ± 1
Table 6.2:  Diffusivity of hydrogen, oxygen, nitrogen 
and carbon dioxide in PDMS at 35ºC (Adapted 
from [127]).
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gaseous layer design was replica-molded by pouring PDMS to a thickness of 10 mm. Both 
layers were partially cured for 20 min at 80ºC. The gaseous layer was then peeled off the 
second mold and both, the first mold and the gaseous layer were activated in oxygen 
plasma (500 W DC for 10 s). Following activation, both layers were manually aligned, 
brought into contact and left 24 h at room temperature to fully cure. A SEM image of a 
cross-cut through the fluidic layer is shown in Fig. 6.5(b). The fluid is transported through 
the upper channel while oxygen or nitrogen are applied to the lower channel and diffuse 
through the PDMS membrane indicated by the dashed lines. In the final device, shown in 
Fig. 6.5(a), this structure is inverted and plasma bonded onto a glass microscope slide to 
Figure 6.5: Photograph of the integrated gas-exchanger 
in dual-layer PDMS. (a) A fluidic layer containing 64 
parallel channels is bonded onto a glass substrate. 
Overlaying this is a second layer with the same number of 
channels for the respective gas. (b) SEM image of a cut 
through the device showing the two layers of channels. 
Both layers are separated by a gas-permeable PDMS 
membrane, allowing gas molecules to diffuse into the fluid 
underneath.
Gas
Fluid
a) PDMS Gas Exchanger
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Gas
Fluid
b) SEM
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provide fluidic sealing. For visualization the gaseous layer was filled with red and the 
fluidic layer with blue-colored DI water.
At a flow rate of 0.5 ml/min the integrated gas exchanger was able to provide a 
maximum DO concentration of 34 mg/l in DI water by flowing pure oxygen gas 
(industrial grade) through the top layer. While this is almost double the concentration of 
18.4 mg/l, as obtained with the external gas-exchanger described in the previous section, 
the maximum value is lower than the 42.5 mg/l reported by Vollmer et al. [115] for a 
similar integrated device. However, the SEM image in Fig. 6.5(b) also shows that the 
membrane realized with the process described above is approximately 10 μm thicker than 
reported by Vollmer et al. This, in conjunction with a potentially different oxygen gas 
pressure in the gaseous layer, might explain the difference in DO between the two designs. 
If needed, the maximum value for DO can be further optimized by reducing the thickness 
of the remaining PDMS membrane during the spin-coating process or increasing the 
device area/number of channels.
6.3.5 WASTE COLLECTION
After passage through the microfluidic device the fluid enters further Tygon tubing and is 
transported to a Pyrex bottle. Depending on the device layout and application several 
bottles can be used for each bioreactor. Up to three outlets per reactor are realized in the 
current design. By utilizing the laminar flow regime this outlet layout allows to isolate 
individual parallel flow streams in the reactor after passage through the device. Each 
collected outflow can then be analyzed separately for biochemical markers and cell 
function indicators in relation to the respective oxygen concentration of the stream 
passing over the cells.
6.4   OPTICAL PICK-UP
Excitation and detection of the oxygen-dependent dye response are performed via 
standard epi-fluorescence microscopy. Central to the optical setup is a Nikon Eclipse 80i 
fluorescence microscope (Nikon, Lidcombe, Australia) providing the platform for sensor 
control and image acquisition. Figure 6.6 shows a photograph of the optical setup used for 
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flow experiments (a) and a close-up of the bioreactor device on the microscope stage (b). 
For measurement the bioreactor device is secured to the microscope stage and interfaced 
with Tygon inlet and outlet tubing. Depending on the device under test this is performed 
by either small, bonded PDMS blocks or a pre-machined plate of clear acrylic. The PDMS 
blocks and the acrylic plate allow rotation of the external tubing and syringes used as 
connectors by 90 degrees from vertical to parallel with the stage, thereby increasing the 
space available over the device for the microscope objectives. The stage of the 
microscope is augmented with a LEC059 microprocessor-controlled stage heater (LEC, 
Scoresby, Australia) consisting of a metal heat spreader with power resistor and external 
control electronics. This stage allows the sample under test to be maintained at a preset 
temperature of 37.4ºC during measurements. Keeping the temperature constant not only 
increases the repeatability of the calibration and stability of measurement, but also helps 
to provide the environmental conditions required for cell culture within the bioreactor. For 
use with the acrylic interconnect plate, the bioreactor device is sandwiched between the 
plate and stage holder. In this case the fluidic outlet holes on the PDMS chip are aligned 
with conduits pre-drilled into the acrylic plate and the sandwiching pressure can be 
adjusted via six screws from the plate to the metal stage holder.
Since the PtOEPK sensor layer exhibits an excitation peak at 590 nm in the visible 
range of the spectrum, it is illuminated through a custom filter cube using the high-power 
mercury light source of the Eclipse microscope. Light emitted from PtOEPK is shifted to 
a peak around 760 nm, detectable by Silicon-based semiconductors, such as CCD 
cameras. The long excitation/emission shift of PtOEPK allows for effective filtering using 
standard filter components. As a technique fluorescence-based oxygen sensing builds 
upon the basic principles of standard fluorescence microscopy. As shown in Fig. 6.7, the 
sensor is illuminated with its excitation wavelength range (blue) and, in return, emits in 
the range shifted relative to its excitation wavelength (red). A dichromatic mirror or beam 
splitter (green) acts as a high pass and prevents the excitation light from passing through 
to the detection system. Both wavelength regions are fitted to the absorption and emission 
spectra of the PtOEPK dye used and are defined by filters placed in the respective light 
path.
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An example of a filter cube arrangement is shown as inset in Fig. 6.7. The graph 
corresponds to a custom filter combination designed for use with PtOEPK with 
excitation/emission filters at 595/760 nm and a dichroic mirror with a cut-off wavelength 
of 620 nm (Chroma, Rockingham, VT, USA). The intensity information transmitted 
through the filter cube from the sensor pattern is recorded using a standard digital camera 
(DCR TRV520E Handycam, Sony, Tokyo, Japan), shown in the top part of Fig. 6.6(a). 
This camera is fitted with a Nightshot mode, which allows to extend the usual imaging 
range from visible to NIR wavelengths. While the microscope comes fitted with a 
5-megapixel high-resolution cooled color digital camera (DS-5Mc, Nikon), the integrated 
IR filters on this and other common microscope cameras prevent their use for NIR 
applications. Images are saved either in uncompressed JPEG-format color images 
Figure 6.6: Photograph of the optical setup for detection of 
the sensor signal and close-up of the bioreactor device on the 
microscope stage.
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(640x480 pixels) on a Memorystick digital memory card or as film on a Digital8 magnetic 
tape. Data captured as film was exported to a PC via the Firewire interface of the camera 
and snapshots were transcoded to BMP-format grayscale files (720x576 pixels) for 
intensity analysis. 
Alternatively to the Sony camera, a dedicated NIR camera (Guppy F-038B NIR, 
Allied Vision Technologies, Stadtroda, Germany) was used. The Guppy camera features 
a firewire interface and is controlled directly via a PC running the AVT FirePackage 
software kit supplied with the camera. Grayscale images recorded through this software 
were saved as uncompressed Tiff files. Raw data from all image sources was imported 
into the Matlab (Mathworks, Natick, MA, USA) software package and processed for 
analysis using the integrated image processing toolbox. 
6.5   SUMMARY
As with any sensor system, the right measurement setup plays an essential role in the 
quality of data obtained from the sensor itself. This chapter has introduced the external 
setup and all components used in conjunction with the integrated sensor film. Centered 
Figure 6.7: Excitation and emission spectra of the filter set used for imaging PtOEPK sensors 
with the transmission curves of excitation filter (blue), emission filter (red) and dichromatic 
mirror (green) shown. The inset depicts a typical filter cube arrangement (Adapted 
from [128]).
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around fluorescent microscopy as a non-contact sensor readout, the setup can be easily 
replicated using standard equipment available in biological laboratories. The main 
differences to conventional plate-based culture systems is the adoption of a fluidic circuit 
to provide continuous flow, the insertion of a custom filter cube, and the use of an IR 
camera. While the PtOEPK/PS sensor films can be used in static, non-flow systems, the 
current setup was developed deliberately to allow flow conditions for testing the target 
BAL devices.
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The true delight is in the finding 
out rather than in the knowing.
Isaac Asimov 
1920-1992, Russian-born American 
Author and Professor in Biochemistry
CHAPTER 7  
Oxygen Measurement
Use of the oxygen sensors for measurement of DO concentration requires initial 
calibration of the sensor film intensity response to certain, known oxygen concentrations. 
This chapter covers the use of the experimental setup, developed and described in the 
previous chapter, for characterisation and calibration of the integrated oxygen sensor 
patterns. The first section of this chapter describes the device interfacing together with 
data acquisition and post-processing. With this process in place, the second section 
summarizes experimental results for the detection of gaseous oxygen. Both, static 
calibration and dynamic sensor behavior for changes in oxygen concentration are 
outlined. As result from the initial sensor characterisation for exposure to gaseous oxygen, 
several parameters affecting sensor sensitivity were identified. These parameters and their 
optimization using the fabrication process are discussed in the third section. The fourth 
section covers the calibration of DO measurement in fluid flow and determines the 
dynamic operating range for use of the PtOEPK/PS sensor patterns at different flow rates. 
This is supplemented by a fifth section discussing the general application of the oxygen 
sensors to Lab-on-a-Chip devices via a demonstration of oxygen visualization, transverse 
graduation of the concentration profile and measurement of the coefficient of diffusion for 
oxygen.
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7.1   SENSOR CHARACTERISATION
After fabrication, individual sensor pattern response was first characterized by exposure 
to different gaseous oxygen concentration for film comparison and to ascertain the 
suitability of the fabrication process. Successively patterns were then calibrated and used 
to measure the concentration of oxygen dissolved in a carrier fluid, such as water. To 
acquire the calibration curve, the microfluidic device was connected with the 
experimental setup and the fluorescence microscope was used to record the sensor 
response. Figure 7.1 shows a schematic of the experimental setup developed for 
calibration of dissolved oxygen measurements. First, an image with closed shutter was 
recorded with the Sony microscope camera to eliminate CCD background effects and 
stray lighting. Following this, the lamp shutter was opened and images for the different 
gaseous oxygen concentrations were recorded. The images were then transferred to a PC 
in video or JPG file format, converted to grayscale and imported into Matlab using the 
Figure 7.1: Schematic of the external experimental setup used for the 
characterisation of local oxygen concentration measurement inside the microfluidic 
device. Sensor readout from the microfluidic system is performed by means of a 
fluorescent microscope and image capturing.
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image processing toolbox. Intensity was averaged over a region of interest (ROI) within 
the complete image by use of a custom m-file script. Finally, the value obtained from this 
ROI was compared to the chosen reference intensity (pure oxygen-free nitrogen, I0 ~ 0% 
O2) and plotted versus the relative gaseous oxygen concentration. 
The ratio I0/I100, in conjunction with the Stern-Volmer constant KSVG or KSVS, is 
commonly used as an indicator of the sensitivity of the sensing film [129,130]. For 
reasons of better comparability of different sensor material systems, and as proposed by 
Amao [112], this ratio was chosen as a general measure of sensor sensitivity for the 
following experiments. Sensor materials with an intensity ratio I0/I100 larger than 3.0 are 
commonly considered suitable for oxygen-sensing devices [131].
7.2   GASEOUS OXYGEN DETECTION
Before individual patterns and sensor films can be used to detect an unknown oxygen 
concentration, the change of fluorescent signal intensity has to be calibrated for exposure 
to a reference concentration. While the final goal is to use the sensors for detection of 
oxygen concentration in a liquid medium, initial calibration was performed for exposure 
to gaseous oxygen to better understand sensor characteristics and dynamics. This is 
especially useful since calibration with gaseous media has the advantage of reduced 
requirements on the experimental setup. Compared to liquid media, sealing is less critical 
and pumping is simplified by use of a pressurized gas source as supply, such as a standard 
gas cylinder. Devices do not have to be permanently sealed and switching between 
different oxygen concentrations (or gases) can be performed almost instantaneously. In 
addition to providing first data on sensor characteristics, experiments using gaseous 
oxygen also demonstrate the suitability of the patterned PtOEPK/PS sensors for gas-based 
detection applications, such as in food packaging [132]. The following two sections 
summarize results for static and dynamic gaseous oxygen measurements with sensor films 
and integrated sensor patterns [94].
For characterisation of sensor signal change in presence of gaseous oxygen the 
sensor patterns were exposed to pure industrial grade oxygen, oxygen-free nitrogen, air 
and mixtures of the three. All oxygen and nitrogen used in the following experiments was 
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supplied by BOC (Auckland, New Zealand) in standard D and G-sized gas cylinders fitted 
with the corresponding pressure regulators. The air used in experiments corresponded to 
a well ventilated room. Room temperature and atmospheric pressure were monitored for 
all experiments. Gases were applied to the sensor films and patterns either with or without 
PDMS channels bonded or clamped on top. The temperature of all sensor substrates, and 
thereby the sensor films, under test was kept at 37.4ºC using the microscope stage heater 
described in Section 6.4.
7.2.1 STATIC GASEOUS OXYGEN
For the calibration of static gaseous oxygen detection single images were recorded after 
equilibration with oxygen and the change of sensor intensity was analyzed using the 
image processing module of Matlab. Figure 7.2 shows a plot of 1/(fluorescent intensity) 
as a function of relative gaseous oxygen partial pressure for sensor patterns realized in a 
400 nm thick PtOEPK/PS layer on a glass microscope slide as substrate. For this 
measurement PtOEPK was dissolved in a 5% w/w solution of PS (standard grade, 200k 
MW), spin-coated and plasma patterned, as described in Chapter 5. The effect of intensity 
quenching by molecular oxygen leads to a significant increase in sensor intensity from the 
presence of pure oxygen (100% O2) to air (~21% O2) and to pure nitrogen (0% O2), as is 
demonstrated by the intensity images on the right in Fig. 7.2. Superposition of the 
Stern-Volmer model, given in Equation (5.4), onto the data in graph in Fig. 7.2 indicates 
good agreement with linear sensor behavior for the region of interest. While this 3-point 
measurement is relatively crude and does not qualify as a comprehensive calibration, it 
nevertheless is useful to demonstrate sensor function and to determine sensor 
performance (in form of the sensor ratio I0/I100).
7.2.2 DYNAMIC GASEOUS OXYGEN
Dynamic sensor response to gaseous oxygen was measured by continuously recording 
sensor intensity for a total duration of 20 min. During this time the sensor layer was 
exposed to different oxygen concentration. Applied gases were switched between 0%, 
21% and 100% relative gaseous oxygen concentration using a inline valve. The resulting 
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video of the sensor intensity change was then digitized and the change was analyzed on a 
single image, frame-by-frame basis in Matlab, as described above for static 
measurements. For all dynamic gaseous oxygen measurements no reduction of the sensor 
intensity due to photobleaching by the excitation source could be detected during the 
exposure period. This is a further demonstration of the excellent photostability of the 
PtOEPK fluorescent dye, as mentioned previously in Section 5.1.1.3.
Figure 7.3 plots 1/(fluorescent intensity) versus time for a section of data recorded 
for an unpatterned 1.1 μm thick layer of PtOEPK/PS. For this measurement PtOEPK was 
dissolved in a 7% w/w solution of PS (280k MW) and spin-coated onto a glass microscope 
slide, as described in Section 5.2.2. The dashed lines in Fig. 7.3 indicate the intensity 
levels corresponding to 100% oxygen (O2), ~21% oxygen (Air) and 0% oxygen (N2). As 
can be seen, the intensity change follows the change in oxygen concentration almost 
instantaneously with an average rate of change of ~2.1 s-1, making the PtOEPK/PS sensor 
Figure 7.2: Three-point calibration curve for the detection of gaseous 
oxygen with a 400 nm thick 5% w/w PtOEPK/PS sensor film pattern. The 
dashed line indicates the linear Stern-Volmer model. Fluorescence images 
on the right show the change in signal intensity in presence of oxygen from 
100% O2 to 0% O2 (top to bottom).
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system ideal for fast detection of changes in gaseous oxygen. The system further exhibits 
excellent repeatability over multiple cycles of switching between different 
concentrations, while retaining a high fluorescent signal intensity ratio I0/I100. 
7.3   SENSOR SIGNAL OPTIMIZATION
As explained above, the sensor signal intensity I of the different PtOEPK/PS films was 
measured for exposure to different gaseous oxygen concentrations just after spin-coating 
and patterning. Partial oxygen pressures of 0% (I0) and 100% (I100) were produced by 
blowing oxygen-free nitrogen and industrial grade oxygen, respectively, through the 
device and onto the sensor patterns. During this initial testing of the sensors it was 
observed that several parameters affect the final sensor signal ratio [10]. These parameters 
included both, molecular weight (MW) of the PS used, as well as the PS concentration 
Figure 7.3: Dynamic sensor response (relative intensity, I0/I) for the detection of 
varying gaseous oxygen concentration. The sensor was exposed to different 
oxygen concentrations by alternating between oxygen-free nitrogen (0% O2), air 
(~21% O2) and industrial-grade oxygen (100% O2), indicated in the graph by the 
dashed lines.
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(% w/w) in the initial toluene solution. The strongest influence on the fluorescent signal 
intensity ratio I0/I100 however, was found to be related to sensor film thickness. From an 
engineering point-of-view this is of great advantage, as the final thickness can be easily 
adjusted via the spin-speed during spin-coating of the sensor layer. The relationship 
between speed and sensor film thickness for different PtOEPK/PS solutions was 
discussed previously in Chapter 5. As was shown in Fig. 5.7, the film thickness decreased 
linearly with increasing spin-speed. 
Using this relationship several samples with PtOEPK/PS films of different 
thicknesses were produced. Comparing the intensity ratios of these films revealed that the 
sensor signal ratio increases with decreasing film thickness. Figure 7.4 summarizes the 
corresponding results for two PtOEPK/PS mixtures at various thicknesses. The plot 
shows the intensity ratio as a function of film thickness measured for the 5% and 7% PS 
solutions used in Section 5.2. For the 7% PS solution I0/I100 increases almost two-fold 
from 3.6 at 1.3 µm film thickness to 6.8 at 0.6 µm. One possible explanation for this 
Figure 7.4: Plot of the sensor intensity ratio I0/I100 vs. film 
thickness for two PtOEPK/PS solutions (I0 corresponds to 0% and 
I100 to 100% gaseous oxygen).
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increase in intensity ratio is the increase in the surface area-to-volume ratio. With 
decreasing film thickness the overall intensity contribution of dye close to the surface will 
increase, due to the fact that the permeability-limited intensity contribution from dye 
molecules in the PS bulk is reduced. The second observation from Fig. 7.4 is the 
dependence of the increase in intensity ratio on PS solution. A 0.7 µm thick film in 7% 
PS solution (MW = 280k) shows a three-fold increase in I0/I100 compared to a 5% PS 
solution (MW = 200k) of equal thickness. This significant difference is mainly attributed 
to the higher molecular weight PS used in the 7% solution. During solvent evaporation 
the system of PS chains strives to attain a state of minimal energy by contraction. 
Molecules above the entanglement molecular weight of PS (Me,PS = 18k) are thought to 
contract more slowly with increasing molecular weight and to be frozen in place before 
complete solvent evaporation [133]. This formation of disordered molecule chains can 
lead to an increase in oxygen-permeability in PS films of higher MW. 
Although preliminary, these results indicate further possibility for optimization of the 
sensor sensitivity through the use of thinner films and PS of different molecular weight. 
A fourth possible parameter not investigated here is the influence of the substrate material 
on sensor signal intensity. The maximum intensity ratio of 11 (average 10.4) for a 350 nm 
thick 7% PtOEPK/PS film is the highest reported on a LOC-compatible glass substrate. 
However, even higher values have been reported for films on a different substrate. 
Hartmann and Trettnak [134] observed an I0/I100 ratio of 20 for a 20 μm thick (wet-layer 
thickness) PtOPEK/PS film on a mylar substrate. This indicates that the choice of 
substrate material could provide an additional parameter in optimizing the intensity ratio. 
In regards of device fabrication, especially for PDMS-based devices, some substrate 
materials might provide a high intensity ratio, however their use might be limited if the 
material is not compatible with commonly used processes, such as surface-activated 
plasma bonding. Notwithstanding the potential for further optimization, it should be noted 
that all the 7% PtOEPK/PS devices presented here exceed the intensity ratio of 3 required 
to be suitable for use as oxygen sensor.
7.4 Dissolved Oxygen Detection
155
7.4   DISSOLVED OXYGEN DETECTION
The main application for the sensors develop as part of this work is the measurement of 
oxygen dissolved in aqueous media, such as full blood or blood plasma. In humans blood 
performs important transport functions for nutrients, oxygen and the removal of waste. It 
further acts as an essential part of the self-repair mechanisms of the body, conveys 
messaging functions and the regulates temperature. About 55% of the blood volume in an 
average human is made up of blood plasma, which in turn consists mostly (~90%) of 
water and some dissolved proteins, glucose, clotting factors, mineral ions, hormones and 
carbon dioxide. 
Oxygen saturation in such an aquatic environment is a relative measure of the amount 
of oxygen dissolved in the water. For example, in freshwater under atmospheric pressure 
at 20°C, O2 saturation is 9.1 mg/l. In addition to temperature and pressure, this value is 
also affected by the chloride (salt) concentration in the water and the maximum saturation 
decreases with increasing Cl-. The latter gains further importance when biologically 
relevant solutions, such as cell-culture media, are considered. These usually contain 
multiple additives including amino acids, salts, glucose and vitamins depending on the 
formulation used. As with detection of gaseous oxygen, sensor response to DO has to be 
calibrated prior to use for DO measurement. The following two sections introduce the 
calibration procedure and give typical results for the calibration of intensity change vs. 
DO concentration and the measured operating range of the sensors in relation to flow 
rate [102].
7.4.1 SENSOR CALIBRATION FOR MEASUREMENT OF DO CONCENTRATION
PtOEPK/PS sensor patterns were calibrated for DO measurement in aqueous media by 
flowing DI water of calibrated oxygen concentration through a bioreactor device, such as 
the one shown in Fig. 5.13. Characterisation experiments were performed with the 
microfluidic chip equilibrated to a temperature of 37.4ºC to ensure compatibility of the 
sensor test with cell-culture conditions. A sensor pattern, as depicted in Fig. 5.13(c), was 
fabricated by spin-coating and RIE patterning in 600 nm thick 7% w/w PtOEPK/PS on a 
glass substrate. The PDMS-based microfluidic part was manually aligned with the sensor 
156
Oxygen Measurement
patterns and clamped using a block of plexi- glas for fluidic interfacing. Intensity images 
for the calibration were recorded on a rectangular sensor patch at the bioreactor exit. DO 
detection was successively calibrated with DI water of five different oxygen 
concentrations produced by the external PDMS oxygenator and determined using the 
Clark-electrode reference sensor. Figure 7.5 shows a typical calibration plot of relative 
intensity as a function of DO concentration at a constant flow rate of 1 ml/min.  The 
maximum DO concentration of 34 mg/l produced by the external oxygenator caused a 
factor of 6.1 change in total fluorescent intensity. The sensor was found to follow the 
linear Stern-Volmer model (Equation (5.4)) with an intensity ratio value I0/I100 of 6.1 at 
this flow rate.
Figure 7.5: Stern-Volmer calibration curve for detection of dissolved 
oxygen in DI water with a 600 nm thick 7% w/w PtOEPK/PS sensor at 
a flow rate of Q = 1 ml/min (T = 37.4ºC).
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7.4.2 SENSOR DYNAMIC OPERATING RANGE
Calibration experiments were further extended to determine the dynamic operating range 
of the sensor. For this the sensor intensity for exposure to nitrogenated and oxygenated 
water was recorded at different flow rates. Sensor response was tested for flow rates from 
0.05 to 2 ml/min applied via the syringe pump and corresponding to the shear-stress range 
of interest in the final device application. Simultaneous visual observation of potential 
effects of shear stress on film adherence found the films to remain strongly attached up to 
the highest flow rate tested (2 ml/min). 
Figure 7.6 plots the measured absolute sensor intensity of oxygenated (~100% O2) 
and nitrogenated (~0% O2) DI water as a function of flow rate. The full-scale operating 
range of the sensor is reached at a flow rate of about 0.5 ml/min and remains constant 
thereafter. For flow rates below this value the operating range decreases slightly with 
decreasing flow rate. A similar effect was observed by Vollmer et al. [115] and attributed 
to parasitic convective losses to the surrounding PDMS matrix. Depending on the initial 
concentration entering the device, oxygen is either added or removed from the fluid by 
mass transfer through walls of the device. This effect is mainly due to the high oxygen 
permeability of PDMS. Since the permeation coefficient of N2 in PDMS has been found 
to be approximately a factor of two smaller1 than that of O2 (800 Barrer for O2 compared 
to 400 Barrer for N2) [127,135,136], the signal decrease for nitrogenated water is larger 
than that for oxygenated water at lower flow rates. If critical, loss of dissolved gases to 
the surrounding material can be reduced by encapsulation of the final device or by use of 
a less permeable polymer for the channel structure. Such an alternative material has been 
proposed for use in microfluidics in form of thermoset polyester (TPE) [137]. Previously, 
fabrication of devices with this material required an additional step after formation of 
photoresist molds and PDMS replication [138]. Recent improvements [139] to the 
fabrication process however, have lead to direct TPE rapid-prototyping becoming a valid 
alternative to the use of PDMS for applications requiring more stable surface properties 
and when solvent-based fluids are involved.
1.Mainly due to the difference in solubility factors of O2 and N2 in PDMS
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7.5   SENSOR APPLICATION
This section introduces the application of the oxygen sensor inside a LOC-type 
microfluidic device by demonstrating visualization of oxygen concentration and 
measurement of the diffusion coefficient of oxygen in water. In Chapter 3 it was 
demonstrated how channel geometry can be used to control the fluid shear stress and 
oxygen gradient experienced by cells cultured within a parallel-plate flow-through 
bioreactor chamber. The analytical model introduced requires only a single inlet stream 
with an initial oxygen concentration and was validated for the example of linear and 
constant gradients using computational fluid dynamics. In this section the bioreactor is 
modified by use of further inlets to yield an additional transverse graduation of DO levels. 
Dissolved oxygen sensors are integrated into the device using the process described in 
Chapter 5 and successively used to visualize oxygen concentration and determine the 
cross-stream diffusion coefficient of oxygen in water. The first part gives a brief 
Figure 7.6: Plot of the sensor intensity data corresponding to flows of 
nitrogenated and oxygenated water across the tested dynamic operating range. 
At low flow rates the operating range decreases slightly due to parasitic 
convective losses to the surrounding PDMS matrix.
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introduction to oxygen sensing in LOC applications. This is followed by an introduction 
of the two microfluidic devices designed and results obtained for transverse oxygen 
graduation. The final part illustrates the use of the device and analytical procedure for the 
measurement of the coefficient of diffusion.
7.5.1 OXYGEN SENSING FOR LAB-ON-A-CHIP APPLICATIONS
Due to the absence of convective mixing at low Reynolds numbers1 diffusion is the 
predominant transport mechanism between two or more parallel input streams. Several 
schemes for solute sorting and detection, such as the H-Filter and T-Sensor [140,141], 
operate using this principle. The T-Sensor in particular has been used extensively to 
measure the diffusion coefficients of solutes from and to adjacent flow streams [140,142]. 
Using the oxygen sensing technology developed here and a channel setup similar to the 
T-Sensor allowed the investigation of oxygen transport and cross-stream diffusion in 
different liquid media. In the following sections generation and visualization of flow 
streams with laterally-varying oxygen concentrations is demonstrated. 
Furthermore, laminar flow, as observed in the device, has been shown to allow for 
partial treatment of cell-cultures and individual cells with biochemical reagents without 
the need for physically separated culture chambers [143,144]. This technique provides a 
powerful tool for studies in cell biology. However, it does not account for the local oxygen 
concentration, a further parameter with significant effect on cell behavior. As previously 
discussed in Section 5.1, dissolved oxygen concentration has been found to be intimately 
linked to cell survival, metabolism and function [88,94,102-104]. These results 
demonstrate the need to precisely control DO levels to increase the relevance of in-vitro
experiments for cell biological studies and assays. The two experimental examples 
introduced in the following sections represent, in their own right, a novel method to 
expose a single cell or multiple cells in culture to different oxygen concentrations in a 
single flow chamber. In addition, the device can be used to control the DO level of 
individual flow streams used to apply different biochemical agents to cells and thus 
increase the validity of in-vitro experiments.
1.Re smaller than Recrit ~ 2400 for a circular tube.
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7.5.2 BIOREACTOR DEVICES
Two different devices and experimental setups were constructed and used to demonstrate 
transverse graduation by multi-stream flow and oxygen visualization/measurement in 
LOC devices. The first example introduced in the following is based on a PDMS 
microfluidic device and external gas-exchangers using macro-scale containers and 
gas-permeable silicone tubing for oxygenation, as described in detail in Section 6.3.3. For 
the second setup discussed here the gas-exchanger was integrated onto the chip using a 
design based on a thin gas-permeable PDMS membrane. Additional PDMS exchangers 
were fabricated (without the bioreactor structure) on separate glass substrates and were 
connected to the integrated device via tubing when required. These devices are referred 
to as external PDMS gas-exchanger in the following.
7.5.2.1 Bioreactor with External Gas-Exchanger
Measurement of locally varying oxygen concentrations inside a microfluidic channel is 
one possible application for the sensors produced by the patterning process [10]. To 
demonstrate this two inlet flows of differing oxygen concentration were applied to the 
device and the change in intensity of an integrated sensor film was recorded. A set of two 
identical external oxygenators, of the type described in Section 6.3.3, was used to provide 
aerated (Air), nitrogenated (N2) or oxygenated (O2) flow of DI water via two inlets. The 
flow rate of both inlets was kept constant at 0.5 ml/min by use of two equal syringes in 
the syringe pump. The two inlets lead to a rectangular reactor chamber (depth 0.2 mm, 
width 2 mm, length 18 mm) and exit through an outlet at the end of the chamber.
Figure 7.7 shows a photograph of the device and the corresponding intensity images 
at the inlet, the midpoint of reactor and the outlet. For illustration purposes this device was 
filled with blue dye-colored DI water. Intensity images in Fig. 7.7(b,d,e) correspond to the 
sensor signal at the bioreactor inlet for combinations of nitrogenated-oxygenated (b), 
nitrogenated-nitrogenated (d) and aerated-aerated (e) streams of water. As can be 
observed, no convective mixing takes place over the reactor length due to laminar flow 
conditions (Re ~ 80). The nitrogenated and oxygenated flow streams remain parallel and 
easy to distinguish from reactor inlet to outlet. Figure 7.7(c) plots the relative signal 
7.5 Sensor Application
161
intensity across the channel width (A-B) for the two parallel nitrogenated-oxygenated 
flows at the reactor midpoint. A clear transition of oxygen concentration between the two 
flows can be observed along the reactor centreline. The deviation of the plot shape from 
a stepwise function increases along the reactor length due to diffusive transport of oxygen 
from the oxygenated flow on the right to the nitrogenated flow on the left. As shown in 
the next section, this can be used to determine the constant of diffusion for oxygen in 
different media. The increase in signal towards the left boundary of the nitrogenated flow 
was attributed to flow instabilities induced by slight leakage at the tubing-PDMS interface 
of the left inlet port. 
Figure 7.7: Detection of laterally varying oxygen concentrations inside a microfluidic 
device: (a) Photograph of the rectangular bioreactor with integrated oxygen sensor film 
and filled with colored DI water for illustration. The two inlets at the bottom were used to 
provide flows of differing oxygen concentration into the device, Q1 = Q2 = 0.5 ml/min. 
(b) Intensity images for dual flow of nitrogenated (N2) and oxygenated (O2) water at the 
device inlet, midpoint and outlet. No convective mixing is observed due to laminar flow 
conditions. (c) Plot of the relative intensity signal across the reactor width at the midpoint 
(A - B) showing a clear transition between the two flow lines. (d,e) Intensity images for the 
device inlet after switching both inlets to nitrogenated and aerated water.
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7.5.2.2 Bioreactor with Integrated Gas-Exchanger
The previous example for parallel flow with two different oxygen concentrations can be 
further extended towards a full LOC device. Miniaturization based on PDMS 
microfabrication allows for additional inlets and gas-exchangers to be integrated on-chip. 
Combining oxygenation and detection on the same substrate has the advantage that, due 
to the reduced fluid volume, concentration changes can be realized faster. The integration 
of the fluidic network onto the chip further increases system stability and thereby 
improves the experimental procedure. 
To demonstrate this a device was designed with three inlet flows of different oxygen 
concentrations provided by on-chip PDMS-based gas-exchangers [11]. The individual 
flows were supplied to a bioreactor in the device and the change in intensity of the 
integrated PtOEPK/PS sensor film was recorded. A set of three identical integrated 
oxygenators was used to provide aerated (8.6 ppm O2), nitrogenated (0 ppm O2) or 
oxygenated (34 ppm O2) flow of DI water via three inlets. Figure 7.8 shows a photograph 
of the assembled device. The gas-exchangers are based on the design introduced in 
Figure 7.8: Photograph of the complete PDMS Prototype with three gas-exchangers and the 
two central parallel-plate bioreactors with integrated oxygen sensors. For visualization 
purposes the rectangular bioreactor and fluidic interconnects were filled with blue water and 
the gas layer with red dye-colored water. The gas-exchanger for aerated flow (left) is a dummy 
device with no second gas layer and relies on equilibration of the fluid via air diffusion from 
the local environment.
PDMS Prototype
Parallel-Plate Reactor
with integrated O Sensor2
Aerated
Flow (Air)
Oxygenated
Flow (O )2
Nitrogenated
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Section 6.3.4. A central one is integrated with the bioreactor on one substrate, while the 
other two are realized on separate substrates. This provides a modular system, where 
additional inlet streams can be created by simply connecting further gas-exchangers via 
short tubing. Alternatively, the unused inlet ports could be used to introduce cells into the 
reactor chamber or flush the device. The gas-exchanger for aerated flow is realized as a 
dummy device to provide the same fluidic resistance, but without second gas layer. It 
relies on equilibration of the fluid via air diffusion from the local environment. 
Oxygenated flow was produced by flowing gaseous oxygen (industrial grade) through the 
top layer of the central gas-exchanger. Similarly, nitrogenated flow was produced in the 
right gas-exchanger by flowing nitrogen (oxygen-free) through the top layer. The flow 
rate of the three inlets was kept constant at 0.1 ml/min for each inlet by use of the dual 
syringe pump. The dimensions of the rectangular and tapered bioreactor chambers were 
the same as in the previous example. Visualization and measurement results obtained 
using this device are discussed in the following sections.
7.5.3 VISUALIZATION OF DO CONCENTRATION
To demonstrate device applicability the resulting flow of laterally-varying oxygen 
concentration was imaged using the oxygen sensors integrated on the bottom of the 
chamber. Upon entering the reactor the parallel streams remain separated due to the 
predominant laminar flow regime. This results in three distinct oxygen concentration 
levels across the width of the chamber. Figure 7.9 shows the intensity images and oxygen 
concentration plots for the rectangular bioreactor chamber. The images from left to right 
in Fig. 7.9(a) correspond to reactor inlet, mid-point and outlet. Aerated water enters the 
chamber through the top inlet, oxygenated through the central and nitrogenated through 
the bottom inlet. The individual streams are easily discernible and remain stable over the 
full 18 mm length of the device. 
Oxygen concentration across the reactor is analyzed in the areas indicated by the 
dashed rectangles, A-B and C-D for the inlet and outlet, respectively. The two 
measurement points are separated along the length of the reactor by a distance of 
16.4 mm. Figure 7.9(b) shows the cross-width plots of the DO concentration at inlet and 
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outlet obtained from the intensity images. The oxygen concentration levels of 34 ppm 
(oxygenated), 8.6 ppm (aerated) and 0 ppm (nitrogenated) indicated by the dashed lines 
in the plots in Fig. 7.9(b) were determined through calibration of the sensor prior to 
measurement. As can be observed, the width of the individual streams or oxygen levels 
varies over the reactor length. These differences in level width from inlet to outlet of the 
individual streams can partially be attributed to lateral diffusion of oxygen from the 
oxygen-rich central stream. However, in addition to the diffusion contribution, the flow 
rate of the nitrogenated stream (bottom in intensity images, right in concentration plot) 
was found to be slightly less than the inlet flow rate of 0.1 ml/min pre-set via the syringe 
pump. The difference originated in the uneven number of inlets, where one of the two 
syringes on the pump was used to supply two inlets each via a y-junction in the tubing. 
Although the second half of flow from the syringe, providing the nitrogenated stream, was 
connected to an additional dummy gas-exchanger for fluidic resistance equilibration, 
combining only one of these two streams in the reactor lead to the aforementioned 
differences in stream width. If perceived critical, this minor problem could be mitigated 
by use of a triple syringe pump with one single syringe per stream or by a device design 
with only even number of inlets. 
The most important observation from Fig. 7.9 however, is the significant decrease in 
slope of the transition between the centre stream and the two outlaying ones from inlet to 
outlet plot. This is indicative of lateral diffusion of oxygen from the oxygen-rich region 
(central oxygenated stream) to regions of lower oxygen concentration (aerated and 
nitrogenated streams). Since the device dimensions, initial oxygen concentrations of the 
three streams and the flow conditions are known, this phenomenon can be used to deduce 
the diffusion coefficient of oxygen in the fluid. This is an important parameter for BAL 
devices at which this work is aimed at, in particular since diffusion constants in different 
media, such as biological salines and plasma, are largely unknown or may differ from 
batch to batch. An integrated non-contact measurement system for the diffusion 
coefficient based on a H-filter device, as presented in this thesis, could allow for inline 
calibration on-chip prior to the bioreactor.
7.5 Sensor Application
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7.5.4 MEASUREMENT OF DIFFUSION COEFFICIENTS
In the following sections the diffusion theory required for the analysis is introduced and 
applicability of the device, integrated oxygen sensor and measurement procedure is 
demonstrated by calculation of the diffusion coefficient of oxygen in water.
7.5.4.1 Diffusion Theory
Diffusion is the spontaneous movement of particles from an area of high concentration to 
an area of low concentration in a given volume of fluid. As the statistical outcome of 
random motion, diffusion increases entropy, decreasing Gibbs free energy, and therefore 
is thermodynamically favorable operating within the boundaries of the Second Law of 
Thermodynamics. Diffusion is mathematically described by Fick's law, which states that 
the net movement of diffusing substance per unit area of section is proportional to the 
concentration gradient and directed towards lower concentration. Thus, there will be no 
net motion if the concentration is uniform. For steady-state diffusion Fick’s first law is 
given by
, (7.1)
where J is the flux, c the concentration, and  the diffusion coefficient. 
The latter depends on the diffusing species and the material through which diffusion 
occurs. For a normal diffusion process the total number of particles is constant and the 
flux of particles into one region must be the sum of particle flux flowing out of the 
surrounding regions. This is described by the following equation of continuity:
. (7.2)
If the diffusion coefficient D is constant in space, substitution of Fick’s first law into 
Equation (7.2) leads to the diffusion equation, which describes the relationship between 
the spatial and temporal behavior of the concentration, as
J D– c∇⋅=
D kBT 6πηr( )⁄=
t∂
∂c ∇ J⋅+ 0=
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. (7.3)
For a simple case of diffusion in a semi-infinite region and with concentration c(x,t)
maintained at a value c(0) for x = 0, the solution to the diffusion equation is of the form
, (7.4)
where erfc is the complementary error function, x is the distance and t the time. The 
characteristic length 
Figure 7.9: Detection and analysis of laminar flow with three different oxygen concentrations. 
(a) Intensity images of three positions along the rectangular bioreactor with integrated oxygen 
sensor film. The three inlets on the right provide flows of DI water with 8.6 ppm (aerated), 
34 ppm (oxygenated) and 0 ppm (nitrogenated) concentration of DO. The flow rate for each 
inlet was kept constant at Q1, Q2, Q3= 0.1 ml/min. (b) Plot of the DO concentration profiles 
across the reactor width at inlet (A-B) and outlet (C-D).
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(7.5)
is called the diffusion length and provides a measure of how far the concentration has 
propagated in the x-direction by diffusion in time t. In the next section it will be 
demonstrated how the relationship in Equation (7.5) can be used to extract the diffusion 
coefficient for oxygen in DI water, or any other carrier fluid, from the triple flow 
experiment described above.
7.5.4.2 Analysis of Triple Flow Data
The data acquired during the triple flow experiment was used to calculate the diffusion 
coefficient of oxygen in DI water. Due to laminar flow in the rectangular bioreactor no 
convective mixing occurs between the three flows of different oxygen concentration. 
However, oxygen molecules will diffuse from regions of high concentration (e.g. the 
middle oxygenated stream) to regions of lower concentration (e.g. aerated and 
nitrogenated streams). This diffusive transport from the central stream is approximated by 
the solution described in Equation (7.4) and reflected in Fig. 7.9 by a flattening-out of the 
concentration profiles towards the bioreactor outlet. 
Figure 7.10 shows a schematic of the procedure used to calculate the diffusion 
coefficient of oxygen in water from the experimental results. The total flow rate into the 
reactor is QBioreactor = 0.3 ml/min. Using this, together with the bioreactor geometry 
depicted in Fig. 7.10(a) and a channel depth of 200 μm, an average fluid velocity of 
vBioreactor = QBioreactor/cross-sectional area = 1.56x10-2 ms-1 can be calculated. With a 
length of approximately 16.5 mm between the two measurement points Inlet and Outlet,
a plug of fluid will spend the time t = measurement length/vBioreactor = 1.05 s traversing 
this distance. Through the diffusion coefficient D the residence time t is directly related 
to the distance the oxygen molecules can diffuse in lateral direction. If the diffusion 
distance is known, t can be used, in conjunction with Equation (7.5), to calculate the 
diffusion coefficient for oxygen. Figure 7.10(b) indicates how the diffusion distance can 
be deduced from the slope of the slope of the concentration profile. The analysis of the 
x 4Dt Ld= =
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plot in Fig. 7.10(c) yields a distance Δxaerated = 105 μm and Δxnitrogenated = 103 μm for 
diffusion into the aerated and nitrogenated streams, respectively. Using these values to 
solve Equation (7.5) for the diffusion coefficient
, (7.6)
yields a diffusion coefficient for oxygen in water DO2inH2O of 2.57x10-5 cm2s-1 at a stage 
temperature of 37.4ºC. This value compares well with oxygen diffusion coefficients of 
2.52x10-5 cm2s-1 at 35.1ºC and 2.78x10-5 cm2s-1 at 40.1ºC for water published in 
literature [145].
To validate the applicability of the diffusion model the measured diffusion coefficient 
was used to solve a 2D CFD model of the bioreactor and flow conditions in Comsol 
Multiphysics. The model geometry was set up to be equivalent to that shown in 
Fig. 7.10(a) with a reactor depth of 200 μm. Flow conditions were modelled using the 
Navier-Stokes application mode with three parallel inlet streams of equal flow rate 
Q = 0.1ml/min each. The pressure at the outlet was set to p = 0. Liquid properties used 
were those of freshwater with a dynamic viscosity η = 1x10-3 Pa*s and density 
ρ = 1x103 kg/m3. Species transport was modelled using the Convection and Diffusion 
application mode. The measured DO2 of 2.57x10-9 m2s-1 was used as isotropic diffusion 
coefficient of the liquid. Each inlet was assigned a constant species concentration of 0, 
0.538 and 2.125 mol/m3, respectively. The boundary condition of the outlet was set to 
convective flux and the two application modes were coupled via the fluid velocity u,
parallel to the long axis of the reactor chamber. Automated meshing and refinement 
yielded a 90.000 element mesh, which was solved using the GMRES linear system solver. 
Simulated oxygen concentration profiles across the chamber width were evaluated at the 
two points indicated in Fig. 7.10(a) as inlet and outlet. Figure 7.10(d) plots an overlay of 
the measured oxygen profiles and the corresponding simulation results (dotted lines) at 
these two positions. As can be seen, there is a good agreement between experimental and 
simulation results considering the noise on the measured data. The slope of the measured 
and simulated profiles coincide, indicating the validity of the diffusion model for analysis, 
as well as the value of the diffusion coefficient measured using the fluorescent sensor. 
DO2
x2
4 t⋅
------=
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Figure 7.10: Schematic of the procedure used to calculate the diffusion coefficient DO2
of oxygen in water from the experimental data. (a) Bioreactor dimensions, (b) lateral 
oxygen concentration profiles, (c) analysis of the diffusion distance from the slope of the 
concentration profiles and (d) comparison of measured oxygen profile with CFD 
simulation results (dotted lines) for a DO2 in water of 2.57x10-5 cm2/s.
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7.6   SUMMARY
Both, for use with gaseous oxygen and to measure dissolved concentrations, calibration 
of the sensor prior to application is essential. This chapter has introduced the two 
calibration methods used for the detection of the oxygen concentration in gaseous and 
liquid media. As a result of the sensor calibration measurements several parameters 
influencing the total sensor fluorescent intensity ratio were discovered. These include PS 
molecular weight, percentage of PS in solution, substrate material and film thickness. In 
following experiments the latter dependency was used to optimize the fluorescent ratio of 
PtOEPK films on glass substrates. Reducing the film thickness down to several hundred 
nanometers by increasing the spin-coating speed yielded maximum intensity ratios I0/I100
of 11 for gaseous and 6.1 for oxygen dissolved in water. In case of measurement of DO 
concentration, calibration can be performed using the same experimental set-up as for 
measurement by simply adding a reference sensor, such as a flow-through Clark electrode 
sensor, to the device inlet. The main difference between gaseous and dissolved oxygen 
measurements was found to be the reduced dynamics for switching of concentrations in 
the latter case. While sensor response to changes in concentration remains nearly 
instantaneous, as observed for gaseous samples, generation and fluidic transport of these 
different liquid samples to the sensor limits the recording of a dynamic sensor response. 
In general however, DO operation of the PtOEPK/PS sensors was found to be very stable 
with very homogeneous laterally resolved intensity response and independent of media 
flow rate in the region of interest for the desired application. Building on the sensor 
calibration, the application of the sensor inside a LOC-type microfluidic device was 
demonstrated by visualizing oxygen concentration and measuring the diffusion 
coefficient of oxygen in water. Dissolved oxygen concentration is an important parameter 
in biological systems. Microfluidics-based devices are leading the way towards 
miniaturization and integration of a multitude of previously macro-scale biological 
processes into LOCs. Oxygen sensing and concentration control constitute two key 
elements in such microdevices. This chapter has demonstrated the application of the 
developed oxygen sensor and flow system to the visualization and measurement of DO in 
PDMS-based microfluidic devices. The importance of oxygen sensing and control was 
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discussed and their potential to improve microfluidic devices based on laminar flow was 
brought into context with existing approaches. Several examples of typical LOC 
applications were discussed. In a first example an external hollow-fiber gas-exchanger 
was used to demonstrate visualization of various DO concentrations inside a PDMS 
bioreactor with integrated oxygen sensor layer. In a second step, multiple parallel streams 
of water with different oxygen concentrations were generated, combined and visualized 
simultaneously in a single bioreactor chamber. This was performed both with external and 
on-chip PDMS-based gas-exchangers to show the applicability of the design for further 
integration. The final example demonstrated how lateral oxygen concentration profiles 
recorded with the latter setup can be analyzed to measure the coefficient of diffusion of 
oxygen in a liquid medium. While not exhaustive, the examples presented in this chapter 
manage to illustrate the multitude of possible novel applications for the PtOEPK/PS 
sensor system in LOCs and cell-culture devices, such as BAL bioreactors. The next 
chapter brings together the integrated oxygen sensor of the developed microfluidic 
platform with in-vitro cell-culture and introduces a concept of a cellular waste drainage 
system specifically designed for BALs. This is followed by the last chapter with final 
conclusions and recommendations for future work.
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The essence of life is statistical 
improbability on a colossal scale.
Richard Dawkins 
1941, British Ethologist, 
Evolutionary Biologist and Writer
CHAPTER 8  
Cell Integration
Parallel to device integration initial cell-culturing experiments have been undertaken, as 
well as investigations of other enabling technologies relating to a planar BAL bioreactor 
device. These experiments include microstructuring of cell adhesion and cell-culture and 
relating protocols, as well as determining their potential influence on sensor function. 
Integration of the PS sensor and PDMS bioreactor shape require lateral control over cell 
adhesion to facilitate hepatocyte seeding and sensor readout. The first section reviews 
existing methods used to pattern cell adhesion promoting extracellular matrix (ECM) 
proteins, such as collagen. This is followed by a discussion of the methods investigated to 
promote localization of cell adhesion and the influence of substrate material on 
cell-culture. Following this, the procedures for integration of cell culture into the 
microfluidic shear device are discussed and sensor function is demonstrated in a cancer 
cell culture. The last section introduces initial investigations on the use of highly aligned 
vertical carbon nanotube (CNT) membranes as a conduit for an integrated bile drainage 
system.
8.1   CELL ADHESION
Further evaluation of the oxygen control principle requires the integration of live cells into 
the bioreactor device introduced in the previous chapters. Figure 8.1 shows a schematic 
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of the individual layers inside the bioreactor chamber. Structural support is provided by a 
glass substrate, such as a microscope slide, onto which the oxygen sensor layer is applied. 
The sensor is then covered with a layer of adhesion promoting protein, such as collagen. 
Cells are allowed to attach to this film and are covered by a further layer of collagen to 
promote expression of natural polarity. Finally, the complete stack is aligned with a layer 
of PDMS containing the corresponding fluidic features.
To facilitate the integration of cells into the oxygen sensor device, the attachment of 
cells has to be controlled and restricted to the regions with underlying oxygen sensor 
layer. Several different approaches have been proposed to control selective cell adhesion 
in cultures. Bhatia et al. [75] used photolithography for adhesion protein patterning. 
Commercial photoresist was structured using a mask and cell-specific adhesion protein 
was deposited onto the resist. After binding of the protein to the substrate, the remaining 
photoresist was lifted-off, producing localized patches of protein. Using this method 
patterned co-cultures of hepatocytes and 3T3 fibroblasts were demonstrated. A second 
approach proposed by Powers and Griffith [146] used affinity-specific cell morphology 
to influence cell layer formation. Different cell types were observed to form differing 
morphologies depending on the concentration of the adhesion protein deposited on a 
substrate and cell-substratum affinity in general. By varying protein concentration and 
substrate affinity this approach was used to produce hepatocyte and endothelial cell 
Figure 8.1: Schematic side view of the bioreactor 
chamber indicating the individual layers of the final 
device (layer thickness not to scale).
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co-cultures with pre-determined morphology. 
Recently, advances in microfabrication techniques based on silicone elastomers such 
as PDMS have seen the introduction of several novel protein patterning approaches. As 
demonstrated in Chapter 5, PDMS provides an excellent material for the high-resolution 
replication of a stencil pattern into polymer thin films. The use of these stamps is not 
limited to dry-patterning of polymers, but can also be extended to bio-materials such as 
cell adhesion promoting protein films. With micro-contact printing, stencil stamps and a 
combination of the two, three different approaches to pattern protein films with PDMS 
stamps have been proposed. De Silva et al. [147] demonstrated localization of cell 
adhesion by micro-contact printing. A PDMS stamp was coated with adhesion-promoting 
biomolecules and brought into contact with a substrate forming a biomolecule pattern. 
Both collagen and laminin patterns were fabricated and cells were found to preferentially 
adhere to the biomolecule patterns. Zinchenko and Coger [148] used PDMS to create a 
stencil-type template of the desired cell pattern. Openings in the stencil allowed the 
deposition of proteins onto an underlaying substrate. After removal of the stencil 
hepatocytes and Kupffer cells were successfully co-cultured by localizing the hepatocytes 
to the pre-defined collagen patterns. Finally, Rhee et al. [149] proposed a combination of 
a PDMS stamp pattern with dry-etching for selective cell adhesion. This approach is 
similar to the process developed for sensor patterning in Section 5.3. PDMS stamps with 
the desired pattern are brought into conformal contact with a bare PS or poly-L-lysine 
coated substrate. When placed in a plasma etcher the stamp pattern in contact with the 
substrate protects the underlaying material. As a result protein patterns or selectively 
oxidized PS is obtained. Thus modified substrates were successfully used to demonstrate 
patterned cell cultures of human umbilical vein endothelial cells, MDA-MB-231 human 
breast cancer cells, NIH 3T3 mouse fibroblasts and primary rat cortical neurons.
8.2   LOCALIZATION OF CELL ADHESION BY MICROSTRUCTURING 
OF COLLAGEN 
Two methods for producing patterned collagen films were investigated. The first 
approach builds on the similarity of the technique proposed by Rhee et al. [149] and the 
process introduced in for sensor patterning Chapter 5. PDMS stamps in combination with 
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RIE in oxygen plasma were adapted for the micro-structuring of cell adhesion promoters. 
This method allows the bioreactor shape to be bonded in the same plasma exposure step 
as used for structuring of the collagen film. Furthermore, oxygen sensor and collagen 
patterning can be performed as part of the same fabrication step. The second method uses 
PDMS stencils, as compared to stamps, to form the collagen pattern. Solution is pipetted 
directly into the stencil opening, which defines the final shape of the pattern. Although 
simpler, this method is limited in realizable shapes, as discussed in Chapter 5 for sensor 
patterning. To implement both techniques 25 mg type I collagen (rat tail, Prod. No. 
C7661, Sigma Aldrich, St. Louis, MO, USA) was purchased and PDMS stamps with the 
required bioreactor shape were fabricated according to the processes described in 
Chapter 4.
8.2.1 COLLAGEN FILM PREPARATION
Water-free glacial acetic acid (17 mol/l) was diluted in two steps to obtain 0.1 mol/l acetic 
acid. First, glacial acetic acid was blended 1:16 with DI water and stirred for 2 h resulting 
in 1 mol/l acetic acid. This was again diluted 1:9 with DI water and stirred for further 2 h. 
A 0.1% (w/v) main stock solution of type I collagen was prepared according to the 
product information provided [150] by weighing 10 mg of collagen and adding 10 ml of 
0.1 mol/l acetic acid. Dissolution was performed by agitating in US over 1 h. A second 
working stock solution of 0.01% (w/v) collagen was prepared by diluting the stock 
solution tenfold. 
In general, collagen films were deposited onto bare glass microscope slides and 
slides pre-coated with PtOEPK/PS films by pipetting from the second working stock. 
After deposition the solution was left to incubate in a fume hood at room temperature for 
a typical duration of 8 hrs overnight. In case of pre-coated PtOEPK/PS films a short (10 s, 
500 W O2) plasma treatment of the substrate was performed prior to pipetting of the 
collagen solution. This allows for continuous wetting of the otherwise hydrophobic PS 
surface and thereby a more homogenous collagen film. Following incubation, excess 
collagen solution was rinsed off with DI water and the film was carefully blow-dried using 
N2.
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8.2.2 COLLAGEN PATTERNING BY RIE
Patterning by RIE requires a pre-deposited layer of ECM on a flat substrate. For testing 
of the procedure, 50x75 mm glass microscope slides were spin-coated with PtOEPK/PS 
solution and left to dry. Collagen was deposited onto the sensor layer by use of a large 
stencil-like PDMS gasket cut to the size of the substrate. For deposition of an ECM 
monolayer previously described stock collagen solution was pipetted into this gasket and 
left to incubate at RT overnight. Excess solution was rinsed off the following day and the 
sample was carefully dried using N2. As described for patterning of the oxygen sensor in 
Chapter 5, a PDMS stamp of the desired sensor and collagen shape was then brought into 
conformal contact with the surface. The pattern was then transferred into both layers in a 
single RIE etch step. 
An example of a collagen layer patterned using this method is shown in Fig. 8.2. The 
complete replicated pattern corresponds to that previously introduced in Fig. 5.13(c). 
Square patches to the right of the pattern and close-ups are depicted as DIC micrographs 
in Fig. 8.2. The insets (a) to (c) show the fine structure of the top collagen patch at 
different enlargements. A continuous layer of collagen can be observed and overall 
dimensions of the replicated pattern agree well with the stamp. Pattern fidelity seems to 
be slightly reduced around the shape boundaries due to the rough protein surface, which 
might limit the conformity of the contact between PDMS stamp and the collagen during 
etching. However, the resolution obtained using this method is more than sufficient for 
localization of cell adhesion inside the bioreactor device.
8.2.3 COLLAGEN PATTERNING BY PDMS STENCIL
The second method investigated for patterning of the collagen layer uses a thin (~200 μm) 
version of the PDMS stencil for deposition and pattern definition. Openings in the stencil 
corresponds to the desired collagen patches and solution is deposited directly into the 
holes onto the substrate underneath. For use with an underlaying oxygen sensor the stencil 
is first aligned during stencil placement. Figure 8.3 shows a composite DIC micrograph 
of a collagen pattern fabricated by use of a PDMS stencil. The pattern has the shape of the 
bioreactor design and can be used to limit cell adhesion to the active area of the reactor 
178
Cell Integration
only. This is of advantage if additional sensor patches without collagen and cell-cover are 
required in the inlet and outlet channels for example. While this method of patterning is 
experimentally simple and fast once the stencil is fabricated, it was observed that collagen 
films deposited this way tend to exhibit less thickness uniformity than those fabricated 
using RIE. As this phenomenon is especially pronounced towards the boundaries of the 
pattern, hydrophobicity of the stencil is a likely cause. In fact, prior treatment of the 
PDMS with a plasma wand (BD-20AC laboratory corona treater, Electro-Technic 
Products Inc., Chicago, IL, USA) for a short (~30 s) period of time lead to significantly 
better wetting of the collagen solution and successively more homogeneous films. 
Figure 8.2: DIC micrographs of a plasma patterned type I collagen layer on a glass 
microscope slide. The pattern was replicated with the same PDMS stamp as used for oxygen 
sensor patterning. The images on the right (a, b and c) show the indicated pattern detail in 5, 10 
and 20x enlargement, respectively. A continuous layer of collagen can be observed, but pattern 
fidelity seems to be reduced due to the rough protein surface limiting conformal PDMS contact 
during etching.
a)
5x
b)
10x
c)
20x
250um
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8.2.4 INFLUENCE OF COLLAGEN ON SENSOR FILMS
The cell-adhesion promoting ECM constitutes a biomaterial, as it is sourced from rat tails 
and consists mainly of glycoproteins. In form of the collagen layer it is in direct contact 
with the PS matrix containing the PtOEPK oxygen sensor dye molecules. Thus it is 
important to determine potential degrading effects of the proteins on sensor function. To 
test this, samples of glass substrates with a spin-coated PtOEPK/PS layer were covered 
with a film of type I collagen, as described in the previous section, and the intensity 
response was monitored daily over a duration of two weeks [151]. For measurement of 
the intensity ratio the sensor was exposed to 100% gaseous oxygen and 100% nitrogen 
(0% O2) once per day. In between measurements sensor films were stored in darkness and 
at 37.4ºC to exclude photobleaching and temperature effects. 
Figure 8.4 shows a plot of the sensor intensity ratio I0/I100 as a function of time in 
days for a typical 600 nm thick sensor patch of PtOEPK/PS covered with collagen by 
evaporation of 200 μl of 0.01% collagen solution. As can be observed, the initial value for 
I0/I100 of 6.05 is somewhat lower than for pure PtOEPK/PS (I0/I100 ~6.8), but remains 
nearly constant over the first 4 days. In total, the ratio decreases by only 8% over the 
measurement time of 14 days. During this period the sensor film was illuminated for an 
accumulated duration of 5 hrs, corresponding to ~20 mins per day. The result indicates 
that the collagen film does not significantly affect the sensor. Furthermore, taking into 
account photobleaching and measurement accuracy, it can be said that the reduction of 
intensity is small enough to make the sensor suitable for long-term observation of oxygen 
Figure 8.3: Composite DIC micrograph of a full bioreactor shape replicated in type I 
collagen by use of a PDMS stencil. The collagen solution was pipetted into the stencil 
pattern placed onto the substrate and left to evaporate to form a solid film.
Collagen Layer
1mm
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concentration. Due to its applicability as adhesion promoter for hepatocytes, only 
collagen was tested in conjunction with the sensor. If other cell lines requiring a different 
ECM are to be used with the PtOEPK/PS sensor, these should be re-tested prior to use.
8.3   SENSOR USE WITH LIVE CELLS
As demonstrated in the previous section, the oxygen sensor function of the PtOEPK/PS 
layer remains unaffected when covered with collagen. However, the application of the 
sensor in this form is only an intermediate step on the way to its use in conjunction with 
live cells. Ideally, cells are either cultured in an alternating pattern with interspersed 
sensor stripes or directly on top of the collagen-covered PtOEPK/PS layer. In both cases 
chemicals secreted by the cells as part of metabolisms and signalling have the potential 
for biofouling of the sensors. In addition, diffusion of oxygen through the cell/collagen 
sandwich (as formed in the latter case) to the sensor layer underneath may be reduced due 
to oxygen uptake of the cells. This has to be evaluated during calibration and accounted 
Figure 8.4: Plot of the sensor intensity ratio as function of time 
(days) for a PtOEPK/PS film covered with a layer of type I 
collagen. The intensity was measured once daily for exposure to 
gaseous oxygen and nitrogen over a period of two weeks.
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for during measurement. In the following sensor function in conjuction with cells is 
demonstrated and initial results of oxygen measurement are given.
8.3.1 CELL CULTURE PREPARATIONS
Ideally, hepatocytes would have been used for the next phase of the work, however this 
proved to be difficult so another cell type was employed instead. Ethical approval to 
procure rat liver cells (Hepatocytes) was obtained from the University of Otago’s 
Christchurch School of Medicine and Health Sciences (CSMHS) with the help of Prof. 
John Evans. A dedicated laboratory for handling of cells has been put in place within the 
Department for Electrical and Computer Engineering at the University of Canterbury and 
awaits PCR-2 biological safety certification. However, at the time of this work no other 
research relating to rat liver cells was being performed at the CSMHS so protocols for cell 
harvesting and culture were not in place. Other cell sources were available for immediate 
use so these were used instead. 
In addition initial contacts were established with Prof. Mehmet Toner’s group at the 
Harvard Medical School (HMS) in Boston, USA regarding the use of liver cells. 
Agreement was obtained for the author to undertake work in Prof. Toner’s laboratory, 
however the current HMS protocols did not permit pre-PhD researchers to be processed 
for admission as visitors - an unfortunate chicken-and-egg situation.
For these reasons, immediate testing of the sensor and as proof of concept in 
conjunction with live cells, it was decided to use human Ishikawa endometrial carcinoma 
cells instead of hepatocytes. This cell line and related protocols were readily available at 
the CSMHS. 
8.3.1.1 Cell-Culture Supplies and Protocol
The nutrient solution and supplements necessary to culture the cells were acquired from 
Sigma Aldrich according to the solution used by Dunn et al. [152] and others for rat 
hepatocytes. This included Dulbecco's Modified Eagle's Medium (DMEM, Prod. No. 
D5796) and insulin (Pro. No. I6634), glucagon (Prod. No. G2044), epidermal growth 
factor (Prod. No. E4127), hydrocortisone (Prod. No. H0888) and penicillin/streptomycin 
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(Prod. No. P4333) nutrient supplements. Plain DMEM was used as perfusion medium for 
cancer cell trials.
Cells were obtained from Cryo-storage at -80ºC in a freezer or in liquid nitrogen. Cell 
dispersion was carried out under aseptic conditions. Preparation was performed in a 
laminar flow cell culture hood (EMAIL Air Handling Biological Safety Cabinet Class II). 
All glassware used for cell preparation was autoclaved before use and together with all 
the solutions were sterilized with ethanol. All cells (in cryo-vial) and solutions were first 
pre-warmed to 37ºC before use. Minimum Essential Medium αMedium (αMEM) 
supplemented with a 10% of Fetal Bovine Serum Medium was used culture medium. 
Once the cells were ready, they were transferred into culture flasks (50 ml with carted 
neck) and 10 ml of the αMEM was added to each flask. Then the cells were stored in an 
incubator (37ºC, 0.5% CO2) for at least 1 - 2 days to allow the cells to adhere to the 
surface. Culture medium was changed after 1 -2 days and replaced with another 10 ml of 
(αMEM + FBS 10%).
When cells had reached a confluent state, they were split in preparation for further 
use. Cultures that had become confluent were placed in the cell-culture hood, where the 
cell culture media was removed by aspiration. Pre-warmed 10 ml of Phosphate Buffered 
Saline (10x PBS pH7.4) at 37ºC was used to wash the cells. The PBS was then removed 
and the wash step was repeated twice more. Following the final aspiration of the PBS from 
the flask, 2.5% trypsin in PBS was added to the cells. Cells were dislodged by light 
tapping onto the side of the flask. The split cells were transferred into a larger 
multi-welled or culturing plate for different experiments. A small sample of a prepared 
cell suspension was removed, and used to perform a cell count with a haemocytometer. 
Cells were then centrifuged at 1500 rpm for 5 minutes at room temperature. After that, the 
supernatant was aspirated and the media (αMEM + FBS 10%) was added, with the 
volume dependent on the cell count performed earlier, the size of the plate and the 
concentration of cells required. The plate was then stored in the incubator for 2 - 6 days 
depending on the type of experiment.
8.3 Sensor Use with Live Cells
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8.3.1.2 Substrate Material for Cell-Culture
The choice of substrates for testing of the sensor in cell-culture was based on the materials 
making up the bioreactor device. Large 50x75 mm glass microscope slides were used as 
base substrate. Slides were used either plain, treated or coated with a variety of sensor 
films and cell adhesion promoters. Commercially available, sterile PS cell-culture dishes 
(OmniTray, Nalge Nunc Int., Rochester, NY, USA) acted as control substrate and carrier 
for the sensor substrates. Glass slides were mounted inside the carrier by use of 
double-sided adhesive tape. Table 8.1 lists the different substrates and material 
combinations prepared for cell adhesion and culture experiments. To limit the exposed 
surface area a PDMS stencil containing the three (rectangular, intermediate and 
optimized) bioreactor shapes was placed on each of the substrates. For samples with 
pre-patterned sensor films the patterns of the stencil were manually aligned with the 
underlaying identical PtOEPK/PS pattern. For samples covered by a Type I collagen layer 
the sensor was exposed to a short (~30 s) atmospheric pressure plasma using the plasma 
wand to assist wetting of the film. Immediately after treatment the collagen solution was 
applied by pipette and left to dry overnight at RT. Excess solution was rinsed off with DI 
water. Samples were stored in the dark and transported in lightproof containers to prevent 
photobleaching.  
8.3.2 CELL-CULTURE OF HUMAN CANCER CELLS
The cell line Ishikawa was established from an endometrial adenocarcinoma from a 
39-year-old Asian woman [153]. It originated from a well differentiated human 
endometrial carcinoma and bears both estrogen and progesterone receptors. The cells 
have been used in numerous basic research areas such as reproductive biology and 
molecular science. Being carcinomic, this type of cell is able to divide in culture and thus 
form confluent layers on a substrate from a seed stock. Hepatocytes on the other hand, do 
not readily divide in culture and need to be re-harvested and re-seeded for each 
experiment. For the following experiment cells were prepared as described before, 
transferred to the substrate to be tested and incubated for a certain period prior to use.
Figure 8.5 shows DIC micrographs of Ishikawa cells after 3 days in culture on a glass 
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substrate used as control. The cells were confined to a bioreactor-shaped pattern of type I 
collagen during culture using a PDMS stencil. As can be observed in Fig. 8.5(a), after the 
stencil is peeled off, cell coverage is concentrated inside the area defined by the stencil 
opening, which is indicated by the white dashed line. Cells were observed to form dense 
clusters, shown in Fig. 8.5(b) and (c), on top of the collagen-covered glass surface. After 
3 days incubation roughly 70% of the surface area of the patch was covered with cells. 
Simultaneously to this sample, cells were cultured on a second substrate with a 
PtOEPK/PS sensor layer between the glass base and the collagen film. For this example 
the shape of the sensor and collagen was again pre-patterned using the developed RIE 
process and a removable PDMS stencil was used to confine the cells during culture. The 
following section discusses measurement of oxygen using this sample.
8.3.3 OXYGEN SENSING IN CANCER CELL CULTURE
To demonstrate the compatibility of the PtOEPK/PS oxygen sensor with direct cell 
culture, oxygen measurement was performed with cancer cells seeded onto a sensor layer. 
Figure 8.6 shows oxygen calibration results of a PtOEPK/PS sensor patch seeded with 
Ishikawa human endometrial cancer cells after 3 days in culture. Prior to testing of sensor 
No. Substrate Layer Treatment Conditions
1 glass slide plain untreated NA
2 cell culture
dish PS
plain untreated sterile
3 glass slide PtOEPK/PS
(7% w/w)
untreated spin-coated
30 s @ 6000 rpm
4 glass slide PtOEPK/PS
(7% w/w)
RIE patterned spin-coated
30 s @ 6000 rpm
5 glass slide PtOEPK/PS
(7% w/w)
Type I collagen
(0.01%)
no RIE, O2 plasma 
for wetting
spin-coated
30 s @ 6000 rpm
200 μl in square PDMS 
for 4 h @ 37.4ºC
6 glass slide PtOEPK/PS
(7% w/w)
Type I collagen
(0.01%)
RIE patterned, O2 
plasma for wetting
spin-coated
30 s @ 6000 rpm
200 μl in square PDMS 
for 4 h @ 37.4ºC
Table 8.1: Substrates, adhesion layers and corresponding surface treatments for 
cell-adhesion trials.
8.3 Sensor Use with Live Cells
185
function remaining culture solution was rinsed off the sample with fresh DMEM and the 
surface was carefully dried using N2. DIC and fluorescent micrograph images of a region 
of the bioreactor-shaped sensor, indicated by the schematic on the top right, are displayed 
on the left in Fig. 8.6(a) to (f). Starting from the top, Fig. 8.6(a) shows the area of interest 
in DIC light microscopy indicating clusters of cancer cells before measurement. The 
following four images (b to e) show the fluorescent intensity response of the underlaying 
sensor layer for exposure to air (~21% O2), nitrogen (0% O2), oxygen (100% O2) and 
back to air, respectively. The final image, Fig. 8.6(f), shows the same area again as a DIC 
micrograph after measurement. 
A graph of the relative intensity I0/I versus the relative gaseous oxygen concentration 
p/p0 for the sensor sample is plotted on the bottom right. The measured intensity ratio 
I0/I100 exhibited by the sensor when covered with a film of type I collagen and cancer cells 
Figure 8.5: DIC micrographs of Ishikawa human endometrial 
cancer cells after 3 days in culture. The white dashed line in (a) 
indicates the outline of the bioreactor shape defined by the PDMS 
stencil during culture. (b) and (c) show close-ups of cell clusters.
5um
100uma)
b) c)
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is 3.8. The second line in the plot indicates the sensor calibration 60 days prior to collagen 
deposition and cell-culture. In this case the I0/I100 is 8.2, approximately double the value 
recorded with cells and collagen. Despite this difference, this successful use of the sensor 
layer in cell-culture demonstrates the applicability of the PtOEPK/PS sensor films to the 
in-situ measurement of oxygen in active biological environments. It further indicates that 
sensor function remains viable even when covered with biofilms and live cells for 
extended periods (~ days). As can be observed, the measured intensity ratio is smaller than 
for uncovered sensor patches, which might be related to both the extended storage time 
prior to cell seeding and the potentially reduced diffusion of oxygen through the 
cell/collagen sandwich. 
Acquisition of the results given above conclude the study presented in this thesis. 
Figure 8.6: PtOEPK/PS oxygen sensor function with cancer cells cultured on top. Micrographs 
on the left show a region of the bioreactor indicated by the schematic on the top right. (a) DIC 
microscopy of cancer cells growing on the sensor film prior to application of O2. Consecutive 
images of fluorescent sensor response of the same area in (b) air (~21% O2), (c) pure nitrogen 
(0% O2), (d) pure oxygen (100% O2) and (e) air. (f) DIC micrograph of the area after sensing. 
The graph on the right shows a plot of relative intensity as a function of oxygen concentration 
before and after cell-culture. (T=37.4ºC)
a) DIC before b) NIR air (~21% O )2
c) NIR nitrogen (0% O )2 d) NIR oxygen (100% O )2
e) NIR air f) DIC after
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Oxygen measurement under medium flow could not be performed as CSMHS protocols 
required a shut-down of all cell-incubation experiments over the summer holiday period. 
To continue work on the oxygen gradient hypothesis will require further cell sources, 
preferably the establishment of hepatocyte harvesting and culture protocols, and the 
certification of the biological containment facility in the Electrical Engineering 
Department to allow flow experiments to be set up under stable culture conditions. The 
last section in this chapter briefly introduces initial investigations into an auxiliary 
technology related to waste removal from hepatocytes cultured in a bioreactor, which has 
the potential to further improve BAL devices.
8.4   BILE DRAINAGE SYSTEM
An additional anatomical feature specific to the liver microstructure is the system of bile 
canaliculi and ductule formed to remove bile fluid from the hepatocytes to the gallbladder 
and intestines. The function of bile in the hepatic system and the human body were 
introduced in Section 2.1.2.3. Briefly, the major constituents of the bile are bile acids, 
cholesterol, water, bilirubin and other organic waste substances. To this day, removal of 
bile from the main perfusion flow has not been addressed by any of the existing BAL 
bioreactor devices. Currently bile fluid produced by the hepatocytes in culture is 
re-introduced into the main flow and potential effects of this on metabolic function of 
hepatocytes seeded further down-stream in the bioreactor are not yet fully 
understood [154]. In humans, blockage of the bile duct by a cancer, gallstones, or scarring 
from injury prevents the bile from being transported to the intestines. This leads to the 
active ingredient in the bile (bilirubin) accumulating in the blood stream and the resulting 
condition is called jaundice.
8.4.1 CONCEPTUAL DESIGN
Bile canaliculi are formed as grooves on some of the lateral faces of hepatocytes in contact 
other hepatocytes. The canaliculi merge and form bile ductules, which eventually become 
the common hepatic duct. Formation of this micro anatomy is a function of inter-cellular 
arrangement and related to the matrix the cells are cultured on [155]. Typical materials 
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used for this are ECM proteins and hydrogels. However, recently preparations of CNTs 
and membranes based on these have started to gain increased interest as a novel 
cell-culture substrate due to excellent cell-adhesion and proliferation properties [157]. 
Furthermore, separate investigations into the transport mechanism of liquid through 
CNTs, which is predicted to be similar to naturally occurring ion channels, have shown it 
to be ultra-efficient and magnitudes faster than through pores of comparable size [158]. 
The discovery of one particular form of CNTs, commonly called vertically aligned carbon 
nanotubes (VACNT), has made it possible to grow both vertically and laterally defined 
mats of highly ordered tubes [156]. Currently the main application of these patterned tube 
arrays is their use as microelectrodes, but great potential exist for applications in 
nanofluidics such as vertical conduits and as membrane material. 
The promising existing findings on nanotube properties in relation to cell-culture and 
fluidic transport lead to the design and initial investigations of a conceptual bile drainage 
system. Figure 8.7 shows a schematic of two possible versions of a potential bile drainage 
system based on capillary flow through a membrane of CNT bundles.The first example, 
shown on the left in Fig. 8.7, is based on bundles of CNTs embedded in a thin PDMS film. 
In this case the cells are cultured on a layer of collagen and the embedded bundles act as 
localized vertical fluidic interconnects to a drainage channel. The second example shown 
on the right uses a mat of VACNTs as direct cell-culture substrate and fluidic conduit. This 
variation in particular allows to utilize potentially advantageous morphological 
cell-substrate interactions. 
8.4.2 INITIAL CNT EXPERIMENTS
A schematic of the fabrication process used for the CNT/PDMS membranes is shown in 
Fig. 8.8. CNT bundles were grown on a pyrolyzed photoresist film (PPF)-covered 
substrate using a thermal chemical vapor deposition process [156]. Lateral confinement 
of the bundles was achieved by deposition through a shadow mask type stencil. The 
substrate was then covered in a thin layer of PDMS by spin-coating to the vertical length 
of the CNT bundles and the top of the CNTs was cleared of remaining PDMS using RIE. 
After thermal curing of the polymer a pre-fabricated second layer of PDMS containing 
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fluidic interconnects was aligned to the bundles and irreversibly bonded to the membrane 
using oxygen plasma activation. This sandwich could be carefully peeled off the PPF 
substrate complete with the embedded CNT bundles. It was then bonded to a third PDMS 
layer with further fluidic interconnects to the backside of the bundles and a glass substrate 
for mechanical stability. 
Figure 8.9 shows optical and SEM micrographs of the experimental bile drainage 
system.  An optical micrograph of the assembled test chip is displayed in the main image. 
Both, top and bottom fluidic interconnects are visible and three channels are partially 
filled with dye-colored water. CNT bundles are visible as darker areas in the middle of the 
round channel ends and a SEM micrograph of the bundle array is shown in Fig. 8.9(a) 
prior to spin-coating of PDMS and release from the substrate. The close-up optical 
micrograph in Fig. 8.9(b) focuses on the top end of a single CNT bundle inside the PDMS 
channel, demonstrating that the CNT tips were cleared of PDMS during RIE. Initial 
experiments with water gave inconclusive results for pressure-driven flow. Liquid was 
observed to move from the top channels to the bottom channels through some of the CNT 
bundles. With the current setup it was not possible to determine whether this transport 
occurred through individual nanotubes or via conduits formed by the potentially imperfect 
PDMS-CNT interface. However, the work carried out here does demonstrate the viability 
of the process.
Figure 8.7: Schematic of two possible versions of the direct bile drainage system for the BAL 
device. Hepatocytes are cultured as a monolayer on a liquid-permeable CNT membrane with 
underlaying drainage channel. By maintaining the pressure in the drainage channel 
Pdrain<Pmain, bile fluid is allowed to drain from the system to an external reservoir.
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8.5   SUMMARY
In this chapter several additional processes and issues relating to in-vitro cell-culture in 
the developed bioreactor device have been addressed. The potential influence of 
biomaterials found in culture media and that of the ECM and cells themselves on sensor 
performance was investigated. A process to pattern a collagen cell-adhesion film 
simultaneously with the oxygen sensor layer was developed and demonstrated for 
selective cell localization. Collagen type I deposited onto the PS/PtOEPK film was found 
Figure 8.8: Schematic of the fabrication process of the CNT/PDMS 
membrane devices.
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to have no detectable influence on the sensor intensity ratio over a period of two weeks. 
Oxygen sensing with cells was demonstrated by culturing human cancer cells directly on 
top of the sensor with an intermediate collagen film. The sensor showed a slightly reduced 
intensity ratio after 3 days in culture compared to the pure film measured 60 days prior. 
However, the ratio I0/I100 remains larger than 3, which is the commonly agreed value 
above which a sensor is suitable for oxygen-sensing devices. As a final notion, a novel 
concept of an auxiliary bile drainage system for BAL devices was introduced. The design 
is based on a novel material combination of bundles of VACNTs embedded in a thin 
PDMS film. Fabrication of a prototype was demonstrated and initial fluid flow through 
Figure 8.9: Optical and SEM micrographs showing the initial experiments related to the 
use of CNT bundles for fluid transport. The main image shows the fluidic interfacing of the 
PDMS-encapsulated bundles with top and bottom channels. (a) SEM micrograph of the 
array of CNT bundles on PPF prior to encapsulation in PDMS and release from the 
substrate (Courtesy of X. Liu). (b) Optical micrograph close-up of an encapsulated CNT 
bundle inside the fluidic channel showing the top of the nanotubes free of PDMS.
50um
Courtesy of X. Liu
20um 20um
a) b)
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the membrane was observed. However, more testing is required to determine the 
feasibility of the concept.
In summary, the results discussed in the first part of this chapter, together with the 
techniques described in the previous chapters, provide a complete toolbox enabling the 
use of the bioreactor with integrated sensor system for cell-culture applications. The 
second part brings forward a novel concept combining fluidic conduits and cell substrate 
in a single promising material for future potential use in a BAL bile drainage system. The 
next chapter will provide conclusions to the work presented in this thesis and recommend 
directions for future work based on the results.
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...the end of all our exploring will 
be to arrive where we started, and 
know the place for the first time.
T. S. Elliot 
1888-1965, Anglo-American Poet, Dramatist, Literary critic
CHAPTER 9  
Conclusions and Future Work
This chapter summarizes the main contributions made by this thesis and draws 
conclusions from the research performed. Recommendations are then made concerning 
future work in the area.
9.1   THESIS SUMMARY AND CONCLUSIONS
The work described in this thesis contributes to the understanding of oxygen 
concentrations in microfluidic cell-culture devices. In particular, it provides the tools 
necessary to generate, control and measure the dissolved oxygen concentration in 
continuously perfused BAL bioreactors, thereby helping to overcome existing 
fundamental transport limitations in parallel-plate designs. The development of the 
model-based bioreactor shape together with the process for the integration of a 
cell-culture compatible oxygen sensor provide these tools. Numerical evaluation of the 
bioreactor shows that the transport model, in conjunction with cell oxygen uptake, can be 
used to design the lateral bioreactor shape to yield custom concentration gradients. This 
is especially useful to maintain a certain, constant oxygen level over the full length of a 
cell-culture as demonstrated by the tapered bioreactor. 
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The bioreactor device is unique in that it can maintain a specific concentration 
gradient without the need for additional membrane-based oxygen input. This is achieved 
simply by implementing the corresponding reactor outline resulting from the model 
equations and providing inlet flow with the desired initial oxygen concentration. 
However, this advantage is gained at the cost of increasing shear-stress over the chamber 
length compared to conventional designs with constant width. Nevertheless, by adjusting 
the inlet flow rate the value of the shear stress experienced by the perfused cells can be 
maintained at physiological levels. Furthermore, in case of application with hepatocytes 
shear-stress constitutes an additional parameter determining cellular function and thus the 
bioreactor can provide a closer match to in-vivo sinusoids than conventional designs.
Simultaneously, the integrated oxygen sensor allows for non-contact in-situ
monitoring of the concentration throughout the whole chamber and inlet and outlet ports 
if required. The novel fabrication process developed for the highly sensitive and versatile 
PS/PtOEPK fluorescent oxygen sensor system allows very homogeneous films to be 
deposited and integrated into common microfluidic devices. PS/PtOEPK itself is not new 
a new material, however, the combination of spin-coating and RIE-etching with PDMS 
stencils for fabrication allows for the first time large-scale custom shaped sensor patterns 
to be produced while retaining film quality. Unlike existing techniques, such as deposition 
by manual pipetting, the new process provides excellent control over sensor film 
thickness via the spin-speed. In addition, since patterning is performed after film 
formation and on a wafer-level, both pattern reproducibility and fabrication throughput 
are significantly increased. Sensor patterns with feature sizes in the lower micrometer 
range have been demonstrated. While this is sufficient for cell-based applications, 
potential for future pattern miniaturization using this approach exists. 
A further discovery in relation to the PS/PtOEPK sensor films, which was directly 
facilitated by the thickness control inherent to the deposition method, is the inverse 
dependence of the fluorescent intensity ratio I0/I100 on film thickness. This ratio is a 
measure of the sensitivity of the sensor layer and could be more than tripled by reducing 
the film thickness from 1.3 μm down to around 300 nm. Through this, the highest 
reported sensitivity ratio for PS/PtOEPK on glass substrates has been achieved.
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The observed homogeneity of the spin-coated sensor films also implies that intensity 
quenching instead of fluorescent lifetime can be used to measure the oxygen 
concentration. This simplifies the required excitation and detection setup to a 
conventional fluorescence microscope with attached CCD sensor and enables low-cost, 
spatially-resolved oxygen profiling. To demonstrate the latter, and device applicability in 
general, lateral oxygen profiling was for the first time ever used to visualize parallel 
multi-stream flow of different dissolved oxygen concentrations and with stable laminar 
interfaces in a single bioreactor. Inlet stream oxygenation based on PDMS membrane 
gas-exchangers was integrated on-chip to provide multiple inlet streams and thereby add 
a second dimension to graduation. Changes of in-situ oxygen concentration inside the 
device could be imaged in real-time and the profile of the transverse graduation of 
concentration levels across flow streams measured at various points along the device 
length. This technique provides a powerful new tool to increase the significance of studies 
in cell biology based on partial treatment of cell-cultures and individual cells with 
biochemical reagents by adding oxygen control. 
In addition, and comparable to use of the T-sensor, it was shown how the device can 
provide an experimental tool to determine the coefficient of diffusion of oxygen in a liquid 
medium. This was demonstrated for the diffusion of oxygen in water and the measured 
coefficient agrees well with data published in literature. Using the obtained diffusivity, the 
shape of the recorded cross-stream concentration profiles could be validated by means of 
CFD simulation.
One of the biggest advantages of the present system in relation to use with biological 
samples and cells is the solid state nature of the sensor. This not only significantly reduces 
the amount of dye needed compared to dissolved sensors, it also means that there is 
practically no contact between biomaterials and sensor. A layer of the ECM protein 
collagen deposited directly on top of the sensor film was shown to have no discernible 
effect on the oxygen sensing capabilities even after an extended period of incubation. 
Initial test with human cancer cells cultured on the sensor layer demonstrated sensor 
function after several days in culture, thus indicating the potential of in-situ oxygen 
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measurement. Whilst a reduction in relative fluorescence intensity was observed, the 
measured I0/I100 ratio remains adequate to make the system a candidate for use as an 
embedded oxygen sensor layer in cell-culture.
9.2   SUGGESTED FUTURE WORK
As well as the development of the bioreactor device for oxygen control and detection, this 
thesis has introduced the laminar flow-based oxygen transport model and several related 
phenomena. Given an ample source of hepatocytes and the resources to perform 
controlled cell-culture, there are now a number of experiments that could be performed 
based on the developed set-up. 
First and foremost should be the establishment of a source of hepatocytes and the 
corresponding protocols for their extraction, culture and seeding into the bioreactor 
device. This would allow for direct experimental verification of the shear-based oxygen 
transport model using the developed sensor system. By demonstrating spatially resolved 
oxygen measurement inside the bioreactor the groundwork has been laid for the 
demonstration of the effect of chamber geometry on concentration profile. The first test 
should include a direct comparison between the tapered design derived in this thesis and 
a conventional straight bioreactor, as realized in the prototype chip, to ascertain the 
resulting oxygen gradients along the device length. Initial contacts towards the 
procurement of cells from the Otago School of Medicine have been established and 
ethical approval to harvest hepatocytes from rat liver cells has been obtained. 
Furthermore, a dedicated laboratory for the handling of biological samples, such as liver 
cells, has been set up in the Electrical and Computer Engineering Department and is 
currently undergoing certification. Whilst there is some disappointment that the author 
could not undertake these important experiments himself, significant steps have been 
taken along the way and the scope of the work is now more in Biological Sciences than 
Electrical Engineering.
9.2 Suggested Future Work
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The feasibility of seeding cells directly onto the oxygen sensor layer was 
demonstrated to some extent in Section 8.3. However, cancer cells and not hepatocytes 
were used in this example and, although successful, some decrease of sensor sensitivity 
due to the cell cover was observed. 
Two primary areas of further research ensue from this. The first area would cover 
more thorough testing of sensor function with perfused hepatocytes and other attached 
cell lines and in comparison to plain control samples. This should help to determine in 
more detail whether the observed reduction of intensity is due only to the reduced 
diffusion of oxygen through the cell-sensor sandwich or whether there is an optical or 
biological influence of the cells on the sensing mechanism in this configuration. 
The second area relates to the developed sensor and ECM patterning process. Should 
it emerge that seeding certain cells of interest directly onto the sensor does not provide the 
required intensity change and detection sensitivity, cell-adhesion patterning can be 
employed. Several methods of selective localization of cell attachment have been 
published [146-149] and can be used together with the results on collagen patterning in 
Section 8.2 as a starting point to investigate the use of repeating patterns of cell patches 
and sensor stripes. This would result in uncovered PS/PtOEPK sensing areas and could 
alleviate the potential problems observed with the sandwich configuration while still 
providing spatial concentration information. 
From a more general point of view, the sensor patterning process and sensor 
application themselves provide multiple avenues for additional research. For example, 
further reduction in sensor pattern feature size and increase in level of reproducible detail 
could be achieved by using the nanoimprint lithography technique, as described by 
Mohamed et al. [159], for sensor fabrication. The initially soft nature of the freshly 
spin-coated PS/PtOEPK films makes them an ideal candidate for imprinting. Nanoscale 
patterns producible with this technique make it potentially feasible to integrate whole 
arrays of sensor patches underneath a single cell. Also, due to the described improvements 
in the sensor fabrication and integration process, PS/PtOEPK films should be investigated 
for other oxygen visualization applications. One such example could be the demonstration 
of purely diffusive spatial oxygen gradients on-chip based on the novel device recently 
proposed for chemical gradients by Atencia et al. [160].
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Beyond the continuation of system development, device application for cell biology 
studies should be explored further, in particular in context with the introduced 
multi-stream configuration. An excellent starting point for the use of the developed 
system in this area is the previously mentioned ground-breaking work by Takayama et 
al. [143,144] on partial chemical treatment of cells using laminar streams. The work 
presented in Chapter 8 of this thesis allows similar experiments to be performed on 
molecular cell-biology, however, now these can be extended in relation to defined local 
variations in oxygen concentration. An additional enhancement of the parallel stream 
concept would be to demonstrate hydrodynamically-focussed media streams of controlled 
oxygen concentration. These would allow one to even more precisely target single cells 
or maybe even specific areas on a cell surface to determine the influence of oxygen on cell 
function. As work by Yu et al. [161,162] suggests, with increasing use of microfluidic 
devices for cell-culture, understanding inter-cellular signalling and the external factors 
involved in this process becomes more and more important regarding comparison with 
in-vivo observations. Through its capability to virtually compartmentalize areas in the 
bioreactor via the individual streams and control the cross-stream diffusion via the flow 
rate the device provides great potential to study these phenomena.
Of secondary importance, it could be of interest to further develop the fabrication 
process for the vertically tapered bioreactor. In this configuration the resulting 
concentration profile on the bottom chamber surface corresponds directly to the 2D 
analytical model, as opposed to the horizontally tapered designed where the profile has to 
be established via 3D simulation. As mentioned in Section 4.2 and demonstrated by 
Ruffieux et al. [99], a carefully controlled reflow bake of the AZ4562 resist could 
alleviate the surface roughness resulting from the grayscale process. In this context it 
should also be mentioned that an extension of the analytical model to a horizontally 
tapering geometry would be worth investigating.
9.3 Final Comments
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9.3   FINAL COMMENTS
The focus of this thesis has been on the initial development of the prototype system 
rather than its optimisation for use as a BAL bioreactor or scale-up to a clinically relevant 
size. These are major areas that require further study. This is exemplified by the initial 
investigations into a bile drainage system summarized in Section 8.4, which should be 
investigated in more detail. It should be of special interest to investigate the use of the 
novel VACNT films as cell-culture substrate, as it might positively influence hepatocyte 
morphology and formation of bile canaliculi. 
The author is often asked if this device will eventually lead to an implantable liver 
replacement. Although this is unlikely due to the large surface area required to seed the 
necessary number of cells for a full liver replacement, it is still of great interest to continue 
investigations relating to miniaturization and integration for an external device. The 
multi-layer device introduced in Section 4.4, as well as the vision presented in [163] are 
recommended as a good starting points for this.
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Today's scientists have substituted 
mathematics for experiments, and 
they wander off through equation 
after equation, and eventually 
build a structure which has no 
relation to reality.
Nikola Tesla 
1856-1953, Austrian-born American 
Inventor, Mechanical and Electrical Engineer
APPENDIX
A   NONDIMENSIONALISATION OF THE CONCENTRATION CONSER-
VATION EQUATION
The steady-state 2D conservation of concentration equation is given as
. (A.1)
Characteristic scales for mass fraction , length  and velocity  are
. (A.2)
Substitution of Equation (A.2) into Equation (A.1) leads to
, (A.3)
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(A.5)
respectively. Further rearranging and introduction of the Peclet number gives
. (A.6)
B   TRANSFORMATION OF THE CONSERVATION INTO THE O.D.E. 
BY SIMILARITY VARIABLE
The transformation process is shown by David et al. [88] for cylindrical co-ordinates. 
Here it is adopted to the cartesian co-ordinate system of the parallel-plate channel model 
depicted in Figure 3.3. Given the non-dimensionalised conservation Equation (A.6)
(B.1)
and the assumption of a linear velocity profile due to a small ratio of mass transfer 
boundary layer thickness to the viscous boundary layer thickness, a stream function is 
defined as
, (B.2)
where  is the ‘friction’ velocity ( ) defined by
. (B.3)
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Using Equation (B.2) the velocity components can then be written as
; (B.5)
and non-dimensionalised to 
, , (B.6)
by use of 
, (B.7)
where the Reynolds Number  is defined as
. (B.8)
Substituting  into Equation (B.1) leads to 
(B.9)
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. (B.13)
Thus by substitution of Equations (B.11), (B.12) and (B.13) into Equation (B.10) we 
obtain
 . (B.14)
Through variables 
, , , (B.15)
Equation (B.14) can then be transformed from a two-variable equation into a one-variable 
equation
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In terms of the initial variables
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the similarity variable  can now be written as
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C   SOLUTION OF THE O.D.E
The general solution to the ordinary differential equation
(C.1)
is
, (C.2)
with  and  constants to be determined via boundary conditions.
(C.3)
(C.4)
. (C.5)
At the surface oxygen uptake is balanced by diffusive transport of oxygen to the surface. 
Hence the surface flux boundary condition is of the form
(C.6)
, (C.7)
where  is the non-dimensional Damkohler number. Using Equation (C.3) constant  
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. (C.8)
Using Equation (C.2) and Equation (C.8) constant  is found to be
, (C.9)
. (C.10)
The full solution to Equation (C.1) then becomes
. (C.11)
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D   BOUNDARY CONCENTRATION
Using Equation (C.11) and  
, (D.1)
with [89]
. (D.2)
Rearranging leads to the following quadratic function
, (D.3)
where  is
. (D.4)
The solution to Equation (C.11) is found to be [89]
. (D.5)
E   LINEARLY INCREASING SHEAR STRESS AND THE SIMILARITY 
VARIABLE
This calculation is to show that, given a linearly increasing shear stress as in
, (E.1)
where  is a constant, the similarity variable  or  introduced in Equation (3.25)
becomes independent of , i.e. constant. 
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F   SOLUBILITY OF OXYGEN IN AIR-SATURATED WATER
Figure F.1: Nomogram of oxygen solubility in air-saturated freshwater showing the 
example determination of the dissolved O2 concentration in DI water at 37.4ºC, 
760 torr and 0 g/l Cl-. Adapted from [125].
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